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Im Rahmen dieser Diplomarbeit wurde eine, von der individuellen Zelle ausgehende, agen-
tenbasierte Computersimulation des Wachstums eines multizellul aren Tumorsph aroiden
entwickelt. Die theoretische Behandlung des Tumorwachstums ist von groem Interesse,
da ein realistisches Modell dazu dienen kann, Experimente in silico zu simulieren. Dies bi-
etet nicht nur zeitliche und nanzielle Vorteile gegen uber der tats achlichen Durchf uhrung
der Experimente, sondern muss auch von einem ethischen Standpunkt aus bevorzugt wer-
den, da Simulationen Laborversuche an Tieren oder klinische Tests an Probanden teilweise
ersetzen k onnen.
Die Simulationsumgebung, welche als Teil dieser Diplomarbeit entwickelt wurde, ist
in der Programmiersprache C++ erstellt, um durch die verwendung von Objekten und
Klassen eine maximale Erweiterbarkeit im Hinblick auf zuk unftige Untersuchungen zu
gew ahrleisten. Eine starke experimentelle Anbindung ist durch die gitterfreie, kr afte-
basierte Interaktion der Zellagenten gegeben. Die Tumordynamik inklusive Zellbewegung,
Zellzyklus und Diusion von N ahrstoen wurde als Multiskalenproblem erfasst.
Um eine realistische Simulation zu erstellen, muss die Zelle als das zu simulierende
Objekt zuerst abstrahiert werden. Dabei geht es um die realit atsgetreue Abbildung der
biophysikalisch relevanten Eigenschaften einer Zelle auf ein mathematisches Modell. Mech-
anismen der Zelle, die f ur eine realistische Erforschung der Onkogenese im Modell entschei-
dent sind, m ussen im Modellansatz implementiert werden.
In erster N aherung kann eine Zelle als viskoelastische, adh asive Kugel betrachtet werden.
Folgt man dieser Betrachtungsweise so sind etablierte Interaktionsmodelle wie zum Beispiel
das Johnson-Kendall-Roberts Modell anwendbar, um die Wechselwirkung zwischen Zellen
realistisch zu beschreiben. Zur Bestimmung der Zellnachbarschaft wurde eine kinetische
und dynamische Delaunay-Triangulation verwendet, welche es erm oglicht, auf elegante
und eziente Weise die Nachbarschaftsbeziehungen im Gewebe zu erfassen, sowie durch
ihre Dualit at zur Voronoi-Zerlegung Zellvolumina und -kontak
 achen zu berechnen.
Die aus dem Johson-Kendall-Roberst Modell resultierenden Kr afte der Zellinteraktion
wurden in einer  uberd ampften N aherung integriert, wie sie f ur Zellen in dichtem Gewebe
anwendbar ist. Hierzu wurden numerischen Algorithmen f ur die Stabilisierung und ef-
zientere Simulation der entstehenden Zelldynamik entwickelt (lokale und globale adaptive
Zeitschrittweite).
Die Einf uhrung eines Zellzyklus und der dazugeh origen Mechanismen f ur die Zellagenten
erm oglicht die realistische Simulation des Gewebewachstums. Voraussetzung daf ur war,
das die Dynamik der N ahrstoe f ur den Zellmetabolismus erfasst werden konnte. Zur Mod-
iellierung der zugrunde liegenden Reaktions-Diusionssysteme l oslicher N ahrstoe wird der
\alternating-direction implicit"-Algorithmus (ADI) angewandt.
Weiterhin wurde ein fortschrittlicher Algorithmus f ur die Zytokinese in agentenbasierten
Simulationen eingef uhrt, der entscheidende Laufzeitvorteile durch eine realistischere Dy-
namik der Zellen w ahrend der Mitose mit sich bringt. Ein implementiertes Modell f ur
die mechanische Proliferationshemmung infolge eines zu hohen Zelldrucks wurde mit der
Wirkung eines n ahrstobasierten Mechanismus verglichen.
Das Wachstum eines multizellul aren Tumorsph aroiden konnte im Verlauf der Arbeit auf
der Basis von experimentell ermittelten Gr oen f ur die Zellagenten in silico modelliert wer-
den. Dabei wurde ein Vergleich der erzielten Ergebnisse mit experimentellen Resultaten
durchgef uhrt. Sowohl f ur das Problem der Zellsortierung aufgrund dierentieller Adh asion
als auch f ur das avaskul are Tumorwachstum, stimmten die Ergebnisse des Modells mit den
experimentellen Resultaten  uberein.
Erste Simulatioinen der Bestrahlung eines Tumors in silico zeigten Eekte wie z.B. die
Arretierung am G2=M-Kontrollpunkt, die qualitativ wie quantitativ mit experimentellen
Beobachtungen  ubereinstimmen. Als Reaktion der Tumordynamik auf partielle Bestrahlung
des Gewebes wurden verschiedene Ph anomene beobachtet, die f ur weitere Untersuchungen
von Interesse sind. Dazu z ahlen Eekte wie z.B. die Resynchronisierung des Zellzyklus
und ein exzessives Tumorwachstum nach erfolgter Bestrahlung.
Die  Ubereinstimmung der erzielten Ergebnisse zeigt, dass das entwickelte Modell auf die
Simulation von komplexeren Eekten der Tumorbestrahlung mit Schwerionen ausgedehnt
werden kann. Eine angestrebte Nutzung ist die Simulation der Bestrahlungsprozesse
mit dem Ziel, die verwendeten Protokolle zu optimieren und damit die Eektivit at der
Strahlentherapie zu erh ohen.
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ivMotivation:
Cancer and theoretical biology
Cancer is a leading cause of death worldwide. In 20071 the disease accounted for 7.9
million deaths which is around 13% of deaths worldwide and up to 25% in the developed
countries. The lifetime probability of developing cancer for a person in the United States
is as high as 45% for men and 38% for women (for detailed statistics on cancer in the
US see Jemal et al. (2007)). Even if cancer therapy is started early after the onset of the
disease, the statistical survival rate, which depends strongly on the type of cancer, is on
average as low as about 30 percent. Within this statistics a patient is counted as cured
if he survives ve years without a recidivism. Since a lot of recidivisms take place after
more than ve years this denition of healing rates is at most problematic.
It is evident that there is a need for more research in the eld of cancer therapy with
the ultimate goal of improving the healing chances. Despite the recent major advances in
biotechnology and the overwhelming amount of experimental data available, the theoreti-
cal mechanisms which govern the onset and progression of cancer are, to a large extent, still
unknown. There is a necessity to develop theoretical models which are able to integrate
the 
ood of experimental data in oder to make new predictions and optimise treatment
strategies. An interdisciplinary approach is inevitable, since the problem of cancer mod-
elling lies at an intersection between biology, medical science, physics, mathematics and
computer science. This is also where the eld of systems biology emerged during the last
years, combining approaches from dierent areas of science.
A holistic model with spatial resolution on the subcellular level would be able to capture
most of the relevant complex phenomena important for the onset and treatment of cancer.
However, such a simulation is not available at present. Building the rst steps for such a
computer simulation which is able to model the dynamics of the tumour and the eects
of irradiation, taking into account processes at the subcellular level, is the goal of this
thesis. The development will be continued within the interdisciplinary CARADI research
project2. Ultimate goal is a model which is able to relate the deposited radiation dose
to the dynamical eects of partial tumour destruction. Such a model could be used to
optimise treatment planning and investigate the complex mechanisms which determine
the tumour's reaction to radiation.
1http://www.who.int/mediacentre/factsheets/fs297/en/
2http://www.systems-immunology.de/RESEARCH/cancer.html
1Advantages of modelling
Theoretical models open up the possibility to check hypotheses within the framework of a
reference system. This is advantageous since experiments can be done in silico without the
need for laboratory animals or clinical trials, which oers not only nancial and temporal
benets but is also to be preferred from an ethical point of view. However, in order to be
useful a model needs to correspond to reality and have predictive power. This is attainable
through the use of physical model parameters and connection to experimental results.
Models diering in their basic assumptions are used in the eld of tissue modelling to
capture cell dynamics (for a comprehensive overview about the eld see Roose et al. (2007)
or Drasdo (2003)):
Dierential equation models rely on population modelling with ordinary dierential equa-
tions (ODEs) or density modelling with partial dierential equation (PDEs). There-
fore they provide well-established mathematical techniques (see Murray (2002a) for
details), however, they do not allow modelling of small systems (which are at the
root of the cancerogenic process). Furthermore, if ODEs are in use, they suer from
a lack of spatial resolution and the introduction of abstract parameters which can
not be easily veried in experimental systems.
Lattice-based cellular automatons or event models make use of model space discretisa-
tion and xed interaction rules. Cells are assigned each to a lattice cite (as in
Dormann and Deutsch (2002)) or are dened by a boundary of sites (see Graner
and Glazier (1992)). Irregular lattices can be used e.g. static Voronoi tessellations
as in Kansal et al. (2000). An extension is the use of probabilistic instead of deter-
ministic interaction rules. Furthermore it is possible to couple diusion to the lattice
within the hybrid cellular automaton approach (as in Deutsch and Dormann (2003),
Beyer et al. (2002)). Cellular automatons are captivating through the simplicity of
the underlying rules, but this simplicity is also the source of problems such as lacking
of biologically relevant mechanisms. Articial rules and discretisation of the system
space may lead to the development of lattice artefacts.
Continuous, agent-based models are centred around cellular agents, which are designed
to resemble real cells. Cell shape and interaction may be dened according to physi-
cal rules (see Palsson (2001), Dallon and Othmer (2004)) or mediated by potentials
(as in Drasdo (2003)). These models oer a continuous, lattice-free representation
of the system space, and thus may represent the tissue in a realistic fashion. The cell
shape can also be determined by the neighbouring cells within a Voronoi tessellation
(see Meineke et al. (2001) and Schaller and Meyer-Hermann (2005c)). Interactions
may be Newtonian force-based where experimental parameters may be taken from,
or integrated into the simulation, which enables a rich communication between ex-
perimental and theoretical approaches to tissue modelling. Each cell is represented
2individually, which is favourable for tumour-modelling because it can represent the
monoclonal origin of cancer and capture the diversity of a tumour.
The general applicability of agent-based models to tissue simulation has been demon-
strated multiple times, for examples see Schaller and Meyer-Hermann (2005a), and Drasdo
and Hohme (2005). For realistic tissue modelling the agent-based approach seems to be
inevitable. Even though it comes at the price of high computational demands, it oers a
range of benets which are of paramount importance.
Goals of modelling
The goal of this thesis is to build an agent-based, lattice-free simulation-environment for
the modelling of tumour growth and treatment. This environment will include:
cell dynamics within a contact model for cell interactions
intracellular dynamics of the cell cycle and its regulation
reaction-diusion of cell nutrients and pharmaceuticals, immuno-agents or the like
tumour dynamics in the formation of a typical tumour spheroid morphology
irradiation modelling within a minimal model of radiation damage
solved as a multi-scale problem. Due to its lattice free architecture it will be a realistic
continuous modell close to real tissue. The agent-based approach makes modelling from
the rst cell possible, using a Newton-based simple interaction system with no arbitrary
rules. Results of this simulation environment will be comparable to experimental results
from clinical trials and can be checked against simple cell culture experiments for cheap and
ecient improvement of the simulation. The use of experimentally accessible parameters
will thus yield synergy eects between experiment and theory. A major use of model
systems will be to scan the wide landscape of possible experiments with simulations in
order to propose such experiments which are likely to produce highly interesting results.
A modular layout of the application and open programming will ensure the expandability
of the application within the CARADI-project.
The CARADI-project
The project will create a modelling environment enabling researchers to examine the
growth of tumours and their reaction to radiation. Applications could be focussed espe-
cially on the planing and optimisation of clinical treatment. The application will feature
a multi-scale approach considering the intracellular dynamics as well as overall tumour
topology.
3The interdisciplinary CAncer RADIation research project aims at modelling tumour
dynamics under the action of irradiation and response of the immune system and includes
microscopic mechanisms of biomolecule damage induced by ionic radiation. For more
information on this project the reader is referred to http://www.systems-immunology.
de/RESEARCH/cancer.html.
Outline
In order to approach the problem of cancer modelling and treatment simulation, this
thesis will rst take a look at the biology of cancer in chapter 1, where a brief introduction
into the topics of cancerogenesis, tumour growth and treatment of cancer is given. As
a modelling approach for tumour growth has to start from the rst cell on, the basic
properties of the cell and their mathematical treatment are the subjects of chapters 2
and 3. Special attention has to be paid to the implementation of a realistic interaction
model for the cell. An implementation of the cell cycle is developed in chapter 5. Dynamic
numerical problems associated with cell movement are treated in chapter 4 which comprises
the development of an advanced adaptive algorithm which handles the time-integration
of the cell's equation of motion. The implementation of cytokinesis within an agent-
based simulation will be the topic of chapter 6. This will feature the development of a
sophisticated cytokinesis procedure which improves the performance of the model. The
advantages of using triangulations for tissue modelling are introduced in chapter 7. An
overview of the nal developed application, which features all the relevant mechanisms for
modelling, is given in chapter 8.
Within chapter 9 the tissue simulation application developed in this thesis is applied
to model problems such as tissue sorting and the dynamics of avascular tumour growth.
The results obtained are compared to experimental ndings. As cancer therapy with
radiation is of special interst for this thesis, chapter 10 will give a brief introduction into the
mechanisms responsible for the success of tumour therapy with radiation, having its main
focus on heavy ion radiation. A minimal model of how to implement the mechanisms into a
simulation environment is developed and applied to tumour simulations. Eects observed
during the modelling are discussed. Chapter 11 will close the thesis with a subsumption
and discussion of the obtained results. Further mechanisms to be implemented and future
elds of investigation for the model are highlighted.
Thus, overall a circular layout will be used, with cancer being the leitmotif of the
investigation. Starting from cancer the thesis will take a closer look at its origins and the
single cell's properties, eventually returning to cancer modelling and irradiation.
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1.1 Cancerogenesis
The human body is comprised of more than 1014 cells which form a complex network of
interacting tissues. Somatic cells die and are replaced all the time in the homeostasis,
as it is the goal to preserve only the unchanged germ line through reproduction (and
eventually recombination with another germ line). Mutations of a single cell can lead to
an unfavourable rise in proliferative tness which might ultimately be fatal. Once a cell
looses its ability to divide in a controlled fashion, a chain of events might begin which
eventually can lead to cancer.
Multi-mutation theory and the origins of cancer
The multi-mutation theory, also called Knudson hypothesis, is the hypothesis that cancer
is the result of accumulated mutations to a cell's DNA. It was rst proposed by Carl
O. Nordling in 1953, when he noted that in industrialised nations the frequency of cancer
seemed to increase according to the sixth power of age. In 1971 Alfred Knudson formulated
the hypothesis, that this correlation could be explained by assuming that the outbreak of
cancer requires the accumulations of six consecutive mutations. The Knudson hypothesis
led indirectly to the identication of cancer-related genes.
Mutations can occur within the cells DNA due to various mechanisms, which include
spontaneous mutations that occur due to errors in DNA replication and repair, ionising
radiation, chemical agents (deaminating agents, such as Nitrous acid, intercalating agents
such as Ethidium bromide etc.) and other mutagens. However, a healthy cell holds a
multitude of complex mechanism to repair such mutations or commit suicide if these
mutations cannot be repaired.
Oncogenes and tumour suppressor genes
If DNA mutations occur in critical positions, such as genes that regulate the cell growth
and response to extracellular signals, the damage can lead to cancerous growth. In fact,
cancerous cells acquire a combination of the properties shown in gure 1.1.
Denition 1 (Oncogenes and tumour suppressor genes)
Carcinogenesis depends both on the
activation of oncogenes - genes that stimulate cell proliferation - and
deactivation of tumour suppressor genes - genes that keep proliferation in check.
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Figure 1.1: Cancerous cells show common
properties which they acquired through mu-
tation. Not every cancer acquires the full set
of features. Figure taken from Hanahan and
Weinberg (2000).
A rst mutation in an oncogene does not necessarily lead to cancer, as normally function-
ing tumour suppressor genes (TSGs) still counterbalance this impetus. Only additional
damage to TSGs would lead to unchecked proliferation. Conversely, a damaged TSG does
not lead to cancer unless there is an activated oncogene in the cell. TSGs generally follow
a two-hit hypothesis: both recessive alleles that code for a particular gene must be aected
before an eect is manifested. If only one allele for the gene is damaged, the second can
still produce the correct protein. Oncogene alleles in contrast are typically dominant.
Examples include genetically mediated disfunctions of the cyclin dependent kinases
regulating pathways (see for example Hilakivi-Clarke et al. (2004)). It is the aim of ongoing
research to uncover more and more oncogenes and TSGs through genetic screening and
to nally unwind the complex interactions in these regulating gene networks.
Development of a tumour
The chain of events which leads from a single deregulated cell to full scale cancer can be
schematised as follows:
1. Genetic mutation which disables response to cell cycle regulation mechanisms within
one cell (monoclonal origin)
2. Hyperplasia - which is still benign - deregulated cell divides and forms a tumour
which remains small
3. Dysplasia (malignant) where the tumour stops responding to killer-signals and grows
exuberantly
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4. In situ cancer, which is threatening the surrounding tissue but still remains compact
5. Invasion (metastasis) upon which cancerous cells are spread throughout the body
An evolving tumour comprises about 108 cells when it becomes visible on x-ray images, ten
times more before it becomes palpable and typically around 1012 cells when its existence
proves to be fatal for its host organism.
1.2 Tumour growth and typical morphology
The typical morphology of a tumour spheroid develops due to the limited nutrient supply
through diusion into the tumour. Glucose availability, for example, is decreasing with
growing distance to the tumour boundary. Therefore, while cells on the boundary are
well-fed and continue to multiply, cells with greater distance to the boundary are either
growing much slower or are forced to enter quiescence at the restriction point. This eect
gives rise to a quiescent cell core during the early stage of tumour spheroid growth.
During later stages of growth, the depletion of nutrients in the core of the tumour
reaches a level upon which survival becomes impossible for the tumour cells. A necrotic
core starts to develop which leads to in
ammation, attracting immune agents into the
core and leading to the excretion of growth-inhibiting factors. At this stage the nal
morphology of the avascular tumour is present. A core of necrotic cells is surrounded by a
layer of quiescent cells with actively dividing cells at the boundary of the tumour spheroid
(see gure 1.2 for an illustration of the spheroid growth).
Multicellular tumour spheroids (MCTS) are a three dimensional cultures of cancerous
proliferating cells. They are often studied in vitro (see for example Casciari et al. (1988),
Wehrle et al. (2000),Freyer (1998)) or in silico (e.g. Ward and King (1997), Drasdo and
Hohme (2005)) as a model system of avascular tumour growth, due to the fact that they
are simple in their cultivation but at the same time able to capture the relevant processes
at the heart of cancerogenesis (see gure 1.2). MCTS show the distinct tumour topology
which develops as described above. This topology should be reproducible by an agent-
based model as a basis for further developments.
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Figure 1.2: Commonly accepted morphology of a MCTS showing the outer proliferating
region, the intermediate quiescent layer and the necrotic core. These distinct regions form
as the MCTS grows in size. Nutrients can only diuse into the spheroid volume through the
boundary, thus, with growing size, the nutrient concentration inside the tumour decreases.
Upon reaching a critical level cells in the tumour core enter quiescence. This core of
quiescence cells increases in size with the tumour until the available nutrient concentration
in the core drops to a level where cells are dying through necrosis.
Figure 1.3: Histological structure of spheroids from dierently transformed rat embryo broblasts.
Representative 5m-thick median, hematoxylin and eosin-stained paran sections of Rat1 (A) and
M1 (B) aggregates with a diameter of 150{200m, and Rat1-T1 (C) and MR1 (D) spheroids with a
diameter between 1200 and 1300m (sector magnication). Bar size is 100m. Figure and caption
from Kunz-Schughart et al. (2000).
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Tumour angiogenesis / Vascularisation
In the beginning tumours cannot grow beyond a certain size, generally 1   2mm3, due
to a lack of oxygen and other essential nutrients. Therefore tumour growth would be
rather slow or even reaching a saturated state due to nutrient limitation and mechanical
inhibition of cell growth. However, tumours may induce blood vessel growth (angiogenesis)
by secreting various growth factors (e.g. Vascular Endothelial Growth Factor or VEGF)
to ensure a continuous supply of nutrients. Growth factors, such as bFGF and VEGF
can induce capillary growth into the tumour, thereby delivering required nutrients into
quiescent regions and serving as a waste pathway for end products of the rapid division
taking place inside the spheroid.
Angiogenesis is a key step for the transition of a tumour from a small harmless cluster
of cells to full scale cancer. Furthermore, angiogenesis also opens up a pathway for the
spreading of the tumour via metastasis, where single cancer cells can break away from an
established solid tumour, enter blood vessels, and be carried to a distant site, where they
can implant and begin the growth of a secondary tumour.
Mutations inside the tumour
In cancerous cells some of the DNA repair mechanisms are no longer working. If, in
addition, the apoptotic pathway is blocked, mutations rapidly accrue within cancerous
cell populations. These mutations allow the cancer cells to develop drug resistance and
escape various therapy attempts. They also lead to the rise of multiple sub-populations in
one tumour, which may show dierent reactions to pharmaceuticals, further complicating
the treatment. This diversity can be easily captured in an agent-based model.
Hypoxia in tumour tissue
According to the Warburg hypothesis, cancer is a problem of mitochondrial deregulation.
It was postulated by the Nobel laureate Otto Warburg in 1924, when he hypothesised that
cancer is caused by the fact that tumour cells mainly generate energy by non-oxidative
breakdown of glucose. Since this breakdown takes place within the mitochondria, accord-
ing to Warburg, cancer should be interpreted as a mitochondrial dysfunction. Warburg
reported a fundamental dierence between normal and cancerous cells to be the ratio of
glycolysis to respiration; this observation is also known as the Warburg eect.
Today this hypothesis is generally assumed to be wrong. Nevertheless, anaerobic metabolism
might play an important part in tumour growth and its interaction with its environment.
Under hypoxic conditions the only possible solution for the survival of cells is a change
in the metabolism to anaerobic combustion of glucose. However, as discussed in section
5.3, this leads to a production of lactic acids. If large parts of a tumour use anaerobic
glycolysis as part of their metabolism this leads to an acetous court around the tumour
spheroid. Depending on the amount of acid produced and the tolerance of the surrounding
tissue this has a strong impact on the interaction between the tumour and its surrounding.
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1.3 Weapons in the war on cancer
Since cancer is one of the major causes of death worldwide, a wide variety of treatment
methods has been developed so far, including classical methods such as surgery, chemother-
apy, and radiation therapy, but also newer and only partially tested approaches such as
immunotherapy, antibody therapy, bacterial treatments or thermotherapy. The choice of
therapy heavily depends upon the cancer type and grade of the tumour.
Complete removal of the cancer without damage to the rest of the body is the goal of
treatment. In early stages this goal can sometimes be accomplished by surgery. However,
the propensity of cancers to invade adjacent tissue or to spread to distant sites by mi-
croscopic metastasis often limits its eectiveness. In general almost every therapy has its
special eld of application and often comes with distinct drawbacks to it. In many cases
combinations of multiple therapeutical approaches are applied in adjuvant therapy, i.e.
chemotherapy given after surgery, or neoadjuvant therapy.
Due to the high rate of mutations, even within one tumour, it is quite unlikely that a
single cure for cancer can be found - a combination of treatments will probably always
oer the best chances in cancer therapy. This is another reason why continued research
is necessary in the eld of tumour biology. This section provides a brief overview of some
available therapies for cancer.
Surgical treatment
As mentioned in the previous paragraph, cancer is curable if the tumour can be completely
excised by surgery. However, this ideal situation is seldom present in clinical cases. The
tumour boundary tends to get irregular through the invasion of surrounding tissue, making
it hard to determine where to stop the excision. If even small parts of the tumour remain
in the body after surgery, they may spread again rapidly and lead to tumour recurrence.
Cells which were previously quiescent due to insucient nutrient supply may restart to
proliferate. Therefore a removed surgical specimen has to be examined thoroughly in
order to make sure that the tumour has been removed with a thin layer of healthy tissue
surrounding it. Surgery is quite often used in combination with chemo- or radiation-
therapy (before or after surgery) greatly increasing the chances of eliminating the cancer.
Another problem arises with inoperable tumours. If the tumour is surrounded by deli-
cate tissue, as it is common with brain tumours as the glioblastoma multiforme, surgical
therapy becomes completely impossible. Surgical excision of metastasised cancers is usu-
ally also not possible. Surgery is often used in order to determine the extent of the tumour
and check if metastasis to regional lymph nodes has happened. Based on this staging a
prognosis can be generated and the need for adjuvant therapies determined.
101 Biology of cancer
Radiation therapy
Radiation has a long history of medical applications and has been in use as a cancer
treatment for about 100 years. Early experiments were done soon after discovery of x-rays
by Wilhelm R ontgen in 1895. Upon the discovery of the radioactive elements polonium
and radium followed their use in medical treatment and research. Later on radiation from
linear accelerators has been used in medical applications (since the late 1940s) because of
their penetrating energies and lack of physical radiation sources.
A basic distinction has to be made between methods where radioactive substances are
brought into the body (brachytherapy) and radiation therapy as the medical use of ionising
radiation (external beam therapy). The former is mainly used to treat localised prostate
cancer, cervical cancer, and cancers of the head and neck, where a sealed radioactive source
is placed inside or next to the area requiring treatment. The latter one may be used for
curative, adjuvant or palliative cancer treatment (where cure is not possible and the aim
is local disease control or symptomatic relief).
Development of imaging technologies such as computed tomography (CT), magnetic res-
onance imaging (MRI) in the 1970s and positron emission tomography (PET) in the 1980s
made eective 3D treatment planing and eective monitoring of dose delivery possible.
The latest advances were the usage of heavy ion radiation for treatment and the dose de-
livery in scanning procedures such as IMRT and IGRT. As a result of these advancements
the treatment outcomes are improving steadily as side eects are decreasing.
As simulation of radiation therapy is a main target of this thesis, the topic is discussed
in detail in section 10.
Chemotherapy
Chemotherapeutic treatment of cancer makes use of cytotoxic drugs which aect rapidly
dividing cells in general. Most chemotherapeutic drugs disturb cell division for example by
preventing cell division or chromosome alignment. As the majority of cells in the human
body is in quiescent state, this treatment aects mostly the cancerous growing cells, but
unfortunately also all healthy tissue that shows a high replacement rate, such as hair
follicles or the intestinal lining. Since repair capacities of healthy cells are usually superior
to cancerous cells, parts of the damaged healthy cells can regenerate after chemotherapy.
While usually aecting all cells, some chemotherapeutic agents can show a certain degree
of specicity by targeting the inability of many cancer cells to repair DNA damage.
It is common practice to combine multiple drugs in a treatment to make use of synergetic
eects (known as combination chemotherapy).
Virotherapy
Virotherapy makes use of \reprogrammed" viruses, such as the herpes simplex or aden-
oviruses, to attack cancerous cells, only leaving healthy cells undamaged. As early as the
1950's doctors were noticing that cancer patients who suered a non-related viral infection,
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or who had been vaccinated recently, showed signs of improvement. This phenomenon has
been attributed to the production of interferon and tumour necrosis factors in response to
viral infection. Nowadays oncolytic viruses are being designed that selectively target and
lyse cancerous cells only.
Vaccination and cell-mediated immunity
Using the immune system of a patient itself to eliminate a tumour is the target of cancer
immunotherapy. Vaccines that generate a specic immune response to cancerous cells
through cell-mediated immunity are the target of research today (see e.g. Knuth et al.
(2000) for details). Allogeneic hematopoietic stem cell transplantation (commonly referred
to as \bone marrow transplantation" from a genetically non-identical donor) also can be
considered to be immunotherapy. Immune cells of the donor will often attack the tumour in
a phenomenon known as graft-versus-tumour eect. For this reason, allogeneic HSCT leads
to a higher cure rate than autologous transplantation for several cancer types, although
the side eects are also more severe.
Other treatment strategies
New treatment methods and strategies for cancer are under development all the time,
from the delivery of nanoparticles (see Koo et al. (2006)), either as a vector for drugs or
for treatment with heating due to radiation, to new combinations of existing treatment
methods. Thermotherapy exploits the sensibility of tumour tissue to temperature and tries
to heat or cool the tumour volume. Targeted therapy makes use of inhibitors for mutated,
overexpressed or otherwise critical proteins within the cancer cell and relies strongly on
the knowledge of detailed genetic mechanisms. Angiogenesis inhibitors are another group
of promising drugs which can help to keep cancer in check through the inhibition of blood
vessel formation in the tumour.
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2.1 Basic characteristics of cells
A single cell is the building brick for complex multicellular organisms, but it is also a
extremely complex object in itself. Each cell is self-contained and self-maintaining in
the sense that it can convert nutrients into energy, carry out specialised functions, and
reproduce as necessary. Its own building plan is stored in each cell's DNA.
All cells have several dierent abilities in common:
Cell division as reproductive mechanism which is realised by binary ssion in prokaryotes
and mitosis or meiosis in eukaryotes.
Protein synthesis wherein proteins coded for by the cells DNA are built.
Metabolism by which nutrients are taken up, energy is extracted and used to build cell
components.
Stimuli response by which cells can respond to internal and external stimuli, like growth
factors, acidity changes and so forth.
Two basic types of cells have to be distinguished, namely eukaryotic and prokaryotic
cells. Eukaryotes are about 10 times the size of a typical prokaryote and contain membrane-
bound compartments in which specic metabolic activities take place. The cell nucleus,
which stores the cells DNA aligned in linear chromosomes, associated with histone pro-
teins, is the most important among these. Note that some eukaryotic organelles, such as
mitochondria, also contain small amounts of DNA called mitochondrial DNA (mtDNA).
Material is moved between these compartments by regulated trac and transport of small
spheres of membrane-bound material called vesicles. While prokaryotic cells are usually
independent, eukaryotic cells are often found in multicellular organisms. Therefore only
the latter ones are of interest for the modelling of multicellular tumour spheroids.
Cell membrane and interaction
A realistic model for tumour growth must start at the single cell1 and its mechanical prop-
erties. Each cell is surrounded by a cell or plasma membrane dening the cell boundary.
This membrane separates the cell interior from the surrounding exterior. It is comprised
of a double layer of hydrophobic lipids and hydrophilic phosphorus molecules. Therefore,
1If not stated otherwise "cell\ refers to eukaryotic cells throughout this thesis for reasons of simplicity.
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the membrane is called a phospholipid bilayer. A variety of dierent functional proteins
are embedded in the membrane (see gure 2.1(b)):
Channels and pumps which regulate the exchange of substances between the cell interior
and exterior by passive or active transport.
Cell adhesion molecules (CAMs) which mediate the binding to the extracellular matrix
(ECM) and other cells.
Receptor proteins enable the cell to detect external signal molecules (e.g. hormones).
For an isolated cell a spherical shape arises through hydrostatic pressure and cell surface
tension (Lecuit and Lenne (2007)). However, the cell shape is largely governed by the
cytoskeleton, which acts as the cells scaold. The cell shape can thus actively change
with its help. The cytoskeleton consists of microlaments, intermediate laments and
microtubules (see gure 2.1(a)). It is also responsible for xing cell organelles in place,
cytokinesis and the separation of daughter cells, as well as growth and motility in general.
Dierential adhesion between cells
Cell Adhesion Molecules (CAMs) are proteins located on the cell surface which are involved
in the binding with other cells or the extracellular matrix. They play an important role in
mediating dierential cell adhesion (see gure 2.1). CAMs are transmembrane receptors
composed of:
 an intracellular domain that interacts with the cytoskeleton (anchor)
 a transmembrane domain
 an extracellular domain which either binds homophilically to other CAMs of the
same kind or heterophilically with other CAMs or the extracellular matrix (adhesion
protein)
CAMs can be subdivided into four protein families: cadherins, integrins, immunoglobulin
superfamily CAMs (IgSF CAMs) and selectins. Cadherins are transmembrane adhesion
proteins which depend on calcium ions. They are responsible for cell adhesion in cadherin-
based adherens junctions, where they are linked with actin laments. Integrins act as
surface receptors in signal transduction and as adhesion molecules. Selectins are trans-
membrane proteins which bind to sugar polymers. IgSF CAMs are a family of diverse
adhesion molecules which are structurally similar to antibodies (Ig).
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(a)
(b)
Figure 2.1: (a) Endothelial cells under the microscope. Nuclei are stained blue with DAPI,
microtubules are marked green by an antibody bound to FITC and actin laments are labelled
red with phalloidin bound to TRITC. Bovine pulmonary artery endothelial cells are used. (b)
Schematic view of the cell membrane depicting its composition and important parts. Figure (a) is
in public domain under terms 1, gure (b) under term 2.
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Figure 2.2: Mechanisms of cell adhesion. Most cell adhesion molecules (CAMs) are transmem-
brane proteins linking to the cytoskeleton of a cell in the intracellular space at the cytoskeleton
anchor. Their extracellular domain might bind to other adhesion molecules or signalling molecules
depending on the CAMs function. Picture in open domain.
The Extracellular matrix
The extracellular matrix (ECM) is a ubiquitous extracellular part of animal tissue (espe-
cially in connective tissue) which provides the cell with structural support and anchorage,
segregating tissues from one another and regulating intercellular communication.
The extracellular matrix includes the interstitial matrix, which is present in the inter-
cellular spaces between various cells and the basement membrane. The interstitial space
is lled with gels of polysaccharides and brous proteins which act as a compression buer
against stress placed on the ECM. Basement membranes are sheet-like depositions of ECM
on which various epithelial cells rest.
Cells are anchored in the ECM through the use of their CAM molecules (Iozzo (1998)).
Especially the integrins bind cells to ECM structures, such as bronectin and laminin, and
to integrin proteins on the surface of other cells.
The ECM is of paramount importance for the cell's dynamic behaviour. It may dis-
sociate cellular growth factors and may act as a depot for them. These local depots can
be released upon trigger events such as grave changes in physiological conditions and are
thus important for the regulation of processes like growth, wound healing and brosis.
In order for a tumour to invade surrounding tissue, it has to decompose the extracellular
matrix using dierent enzymes (e.g. serine and threonine proteases). This mechanism is
also important for tumour metastasis. For a detailed description, the reader is referred to
the standard textbooks of the eld, such as Cotran and Robbins (1994).
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The DNA
The deoxyribonucleic acid (DNA) of a cell holds the information necessary for its develop-
ment and functioning. It consists of two long nucleotide polymers with supporting back-
bones of ester bound sugars and phosphate groups. The DNA strands are anti-parallel,
as they run in opposite direction to each other, both coding the same information. The
nucleotides attached to each sugar are either adenine (abbreviated A), cytosine (C), gua-
nine (G) or thymine (T). Hydrogen bonds between these bases stabilise the DNA and the
genetic code is stored within the base sequence. The eukaryotic DNA is organised in one
or more linear molecules, called chromosomes, which are associated with histone proteins.
All chromosomal DNA is stored in the cell nucleus, separated from the cytoplasm by a
membrane.
The DNA codes the building plan for the cell itself as well as for all the proteins it will
produce. This plan is translated in protein biosynthesis to produce functional proteins
from amino acids. One strand of the DNA is used to obtain a template called messenger
RNA (mRNA) in the process of transcription. Translation of this template occurs in the
ribosomes of the cytoplasm. Their subunits surround the transcribed mRNA. According
to its plan and the rules inherent in the genetic code, polypeptides are built using the
sequence of the mRNA as a template to guide the synthesis of a chain of amino acids that
eventually forms a protein.
Further details
Due to the complexity of the cell the introduction of all its beautiful mechanisms is beyond
the scope of this thesis. A comprehensive but not at all exhaustive overview can be found
in Alberts et al..
2.2 Agent-based representation of a cell in C++
Within a simulation a detailed representation of a cell as an object is needed. In order
to create a theoretical modelling framework of cell populations, the governing attributes
of a cell have to be realistically abstracted into a mathematical model, which has to be
as simple as possible in order to remain computationally feasible (see table 2.2). Using
the object oriented programming language C++ a simple approach for the representation
of a cell is the denition of a cell-class, which provides variables and functions that
may be used by every instance of that class. Each cell is spawned by the constructor
function of this class and is thereafter existent as an individual object. Each cell object is
characterised by a state vector dening all cell attributes which are of importance to the
simulation.
Dening properties of a cellular agent which are included in this state vector are for
example:
172 The cell and its in silico implementation
Cell mechanism Implementation type Comment
elasticity mechanistic Hertz/JKR contact model
adhesion mechanistic JKR contact
CAM mechanistic adhesion term
pressure mechanistic pressure force
stimuli response mechanistic active motility responding to gradient
ECM eective frictional coecient
protein synthesis eective cell biomass conversion and growth
DNA eective damage model
receptor proteins not implemented signalling only through diusion
channels and pumps not implemented nutrients distributed through diusion only
Table 2.1: Important cellular mechanisms and their type of implementation within this simulation.
Mechanistic implementations rely on a realistic force based model for mechanism. Cell mechanisms
implemented eectively are abstracted and simplied during their inclusion. The function of im-
portant unimplemented mechanisms is taken over by other implemented mechanisms.
mechanical parameters such as size, Poisson's ratio and CAM concentration on the mem-
brane
internal parameters e.g. cycle phase, phase duration, DNA content
Functional properties of the cell, such as the cell cycle or replication, have to be imple-
mented as member functions of the cell-class. This functions change the properties of
the cell and its surrounding accordingly to observed mechanisms (e.g. mitosis, adhesion
to neighbours). A full overview of the implementation developed in this thesis is given in
section 8.
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3.1 Cell interaction methods
Although much more complicated in real life, from a physicists point of view a cell can be
abstracted to be an elastic, adhesive sphere. These abstracted cellular agents can grow,
multiply (proliferate), and die (through necrosis or apoptosis). They may eventually
aggregate to form a regulated tissue or cease to respond to regulatory signals and start to
grow exuberantly, eventually forming a tumour.
A rst step will be to deal with the interaction of two cellular agents. There are multiple
ways for cells in a tissue to interact. Each of them may be modelled within a simulation
to obtain realistic results. Possible interactions include:
 repulsive forces through Hertzian contact force
 adhesive forces through CAM-adhesion
 shear forces from moving neighbour cells
 repulsive pressure from cell indentation (hydrostatic pressure)
Complex phenomena like mechanical proliferation inhibition emerge from the interaction
of these basic principles. Considering the simple cell model of elastic spheres, the aim is to
nd a realistic contact model which can be used in order to model the cellular interactions.
It has been shown (see Chu et al. (2005) and Schaller and Meyer-Hermann (2005a)) that
the Johnson-Kendall-Roberts model is a possible choice to calculate the cell interactions
within the necessary parameter regime.
3.2 Abstraction of the cell interaction
The Hertz model
If two curved surfaces get into contact they are subject to localised stresses that develop
due to the slight deformation under the imposed load. Heinrich Rudolf Hertz rst studied
these stresses and published his work on the topic in Hertz (1882). This stress is known
as Hertzian contact stress and it is usually described with respect to the positions xi;xj
of contacting spheres of dierent radii ri and rj. The amount of deformation and the
rising repulsive hertzian contact force Fhertz
ij depends on the elastic modulus E and the
193 Cell shape and interaction
Figure 3.1: Shape of two free cells and of two cells in contact as seen under the microscope
(a+b) and schematically (d+e). Cell shape resulting from a mixture of tension (mediated by
the actomyosin network (f)) and adhesion (through E-cadherin on the cell membrane (g)). (c)
shows the arrangement of cells in a dense tissue which resembles polyhedra as found in a Voronoi
tessellation. Figure from Lecuit and Lenne (2007).
Poisson ratio  of the material. With ^ eij =
xj xi
kxj xik dening the normal of the contact
plane between the two spheres and
hij = ri + rj   kxj   xik (3.1)
dening the penetration depths of the spheres, the Hertz force is given by the following
expression:
F Hertz
ij (xi;xj) = E
ij
q
r
ij h
3=2
ij ^ eij: (3.2)
The eective elasticity E
ij and the eective radius r
ij used in equation 3.2 are determined
by the elastic constants Ei;Ej, the Poisson ratios i;j and the radii of the spheres ri;rj
as follows:
1
E
ij
=
3
4
"
1   2
i
Ei
+
1   2
j
Ej
#
(3.3)
1
r
ij
=
1
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+
1
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(3.4)
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Figure 3.2: The Hertz model for
elastic interactions. The defor-
mation of two elastic spheres pen-
etrating each other by a distance
h is shown. In comparison the
deformation in the presence of
adhesion (JKR model) is shown.
The contact plane indicated by
the dashed line corresponds to
the plane where the common face
of the corresponding Voronoi cells
of the two spheres is located. Fig-
ure from Beyer (2007).
Adding adhesion { derivation of the JKR model
The Hertz model may account only for the repulsive forces in cell interaction. Since cells are
sticky through the expression of adhesion molecules on their surface, an additional adhesive
term is needed to capture cell interaction. This leads to the model of Johnson, Kendall
and Roberts (JKR) who showed in Johnson et al. (1971) that the eective contact radius
aij between two spheres will be enlarged if adhesive forces are present (see gure 3.2).
The adhesive contribution to the force between the spheres is given by
Fadh
ij =  
q
6ijE
ijr
ij
3=2h
3=2
ij (3.5)
and depends on the surface energy . The eective elasticity E
ij and eective radius r
ij
are equal to the ones dened for the Hertz model in equation 3.3.
A linear combination of the purely repulsive Hertz model (Landau and Lifshitz (1959))
and the adhesive contribution from equation 3.5 yields the JKR contact force:
Equation 1 (Johnson-Kendall-Roberts-force)
F JKR
ij (xi;xj)  fE
ij
q
r
ij h
3=2
ij  
q
6ijE
ijr
ij
3=2h
3=2
ij g^ eij (3.6)
FJKR
ij is positive (repulsive) for large virtual overlaps, and negative (attractive) for small
virtual overlaps hij (see gure 3.2 on page 24). Objects interacting according to the JKR
model therefore tend to stay in an equilibrium distance for which the resulting force on
the interaction partners is zero (as depicted in 3.3). This equilibrium distance depends on
the radius of the object and is given in table 3.2 for cellular objects of dierent radii.
The load-displacement relationship given by equation 3.6 is an approximation follow-
ing Schaller (2006) which is valid in the used parameter regime. Johnson et al. (1971)
contains a denition for the JKR contact surface which is not easily transformed into a
representation based on the penetration depth hij without ambiguities.
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Figure 3.3: Visualisation of two spheres
under JKR interaction in equilibrium dis-
tance. Pulling the cells further apart
would result in FJKR
ij to be attractive as
the adhesive contribution is dominating.
Further pushing of the cells together re-
sults in strong repulsive JKR force.
method cell type viscosity [Pas] elasticity [Pa] forces f [nN] remarks
magnetic bead mi-
crorheometer
3T3 broblasts 2000   4000 G = 2   4  104 2 no strain
hardening
below 2 nN
magnetic tweez-
ers, displacement
eld
J774 macrophages 210  143 G = 20   735 no strain
hardening
pressure plates chicken embryonic 104   105 G = 100   1000
micropipette as-
piration, atomic
force microscope
erythrocytes 14-27
poking with glass
needles
REF 52 broblasts 70 response is
local
pulling cells S180 + dextran E = 3500  1500 JKR theory
valid
Table 3.1: The results of dierent methods for measuring mechanical properties of cells. Elastici-
ties are given as shear modulus G or Young's modulus E. Forces are either typical forces generated
by cells or force applied to cells during experiment. Measurements from Bausch et al. (1998) (line
1 and 2), Forgacs et al. (1998), Hategan et al. (2003), Heidemann et al. (1999), and Chu et al.
(2005). Compiled in Beyer (2007).
Realistic parameters for the JKR model
A advantage of the JKR model lies within the fact that it uses experimentally accessible
parameters. Techniques like the atomic force microscope (AFM) or scanning force micro-
scope (SFM) reach resolutions of fractions of a nanometer and are at the same time widely
available and thus open up the possibility to probe these parameters. Recent advances
include sophisticated methods such as scanning probes and eld gradient traps (like op-
tical tweezers) which can be used to examine mechanical parameters of living cells (see
Zhang and Liu (2008), Neto et al. (2006), and Homan et al. (2006)). Through these
techniques it is possible to measure single cell parameters like the elastic modulus, the
Poisson ratio or the rupture force for a cell membrane (see table 3.2 for examples). Using
an individual and force based model with JKR interaction for the cellular agents these
measured parameters may be integrated (see Chu et al. (2005)).
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cell type initial size (start of G1)
[m]
nal size (end of G2)
[m]
JKR equilibrium dis-
tance [m]
small cell 4.76 6.0 7.32
medium cell 7.94 10.0 13.28
large cell 11.11 14.0 19.3
huge cell 15.87 20.0 28.6
Table 3.2: Example values for cell sizes and the resulting cell equilibrium distance in the JKR
model. Parameters for JKR interaction are  = 0:5; E = 1nN=m 2;  = 0:1nN=m 1.
Numerical evaluation of the JKR interaction
To obtain the JKR forces for the interacting system of cells, equation 3.6 was implemented
in the get forces()-function of the Cell-class. In order to ensure the correctness of the
implementation, the output of the function was compared to the analytical solution.
Implementation of dierential adhesion
To include dierential adhesion strength in the model, cell agents show a distinct concen-
tration of receptors crec and ligands clig on their surface and are thus able to show dierent
binding energies depending on their concentration of CAM:
Equation 2 (Dierential adhesion through CAMs)
Fadh
ij = Aijadh1
2
(crec
i c
lig
j + c
lig
i crec
j ) (3.7)
This force component can be added to the interaction force yielded by the JKR interaction.
In this simplied approach the receptor and ligand concentration is assumed to be equal
across the whole cell surface. The concentrations ci;cj can well be time-dependent e.g.
according to the cell cycle.
An alternative way to include dierential adhesion is to alter the JKR parameters e.g.
the surface energy term to depend on the cell type of the interaction partners.
Other models for cell interaction
A variety of models exist for the calculation of cell interactions which take into account
viscoelastic and nonlinear mechanical properties found in cells or make use of the tensegrity
model (see for example Bausch et al. (1999), Forgacs et al. (1998), and Canadas et al.
(2002)). A comprehensive overview of current models can be found in Schaller and Meyer-
Hermann (2005a). See also the works of Drasdo et al. (1995), Palsson (2001), Meineke
et al. (2001). While these models might be more sophisticated than the JKR interaction
model, for a large simulation the employed contact model must be as realistic as possible
at a given computational cost. High resolution and complex mechanisms for a single
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Figure 3.4: Analytical solution of the JKR force for dierent parameters. The solid black line
depicts the JKR force in nN for cell of 10m size and the parameter set typically used within this
thesis ( = 0:5; E = 1nN=m 2;  = 0:1nN=m 1). Deviating parameters for blue  = 0:75,
red E = 2nN=m 2, and green  = 0:2nN=m 1 curve. The JKR force is strongly repulsive
for large overlaps (unphysiological regime) and attractive for a range of small overlaps. Resulting
force is approximately linear for small de
ections from the equilibrium position (between 16 and
18m). Contact between the cells is lost at a centre to centre distance of double the cell's size.
cell encompassed in a too sophisticated model render computation of complex tissues
impossible, due to the huge number of simulation agents.
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4.1 Biological cell movement
Tissue gains its stability from the anchoring of its cells through CAMs, which form in-
terconnections between adjacent cells and the extracellular matrix (ECM). Nevertheless,
cells are highly motile objects and can move through this dense network by methods such
as ECM-cleaving and the formation of protrusions.
The ability of a cell to move spontaneously and actively is called motility. This active
movement usually requires the consumption of energy by the organism. Motility often
refers to directed cell movement down gradients of which prominent examples include
chemical gradients (chemotaxis) or gradients of cell adhesion sites (haptotaxis). Cells may
have a dened time during which they can keep an orientation when following a gradient
(often called polarisation time) and move actively in a distinct direction for prolonged
periods of time until they repolarise.
A comprehensive introduction into the mechanisms of cell movement can be found in
Fletcher and Theriot (2004).
Active cell movement will play a minor role when modelling multicellular tumour spheroid
formation as the dominating component of cell movement will be passive cell movement
through mitotic pressure and cell growth.
4.2 Integration of the cells equation of motion
Cell interaction with the JKR model yields forces in the range of nN depending on cell
distance, physiological parameters and cell radius. Summation of these forces on a cell
results in a total force which leads to passive cell movement. If cell cycle dynamics are
disabled, this leads to a cool-down of the tissue into an equilibrium (see gure 9.2 on page
82).
The basic scheme to implement cell movement is to calculate the total interaction force
for all cells in discrete timesteps, obtain a cell displacement for the current force determined
by an adaptive timestep and then displace the cells simultaneously. Nearly motionless and
very fast cells may be update asynchronously to improve the computational performance
of the simulation. The nite steps result in an approximate solution of the cell movement,
which is applicable as long as the allowed stepsize for the algorithm remains small.
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Using an overdamped approach
In the previous section it was mentioned that cells are integrated into the ECM. This
anchoring and binding to other cells results in an eectively dense medium of high viscosity.
Modelling all the cell-ECM-interactions would be impossible for a large scale simulation
of tumour dynamics, therefore the eects of the ECM are integrated into the simulation
via a friction term in the cells equation of motion. A partial model of the dierential
interaction of cells with the ECM can easily be integrated by changing the viscosity of the
medium in dependence of the integrin concentration on the cells surface.
Stokes friction can be used to calculate the friction of a cell



i = 6Ri (4.1)
A cell's velocity decay is then given by the expression
v(t) = v0 exp

 
6r
m
t

: (4.2)
If we assume movement of a cell with radius r = 5m and an initial velocity of v0 =
1ms 1 within water of viscosity  = 10 2P we can easily calculate a stopping distance
using equation 4.2. This distance is mv0
6r  10 11m = 0:01nm, which shows the extreme
velocity decay. Taking into account that the eective viscosity of a dense tissue is much
higher than that of water and the fact that cells are additionally bound in the ECM
via there CAMs, it is obvious that neglecting accelerations does not impose an error on
the simulation. Similar arguments for the soundness of the overdamped approach can be
found in Dallon and Othmer (2004), Schaller and Meyer-Hermann (2005a) and Beyer and
Meyer-Hermann (2007).
The cell's equation of motion
We obtain the Newtonian equation of motion for the cells by summing up all the forces
which act on a cell i:
F i(t) = mi xi(t) = F act
i (t) + F
fric
i (t) +
X
j2Nc
F inter
ij (xi(t);xj(t)): (4.3)
This includes active cell movement forces F act
i i.e. from chemotactic movement, cell-
ECM-friction F
fric
i and interaction forces with the cells neighbours in contact F inter
ij .
Using Stokes friction for the cells and inserting expressions for the force components one
obtains
mi xi(t) = F act
i (t)   
 _ xi(t) +
X
j2Nc
fF JKR
ij (xi(t);xj(t)) (4.4)
+F CAM
ij (xi(t);xj(t)) + F
pre
ij (xi(t);xj(t)) + F
drag
ij (xi(t);xj(t))g: (4.5)
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With F JKR
ij being the JKR force between neighbouring cells and F CAM
ij the appropriate
adhesion force mediated by the cell's CAM molecules. The pressure force F
pre
ij (xi(t);xj(t)),
which rises between neighbouring cells is implemented in the application but not used dur-
ing most simulation runs. Other force components which can be included in a straightfor-
ward manner comprise cell drag forces F
drag
ij (xi(t);xj(t)).
Assuming movement of the cell in a dense medium, the overdamped approach as intro-
duced in the previous passage can be used to neglect acceleration:
 x(t)  0 (4.6)
Combining equation 4.3 (omitting seldom used force components for reasons of clarity)
and 4.6 yields the equation of motion:
0  mi xi(t) = F act
i (t)   
 _ xi(t) +
X
j2Nc
fF JKR
ij (xi(t);xj(t)) + F CAM
ij (xi(t);xj(t))g (4.7)
This can be rewritten to obtain the cells velocity from the equation
Equation 3 (Cell's equation of motion)
_ xi(t) =
1


fF act
i (t) +
X
j2Nc
fF JKR
ij (xi(t);xj(t)) + F CAM
ij (xi(t);xj(t))gg (4.8)
Equation 4.8 is evaluated for every cell in every timestep of the simulation. The resulting
velocity is stored in the cell object.
Integration of object dynamics
The cell's velocity according to equation 4.8 has to be integrated in order to propagate
the dynamics of the system correctly. In this process, the displacement that would result
from movement with the given velocity for a given timespan is approximated with the
help of an integration scheme. Here the forward Euler algorithm is the method of choice.
Named after Leonhard Euler, the Euler algorithm is a rst order numerical procedure for
solving ordinary dierential equations (ODEs) with a given initial value. It is the most
basic kind of explicit method for numerical integration for ordinary dierential equations,
but preferable in this application for reasons that will be obvious shortly.
The idea is that while the trajectory of the cell is initially unknown, its starting point,
which we denote by x0, is known. This starting point corresponds to the initial cell position
within the simulation. Then, from the dierential equation, the slope to the trajectory
at x0 can be computed, which corresponds to the cells velocity given by equation 4.8.
Now the system is propagated for a small step along that tangent line up to a point x1.
If we assume that the timestep t was small enough, x1 will approximately be still on
the initial curve. This scheme can be repeated and after several steps, a polygonal curve
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x0x1x2x3 ::: is computed. If the timestep is small enough, this curve does not diverge too
much from the original unknown trajectory, and the error between the two can be made
arbitrarily small. It is possible to approximate the solution of the initial value problem
x0(t) = f(t;x(t)); x(t0) = x0; (4.9)
by using the rst two terms of the Taylor expansion of x, which represents the linear
approximation around the point (t0;x(t0)). This point is our cell's initial position. One
step of the Euler method from tn to tn+1 = tn + t is
xn+1 = xn + tf(tn;xn): (4.10)
which gives the approximate new position of the cell in the simulation. This straight-
forward approximation of the forward Euler method is applicable since the simulation
timestep is small. At the same time, the choice of this simple algorithm is motivated by
the inherent complexity of the problem which is to be simulated. An iterative algorithm
of higher order like Runge-Kutta can be implemented easily but introduces the need for
intermediate points at which the dynamics have to be evaluated. This involves recompu-
tation of the systems triangulation, which renders higher order algorithms inecient. An
algorithm of second order results in an eective bisection of the simulation timestep, since
intermediate steps are not known to the simulation. Implicit schemes for the solution of
the system are not applicable since an inverse of the regular triangulation is not accessible.
4.3 Determination of the integration timestep
As mentioned in the introduction to the Euler algorithm, the choice of the stepsize is of
paramount importance for the validity of the numerical approximation. If the stepsize is
too big, the system will diverge from its analytical solution. An overly small stepsize, on
the other hand, must be avoided in order to keep the system computable. An obvious
choice for the timestep t is a solution which results in a maximum displacement that
is still small compared to the simulation object. Thus for cell objects this maximum
displacement x may be made dependent on the cell radius x = 0:1Rcell. This choice
is also preferable because this is exactly the region in which the JKR interaction yields a
highly realistic model for the cell interaction (see Chu et al. (2005)).
Global adaptive stepsize
In order to make a system of agents moving with dierent speeds computable, an adaptive
timestep is necessary to ensure that agents are only allowed to move within a realistic
velocity frame, as discussed above. A robust approach to this is the variable timestep t
used to propagate the system. This timestep depends on the velocity of the fastest object
in the system and is chosen such, that the propagation of the fastest object at the given
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timestep does not exceed the allowed movement threshold:
Denition 2 (Global adaptive timestep)
t =
x
vmax
(4.11)
This relation is referred to as global adaptive timestep from now on. By this method the
dynamics of the system can be integrated in a robust manner (see gure 4.1). However this
method comes at the high price of enormous computational demands, since the timestep
for the whole system is dened by the fastest agents.
Local adaptive stepsize
Single cells can speed up due to numerical inaccuracy or unfavourable congurations. This
is especially the case in regions with high mitotic activity. A cell may be aected by mul-
tiple neighbours whose interaction forces add up in a way that yields an unphysiologically
high cell velocity. So, in a model with a global adaptive timestep, few articially fast cells
determine the stepsize for the whole system. Thus, even cells which could be propagated
with greater timesteps without the risk of numerical errors are moved with a small step-
size. A much more favourable simulation scaling could be achieved if the high resolution
would only be applied where it is needed. This is the goal of a local adaptive stepsize
algorithm. Since the articial velocity of fast cellsis up to two orders of magnitude higher
than the velocity of the slow cells in the system (see gure 9.1 for details), an adiabatic
approach is applicable. In this case, the global adaptive stepsize algorithm (as in 4.11) is
used to determine a propagation timestep which is not adapted to the fastest cell in the
simulation, but to the average velocity of cells times a multiplicative scaling factor fave:
Denition 3 (Local adaptive stepsize)
t =
x
vavefave
(4.12)
Due to the nature of the velocity spectrum, which shows only few mavericks, this approach
results in the vast majority of cells being treated with a timestep as large as possible (in
order to still stay below the spatial resolution x). The few fast cells which lie above vave
are treated asynchronously with a smaller timestep before the whole system is evolved.
Their velocity is recalculated for their new position repeatedly, taking into account their
virtual displacement until the full propagation timestep of the whole system is reached
(see gure 4.2). Typical total displacements resulting from this algorithm are of the same
magnitude as the spatial resolution x, but may be cut if adaptive movement would
exceed x. As the velocity of articially fast cells is orders of magnitude higher than the
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(a) Simulation of two cells separating due to JKR interaction with global adaptive
timesteps.
(b) Simulation of two cells under JKR interaction. Red colouring corre-
sponds to higher cell velocities.
Figure 4.1: (a): Simulation of two cells with dierent initial distances separating due to JKR
interaction. Cells move into the JKR equilibrium distance, where the resulting force between them
is zero. Note the markers which show the global adaptive timestep algorithm at work, limiting the
displacement to dxmax = 0:25m per timestep. Therefore in regions with higher slope the marker
density is increased on the same curve corresponding to a smaller timestep. (b): Simulation of two
cells under JKR interaction starting at normalised distance of  = d=2rcell = 0:99 (rst contact
- corresponding to the upmost curve in the left gure). Red colouring corresponds to higher cell
velocities. Timesteps of 90 s starting in the upper left corner at t = 0 and  = 0:99 until equilibrium
is reached at   0:7 (bottom right).
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Figure 4.2: Basic concept of the local adaptive
treatment for cells. If the cell velocity exceeds the
vavefave-threshold it is not propagated to the ac-
cording position (indicated by the dashed arrow)
but instead displaced multiple times according
to the global maximum displacement x. Sur-
rounding cells are assumed to be static in an adi-
abatic approximation.
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Figure 4.3: Typical velocity prole of a multicellular tumour spheroid in simulation. Compare
gure 9.1 for the velocity distribution throughout a tumour spheroid. Note that few fast mavericks
exceed the typical cell velocities by orders of magnitude. The average cell velocity is used as
threshold for the local adaptive treatment. It can be shifted as described in equation 4.12 with
help of the factor fave.
average velocity of cells, it can be assumed that their surrounding does not change during
their asynchronous treatment.
The application of a local adaptive stepsize algorithm as described in equation 4.12
results in a great increase in simulation performance, as shown in gure 4.4.
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(a) Algorithmic simulation eciency without local
adaptive treatment.
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(b) Algorithmic simulation eciency including local
adaptive treatment.
Figure 4.4: Local adaptive treatment of the fastest cell agents results in an tenfold decrease in
computational time for a typical setup. Number of global adaptive timesteps needed to advance
the simulation for one default timestep in purple, total runtime in orange. Note the decrease in the
number of iterations right from the start in b). Even large cell numbers with numerical unfavourable
cell interactions do not increase the computational eort in run b) signicantly compared to a).
See gure 4.5 for statistics of this simulation run.
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(a) Simulation statistics without local adaptive
treatment.
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(b) Simulation statistics including local adaptive
treatment.
Figure 4.5: With local adaptive treatment a decrease of the default timestep is only necessary
for faster cell agents. Although the top cell velocities are similar to run a) note the much higher
adaptive timestep used to propagate the majority of cell agents when local adaptive treatment is
used in run b). This results in a tenfold decrease of simulation runtime, as shown in 4.4.
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Figure 5.1: The cell cycle: microtubules stained blue, genetic material in purple. From www.cbp.
pitt.edu/faculty/yong_wan/
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(a) (b)
Figure 5.2: (a) The cell cycle in vivo: microtubules stained green, genetic material in blue. From
www.cbp.pitt.edu/faculty/yong_wan/. (b) Schematic visualisation of the cell cycle phases.
5.1 The life and death of a cell
During its lifespan a cell undergoes multiple repetitions of a characteristic cycle of distinct
functional phases known as the cell cycle. The rst three of these phases are subsumed
under the name of interphase, in which the cell prepares itself for the initiation of cell
division. Tthe fourth phase, in the active part of the cycle, is the mitotic phase, in which
the mother cell divides into two daughter cells, which begin the cell cycle anew. A fth
phase exists in which fully dierentiated cells, senescent cells or cells in unfavourable
environments reside. This phase is characterised by inactive behaviour in respect of the
cell cycle.
The cell cycle
G1 Phase
Gap/growth phase 1 or short G1 is characterised by high biosynthetic activities of the
cell. Cells grow in size in response to mitogenic signals, such as soluble extracellular
growth factors. Thy synthesis of various enzymes which are required in the S phase is
performed. Protein kinases (PKCs), enzymes which catalyse the addition of phosphate
to other proteins (phosphorylation), are activated. The cyclin dependent kinases (CDKs)
are a group of such protein kinases whose activity is central to this process (see section
5.1).
The rst group of cyclins to become activated are the D-type cyclins, which bind and
activate CDK4 or CDK6. The active cyclin D/CDK4-6 enzyme phosphorylates Rb, the
retinoblastoma protein, which impedes its ability to bind and inactivate transcription
factors. These factors, such as E2F-1, when released from Rb, bind to the promoter
regions of specic genes, resulting in increased RNA transcription.
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The duration of G1 may vary on a large scale (more details on the cell cycle control can
be found in Morgan (2007)).
The Restriction Point
At the end of G1 cells have to pass the regulative tests at the so-called restriction point,
where the decision is made on whether the cell should continue in the cell cycle or pause in
G0. Due to its importance for growth regulation, the mechanisms of the restriction point
are treated in full detail in the next section.
S-Phase
During synthesis phase (or short S phase) the DNA stored in the chromosomes is exactly
replicated through the activity of a family of enzymes including the DNA polymerases.
When all of the chromosomes have been replicated, each chromosome has two identical
sister chromatids. Thus, during this phase, the amount of DNA in the cell is eectively
doubled, though the ploidy of the cell remains the same. Except for the histone production
the rates of RNA transcription and protein synthesis are very low during this phase. The
duration of S phase is relatively constant among cells of the same species.
S phase can easily be distinguished from other phases by the ability of the cell to stably
incorporate 
uorescently or radioactively tagged nucleotides, the building blocks of DNA,
into their chromosomes. To activate the replication machinery cells depend on the protein
kinase activity cyclin A coupled to CDK1 and CDK2.
G2 Phase
After verifying the exact copy of the genetic information, the cell enters the gap/growth
phase 2 or short G2, which lasts until the cell enters mitosis. Activity of the mechanisms
responsible for protein synthesis rises again during this phase. Especially microtubule-
synthesis plays an important role in the preparation for mitosis. Inhibition of protein
synthesis during G2 phase prevents the cell from undergoing mitosis.
CDK1 (a.k.a. cdc2) replaces CDK2 as the predominant cyclin and it couples with either
Cyclin A or one of the B-type cyclins to catalyse the phosphorylation of proteins specic
to the G2 and M phases of the cell cycle.
G2 checkpoint
The G2 checkpoint initiates or prohibits the entry into mitosis, depending mainly on the
Mitosis Promoting Factor, MPF.
Mitosis
Mitosis (or short M phase) is the phase of the cell cycle in which cells leave the preparing
interphase and eventually divide physically into two separate daughter cells.
The mitotic phase itself is usually subdivided in four distinct phases, namely prophase,
metaphase, anaphase, and telophase. Since this further distinction is of no importance
for this thesis and could well be the topic of a whole series of books itself, this division is
neglected here.
The relatively short M phase consists of two functional processes: nuclear division
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(karyokinesis) and cytoplasmic division (cytokinesis). During karyokinesis the doubled
information stored in the DNA is equally divided in two parts, one for each daughter
cell. In order to do so, rst the nuclear membrane is dissolved (which later reforms, once
cell division is complete). The chromosomes condense into compact structures and are
then aligned in the future plane of separation called the metaphase plate. Microtubules
splay out from opposite ends of the cell, attach themselves to the chromosomes kineto-
chores (amphitelic attachment) and shorten, pulling apart the sister chromatids of each
chromosome such that each half of the cell gets exactly one copy of the DNA. A new nu-
clear envelope forms around the separated sister chromosomes. Although there are control
mechanisms which prohibit further advance through mitosis upon attachment or separa-
tion errors, syntelic attachment (when microtubules from the same pole bind to both sister
kinetochores) occurs { especially in cancerous cells { which results in one daughter cell
inheriting multiple copies of a chromosome (aneuploidy).
At the completion of mitosis, cells undergo cytokinesis, or separation into two halves.
Actin and Myosin-II form a band around the cell waist and generate local tension. This
band gradually constricts like a belt until the cell pinches in two.
The B-type cyclins remain active throughout M-phase, but their activity immediately
ceases once cell division is complete and the two daughter cells once again enter G1.
Quiescence (G0 Phase)
Post-mitotic cells reside in a phase called G0, which includes both quiescent and senescent
cells. These cells are non-proliferative and may remain quiescent for long periods of time,
possibly indenitely. In fact most cells in an adult body are in quiescence, neurons and
skeletal muscle cells even being in a terminally dierentiated G0 state. However, most of
the cells in G0 can reenter the cell cycle if the right conditions are met (mitogenic signals
available, nutrient supply sucient etc.). Cells which do not receive mitogenic signals in
G1 may enter G0 due to CDK inhibition. Cellular senescence leading to G0 can occur in
response to severe DNA damage or degradation, and is sometimes used as an alternative
to self-destruction of such a damaged cell by apoptosis.
The metabolic demands of G0 phase vary according to the specialised functions be-
ing carried out by the quiescent cell, but there is often lower levels of gene expression,
macromolecular biosynthesis and energy consumption compared to actively dividing cells.
Regulation of the cell cycle through growth factors and CDKCs
In healthy tissue the cell transitions sequentially through the cycle phases in response to
regulatory signals and growth factors. These are specic proteins which are capable of
stimulating proliferation and dierentiation in a distinct type of tissue. Commonly known
families of growth factors include
FGF (Fibroblast Growth Factor) promoting angiogenesis, wound healing, and embryonic
development
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(a) (b)
Figure 5.3: (a) Cdk 2 (blue) and the complex of Cdk 2 (red) and Cyclin A (purple) ((b)). The
active centre and the associated ATP-molecule are shown in white. The loops of Cdk 2 which
move furthest when binding Cyclin A are stained in colour (green for inactive, yellow for active)
showing the eect of the conformation change upon binding on the active centre of Cdk 2. Image
source http://www.molekuelkueche.de/img/molecularModeling/Cdk2_CycA(inactive).jpg
VEGF (Vascular Endothelial Growth Factor) promotes blood vessel dierentiation in vas-
culogenesis and angiogenesis
EGF (Epidermal growth factor) important for regulation of cell growth, proliferation,
and dierentiation - increases cancer risk (see Herbst (2004))
Diusion of growth factors in the system can be included in the simulation through mod-
elling their concentration on a diusion grid. Molecular networks can couple these growth
factors to the cell cycle progression.
Another source of regulating signals was discovered only recently. In 2001 the Nobel
Prize in Physiology or Medicine was awarded jointly to Leland Hartwell, Tim Hunt and
Paul Nurse for their discoveries of "key regulators of the cell cycle\. Using genetic and
biochemical methods, they identied the molecules CDK and cyclin that control the cell
cycle in eukaryotic organisms. The CDKs (cyclin dependent kinases) bear their name
because their activity requires binding to a protein partner, a cyclin, whose levels of
expression and activity vary depending on the phase of the cell cycle (see gure 5.3 for the
structure of CDK2 during binding). The bound CDK and cyclin form a cyclin-dependent
kinase complex (CDKC) which phosphorylates other compounds under consumption of
ATP. CDKC function depends on the type of cyclin attached to CDK, therefore the cell
cycle progression can be regulated by the type of cyclin present (see gure 5.4).
Cell cycle checkpoints mediated through CDKs
Cell cycle checkpoints are control mechanisms that ensure the delity of cell division in
eukaryotic cells. These checkpoints verify whether the processes at each phase of the cell
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(a) (b)
Figure 5.4: (a) CDK and cyclin are key molecules that control and coordinate DNA-synthesis,
chromosome separation and cell division. CDK and cyclin together drive the cell from one cell
cycle phase to the next. (b) Cyclin type and amount vary throughout the cell cycle.
cycle have been accurately completed before progression into the next phase. Progression
is typically prevented through negative signalling and, if necessary, repairs are initiated
(e.g. in the case of DNA damage)
Several checkpoints are designed to ensure that damaged or incomplete DNA is not
passed on to daughter cells. Two main checkpoints exist: the G1/S checkpoint and the
G2/M checkpoint. The G1/S transition is a rate-limiting step in the cell cycle and is also
known as restriction point.
The well known transcription factor p53 (also known as protein 53 or tumour protein
53) plays an important role in triggering the control mechanisms at both G1/S and G2/M
checkpoints (see Agarwal et al. (1995) and Taylor et al. (1999)).
An important function of many checkpoints is to assess DNA damage, which is detected
by sensor mechanisms. When damage is found, the checkpoint uses a signal mechanism
to either stall the cell cycle until repairs are made or to target the cell for destruction via
apoptosis. The same sensor-signal-eector mechanism seems to be in use for all assessment
of DNA damage, which makes damage to these mechanisms highly carcinogenic.
G1/S Checkpoint (Restriction point)
Located at the end of the cell cycle's G1 phase, the restriction point marks the key de-
cision whether the cell should divide, delay division, or enter a resting stage. Most cells
stop at this stage and enter quiescence e.g. due to unfavourable environmental conditions.
The restriction point is mainly controlled by action of the CKI-p16. This protein inhibits
the CDK4/6 and ensures that it can no longer interact with cyclin D1 to cause the cell
cycle progression. In growth induced or oncogenic induced cyclin D expression, this check-
point is overcome because the increased expression of cyclin D allows its interaction with
CDK4/6 by competing for binding. Once active CDK4/6-cyclin D complexes form, they
phosphorylate the tumour suppressor retinoblastoma (Rb) and this relieves the inhibition
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of the transcription factor E2F. E2F is then able to cause expression of cyclin E, which
interacts with CDK2 to allow for G1-S phase transition. Therefore, reentry into the cell
cycle can be achieved by growth factor induced expression of cyclin D proteins.
The existence of a restriction point can be demonstrated by depriving cells from growth
factors in their medium. Many types of cells will continue to complete a single cell cycle
if they are in S-phase, G2 or Mitosis, but will then arrest in the next G1 phase.
G2/M Checkpoint
The second checkpoint is located at the end of G2 phase, triggering the start of the M
phase (mitosis). In order for this checkpoint to be passed, the cell has to check a number
of factors to ensure the cell is ready for mitosis. The CDKs associated with this checkpoint
are activated through phosphorylation by the action of a Maturation promoting factor (or
Mitosis Promoting Factor, MPF).
The molecular nature of this checkpoint involves an activating phosphatase, known
as Cdc25, which under favourable conditions removes the inhibitory phosphates present
within the MPF complex. If the DNA is damaged prior to mitosis, the cell cycle is arrested
via inactivation of the Cdc25 phosphatase to prevent transmission of damage to daughter
cells.
Anaphase Checkpoint
The mitotic spindle checkpoint occurs at the point in metaphase where all the chromosomes
should have aligned at the mitotic plate and be under bipolar tension. The tension created
by this bipolar attachment is what is detected and what initiates the anaphase entry.
Degradation of cyclin B ensures it no longer inhibits the anaphase promoting complex,
which in turn is now free to break down securin.
Telomere shortening and cell mortality
A single cell can divide a number of times up to the Hay
ick limit, after which the cells
telomere reaches a critical length. Human cells in a cell culture divide about 52 times before
entering a senescence phase (entering G0). During each mitosis the telomere appendix on
the DNA is shortened in the replication process, acting as a kind of inner clock for the
cell. This limited division capability protects the organism from cancerogenesis as the
possibility for a cell to acquire the necessary mutations for uncontrolled growth is limited
with its active lifespan. Since the telomere is essential for safe DNA replication, sending
the cell into senescence upon reaching a critical length is also a protective mechanism
against genomic instability.
Many stem cells, as they are undierentiated, are not aected by the Hay
ick limit.
They exist in every tissue and may continue reproducing for the lifespan of the organism,
thus replenishing the pool of \mortal", fully dierentiated cells. Cells which divide without
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Figure 5.5: CDK and cyclin regulate the progression through the cell cycle.
limit usually express the telomerase enzyme or use other mechanisms to lengthen their
telomere. These methods are also used by cancer cells to divide uninhibited.
Death of a cell - Necrosis vs. Apoptosis
As cells inside a multicellular organism exist in a social fabric it is inevitable for them
to provide a mechanism for self-destruction to be used if they threaten the welfare of the
tissue. This mechanism is called apoptosis and is of great use to eliminate a cell which is no
longer capable of dividing safely e.g. due to severe DNA damage. It is important to note
that apoptosis needs a distinct enzymatic pathway, which is often disabled in malignant
cells due to oncogenreferredic mutations. Extreme environmental conditions or damage
of the apoptotic pathway may lead to cells dying without any regulation. This process
is called necrosis and is hazardous for the complete tissue through in
ammatory eects.
Both processes are described in detail in the following sections.
Apoptosis as programmed cell death (PCD)
Apoptosis is often also referred to as the \physiological death of the cell". It is the regulated
mechanism used by the body to dismantle unneeded cells. Apoptosis means \falling o"
in Greek, and this name holds true since it is the cellular suicide commando. In general,
apoptosis is associated with benets for the whole organism. Prominent examples include
the sculpting of digits by apoptosis of cells between the digits during early ontogenesis
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Figure 5.6: An apoptotic cell breaking away
into apoptotic bodies which are phagocytised
by a macrophage. Picture in public domain by
the US National Library of Medicine.
and the renewal of the bone marrow and intestine (which kills billions of cells by apoptosis
in a healthy adult in every hour). Furthermore, cell death helps to regulate cell numbers
and maintain homeostasis, as a counterweight to cell division. The mode of apoptosis
ensures a secure recycling of the dying cell's parts. Two important examples of the direct
initiation of apoptotic mechanisms in mammals include the TNF-induced (tumour necrosis
factor) model and the Fas-Fas ligand-mediated model, both involving receptors of the TNF
receptor (TNFR) family coupled to extrinsic signals.
The process of apoptosis can be subdivided into several characteristic steps:
 breakdown of the proteinaceous cytoskeleton by caspases; cell shrinkage and round-
ing
 chromatin condensation into compact patches (pyknosis)
 nuclear envelope discontinuities and DNA fragmentation (karyorrhexis)
 high levels of endonuclease activity, degradation of DNA
 irregular buds (blebs) in the cell membrane
 cell breaking apart into vesicles called apoptotic bodies
 phagocytosis of apoptotic bodies by immune agents (depicted in gure 5.6)
A main application of apoptosis are cells which are damaged beyond repair, infected
with a virus, or undergoing stress conditions such as starvation. Safe elimination of those
cells is of importance for the whole tissue.
Therefore, apoptosis plays a prominent role in cancerogenesis: if a cell is unable to
undergo apoptosis, due to mutation or biochemical inhibition, it can start to divide exces-
sively and develop into a tumour. For example, the infection with papillomaviruses causes
a viral gene to interfere with the cell's p53 protein of the apoptotic pathway. This inter-
ference in the apoptotic capability of the cell plays a critical role in the development of
cervical cancer. For more details on the interplay between apoptosis, cancer development
and treatment response see Brown and Attardi (2005).
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Pathological death of cells: Necrosis
Necrosis occurs when cells die of extreme changes in the physiological conditions. It
is, therefore, also referred to as \unnatural death" of cells and living tissue. It can be
induced by a variety of external factors, such as thermal changes (extreme heat or cold
or fast temperature 
uctuations), chemical factors (lack of oxygen or existence of toxic
substances), infection with lytic viruses or activation of the complement system.
In total, necrosis has no advantage for the organism as the uncontrolled release of
intracellular content after plasma membrane rupture is the cause of in
ammations. Lysic
enzymes released by this rupture start to degrade neighbouring cells which can lead to
further necrotic deaths. In addition, the cleanup of cell debris by phagocytes is dicult,
as the disorderly death generally does not send cell signals which tell nearby phagocytes
to engulf the dying cell. This lack of signalling makes it harder for the immune system
to locate and recycle dead cells which have died through necrosis than those that have
undergone apoptosis. Necrosis follows a typical scheme:
 cell swelling due to loss of the selective action of the plasma membrane and osmotic
in
ow
 chromatin digestion
 disruption of the plasma membrane and organelle membranes
 DNA hydrolysis, organelle breakdown
 cell lysis
Necrosis plays an important role in the development of tumour spheroids (Bell et al.
(2001)) and necrotic waste materials might have a strong eect on the surrounding tissue
by inducing apoptosis, calling immune agents to the site or other mechanisms. This can
be modelled by keeping track of toxic necrose waste products on a separate diusion grid
within a simulation.
Stem cells and the maintenance of homeostasis
Tissues in multicellular organisms are always on a ne line between exuberant growth
and extinction. They must maintain a viable cell count in order to fulll their duties.
Maintenance of homeostasis is therefore a property of living organisms, regulating their
internal environment so as to maintain a stable, constant condition. In a tissue this
translates into keeping a nearly constant number of cells by balancing cell division and
cell death.
Most cells in an organism cease to divide after they are terminally dierentiated. De-
pending on the type of tissue they may:
 go into permanent quiescence (e.g. neurons)
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 reenter the cell cycle under certain conditions (e.g. liver cells)
 stay active almost all the time (e.g. intestine)
In healthy tissue the cell population is replenished by stem cell division (symmetric or
asymmetric (see Dingli et al. (2007) and Huntly and Gilliland (2005))). At the same time
homeostasis is maintained with the help of apoptosis.
5.2 Implementation of the cell cycle for simulation agents
In order to capture the behaviour of cells in a simulation, the mechanisms of the cell
cycle as described in the previous sections were implemented in a cell-class within this
thesis. The basis for this is the agent-based representation of cells (see section 2.2) within
an object-oriented programming language such as C++. This section will introduce the
chosen implementation.
Insertion of cells at simulation start
Basic information about each cell is stored within its state vector. This vector of variables
contains information such as the current cycle phase and the remaining phase length (see
also section 8.1 on page 73). Member functions of the cell handle the regulation of the
cell cycle progress. phase length At the initialisation of a simulation run, a predetermined
number of cells is inserted. Inserted cells can be marked as malign or benign and inser-
tion is done using a Monte Carlo algorithm to obtain a chosen conguration (spherical
e.g. malign cells surrounded by benign ones, mixed or pointwise). Upon instantiation cell
agents are assigned a random phase (G1, S or G2), a random phaselength is drawn from
a given distribution (e.g. Gaussian around a typical phaselength with given width) and
an according size is calculated (initial size plus already performed growth). Simulations
starting with few malignant cells will show an oscillating behaviour with respect to the
overall cell cycle phases of cells since progression will be synchronised to large extents
depending on the chosen parameters for the phaselength distribution. However, this oscil-
lation is damped due to the partial randomisation of phaselenghts and other eects such
as cell cycle arrest in G0. Synchronisation is completely lost after a few cell cycles (as can
be seen in gure 9.9).
Important cell cycle control functions
The cycle of each cell agent is controlled by the
void check_phase ( double& dtass, Triangulator<double,Cell>& tri )
function. It handles all of the cell's internal event triggering, growth and shrinking. Fur-
thermore, it checks if the available nutrient concentration has fallen below the critical limit
for cell necrosis. The remaining phaselength of a cell agent is decreased according to the
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Figure 5.7: Sketch of the cell cycle as implemented in the simulation.
passed timestep dtass. If the remaining phaselength reaches zero, check_phase initiates
a phase transition handled by the void update_phase-function.
update_phase includes all the cell cycle checkpoints described in the previous sec-
tion. At the G1=S-transition the nutrient availability is checked on the diusion grids
Soluble<double> DIFF_GLUCOSE and Soluble<double> DIFF_OXYGEN. The cell can be
sent into quiescence if a minimum nutrient threshold is not reached. Apart from the nu-
trient check, at the restriction point update_phase performs a check of the pressure on
the cellular agent mediated by its neighbours, via the check_mechanical_inhibition
function. If this pressure exceeds the threshold, cell cycle progression is delayed and the
cell is sent into quiescence. All checkpoints can be disabled if i.e. entry into quiescence
should only be possible by high pressure on a cell and not mediated by nutrient conditions.
If all checks done by update_phase are positive, the cell is advanced into the next cycle
phase, changing its internal variables and drawing a new phaselength from the distribution
via the set_phaselength function. So far no external growth signals are processed and
the molecular network around the CDK4/6 inhibition is not taken into account directly for
reasons of simplicity. However modelling the cyclin interaction is possible once a molecular
network is coupled to the update_phase function.
S phase is characterised by the replication of the DNA. This is mainly an internal process
of the cell without impact on the tissue. DNA replication can be marked as incorrect with
a certain probability, forcing the cell to prolong S phase or go into quiescence until repairs
were successful. As DNA replication is a highly accurate process this mechanism is not
used by default.
In G2 the cell grows to reach its nal size for mitosis. The G2=M-transition is accom-
panied by a DNA damage checkpoint. If the cell is marked as damaged (e.g. by the
irradiate function) repairs are initiated that succeed with a dened probability. Upon
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success of the DNA repair the cell enters mitosis. If repairs are unsuccessful, the cell stays
in G2 phase attempting further repairs. Upon failure of a determined number of repair
attempts, the cell is sent into senescence or apoptosis if possible. If the cells DNA was not
damaged at the G2=M checkpoint the cell enters mitosis immediately. Until now Cdc25
dynamics and the Mitosis Promoting Factor, MPF are not taken into account directly.
This is feasible in the same way as for the G1=S checkpoint, through the coupling of a
molecular network to the cell. The MPF activates the CDK in response to environmental
conditions being right for the cell, and allows the cell to begin DNA replication.
Upon initiation of mitosis the update_phase function calls the proliferate function
to handle cytokinesis. Karyokinesis is taken to be an fully internal process of the cell.
However, an anaphase checkpoint can be inserted, halting the progression through mitosis
in the beginning due to an attachment error of the chromosomes with a dened probability.
Quiescence of a cell in G0 is associated with a predetermined phaselength decreased by
the check_phase function. At zero phaselength the update_phase functions checks for
nutrient availability and cell pressure. If both checks are positive the cell is re-entered into
the cycle exactly where it was sent into G0, but if one of the checks is negative quiescence
is prolonged. Cells which have been 
agged as senescent due to irreparable DNA-damage
or terminal dierentiation stay in G0 for unlimited time.
Necrosis is determined by a given phaselength during which the cell will shrink con-
stantly (handled by the check_phase function) and eventually be deleted from the simu-
lation. Toxic or hazardous products of necrosis can be modelled on the
Soluble<double> DIFF_NECROSIS diusion grid such as lysic enzymes. If their concen-
tration is above a certain concentration threshold, neighbouring cells can be aected.
Sample cycle
always nutrients checked and necrosis initiated if below necrosis threshold
G1 phase growth with constant rate
G1/S checkpoint nutrient check for G0 threshold; pressure check
G2 phase growth with constant rate
G2/M checkpoint DNA damage check; stall and repair or send into senescence if all
repair tries failed
Necrosis and apoptosis
Cells undergoing necrosis within the tumour volume are removed from the cell cycle.
They are shrinked to a predened end radius over the duration of the necrosis phaselength
N. After the expiration of their phaselenght they are removed from the simulation. It
is assumed, that the necrotic debris of cells is removed through the decomposition by
immuno-agents and diusion. Eects of toxic substances or other chemicals produced
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by cell necrosis, which might aect other cells, can be examined through modelling of
their diusing according to section 5.4. Due to the fact that the apoptotic pathway is
commonly disabled in cancerous cells, apoptosis is generally not used within the simulation.
Implementation is done similar to necrosis with the dierence of a faster cell removal
(through the activity of phagocytes) and the apoptotic cell acting as a minor nutrient
source for the time of its degradation.
5.3 Consumption of nutrients
Cell respiration and metabolism
Each cell takes up nutrients in order to convert their biochemical energy into adenosine
triphosphate (ATP) within the process of cellular respiration. The energy stored in ATP
can then be used to drive processes requiring energy, including biosynthesis, locomotion
or transportation of molecules across cell membranes.
Under normal conditions cells mainly generate energy from oxidative breakdown of
pyruvate. Pyruvate is an end-product of glycolysis, and is oxidised within the mitochondria
(see gure 5.8 for an comprehensive overview of the metabolic reactions involved). This
process is called aerobic respiration and can be summarised in the simplied reaction:
Equation 4 (Aerobic cell respiration)
C6H12O6 + 6O2  ! 6CO2 + 6H2O + E (5.1)
Hc =  2880kJ (5.2)
Through glycolysis and the Citric acid cycle (CAC), glucose is oxidised to CO2 and wa-
ter, yielding energy in the form of ATP. Aerobic respiration requires oxygen in order to
generate energy (ATP) because pyruvate needs to be fully oxidised (Krebs cycle) in the
mitochondria.
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Figure 5.8: Cellular respiration including glycolysis, Krebs cycle, citric acid cycle, and the
electron transport chain. From http://upload.wikimedia.org/wikipedia/commons/7/74/
CellRespiration.svg under terms 3.
Under unfavourable oxygen conditions pyruvate is not metabolised by cellular respi-
ration, but undergoes a process of substrate phosphorylation. This is a fast but rather
inecient process.
Equation 5 (Anaerobic cell respiration)
C6H12O6  ! 2C3H6O3 + E (5.3)
Hc =  120kJ (5.4)
In this anaerobic respiration, pyruvate is not transported into the mitochondrion but
fermented in the cytoplasm. A common waste product of this process is lactic acid in
muscle cells. Alcohol produced in yeast fermentation is also produced within this process
(ethanol fermentation).
As the aerobic metabolism is about 19 times more ecient than anaerobic metabolism
(compare equations 5.2 and 5.4), it is the preferred metabolic activity in eukaryotic cells.
However, tumour cells may show deviations to this behaviour as a reaction to the anaerobic
conditions usually found inside a tumour spheroid.
It is clear that tumour cells may use anaerobic respiration to survive inside hypoxic
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cycle phase oxygen consumption rate [amol/s] glucose consumption rate [amol/s]
G0 15 75
G1 20 95
S 18 85
G2 20 95
M 18 85
N 0 0
A -5 -20
overall rate 205 9510
Table 5.1: Cell cycle dependent nutrient consumption rates used in the simulation. As no data
about the cell cycle dependency of these rates was available in the literature they are set by an
educated guess to resemble the commonly reported level of biomolecule synthesis. Consumption
rates are assumed to be negative for apoptotic cells since apoptotic bodies can be recycled. Basis
for the estimation of the cycle dependent rates is an overall rate investigated in Casciari et al.
(1992), Kunz-Schughart et al. (2000), and Wehrle et al. (2000).
conditions. This leads to the generation of lactic acid which surrounds the tumour with
an acidic court.
Cell cycle dependent nutrient consumption
The nutrient consumption of a cell varies throughout the cell cycle phase. Quiescent cells
tend to show lower levels of gene expression, macromolecular biosynthesis and therefore
energy consumption compared to actively dividing cells. To capture this behaviour in the
simulation, cells show a certain nutrient consumption rate according to their cycle phase
as shown in table 5.1. As no data about the cell cycle dependency of these rates was
available in the literature, they are set by educated guessing to resemble the commonly
reported level of biomolecule synthesis. Furthermore, nutrient uptake rates depend on
other parameters such as the nutrient availability itself and even the tumour spheroid
size (see Freyer and Sutherland (1985) for evidence on a reduction in the rates of oxygen
and glucose consumption of cells in EMT6/Ro spheroids during growth). However, these
further mechanisms are not included in the implementation yet. The nutrient consumption
rate of the cell is distributed to the nodes of the diusion grid surrounding the cell position
via trilinear interpolation by the add rate()-function. The rates are cleared using the
clear lattice rate()-function and updated in constant intervals to capture the changing
cell positions and phases.
5.4 Nutrient modelling with reaction diusion equations
Nutrient distribution inside the simulation volume can be modelled with the help of re-
action diusion equations (RDEs). Each diusing substance (e.g. glucose and oxygen) is
modelled on a separate reaction diusion grid through the solution of partial dierential
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equations (PDE). The numerical representation of the PDEs solution is discrete in both
time and space within a nite-dierences approach.
Typical reaction-diusion equations will be of the form:
Equation 6 (Reaction-diusion equation)
@u
@t
= r[D(x;t)ru(x;t)] + Q(x;t); (5.5)
with u(x;t) being the local concentration of a soluble,
D(x;t) the local diusion coecient and
Q(x;t) as reaction term (source or sink for the soluble under consideration).
Complex diusion cases might be treated with a vectorial diusion coecient D(x;t).
However, in the cases to be solved within this thesis, scalar diusion is sucient.
There exists a range of applicable solvers for this type of reaction diusion dynamics,
which can be divided into implicit and explicit methods. Here the alternating-direction im-
plicit algorithm (ADI) according to Press et al. (1994) is applied, where each propagation
timestep is divided into several sub-steps and, during each sub-step, a single dimension is
treated implicitly while the others are treated explicitly.
Spatial discretisation
Within the nite-dierence approach, the spatial discretisation of equation 5.5 can be
performed by dividing the system into disjoint volume elements Vi. Within these volume
elements, one locally denes spatially averaged quantities by
ui(t) =
1
Vi
Z
Vi
u(x;t)dx (5.6)
The spatial derivatives occurring in the diusion equation 5.5 can then be transformed
into nite dierences according to:
Denition 4 (Spatial discretisation)
@u(x;t)
@x

 

@Vi\@Vi0
!
ui0(t)   ui(t)
jxi0   xij
xi0   xi
jxi0   xij
; (5.7)
where xi denotes centres of the volume element Vi.
Time discretisation
The reaction-diusion equation 5.5 has to be discretised in time as well as space in order
to be suitable for the application of a numerical solving algorithm. This can be achieved
via
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Figure 5.9: Finite dierence ap-
proach: for spatial discretisation
the computational domain is divided
into disjoint volume elements VI as
described in equation 5.7. Intro-
ducing also a time discretisation ac-
cording to equation 5.8 results in
a fully discretised reaction-diusion
equation which can be solved by nu-
merical algorithms.
Denition 5 (Time discretisation)
@uI
@t
!
un+1
I   un
I
t
; (5.8)
with un+1
I = un
I(t + t) and uI = uI(t),
where for rectangular lattices in three dimensions the index I = fi;j;kg is a triple of
indices, each one denoting the spatial position in one dimension. This denition of the
time discretisation is symmetric around t + t=2.
Solution of the RDE
If the reaction volumes VI are constant in time (@VI
@t = 0), one can average equation (5.5)
as described in equation (5.6). Using Gauss's theorem:
Z
V
rF d(n)V =
I
S
F  n d(n 1)S; (5.9)
one obtains
@uI
@t
=
1
VI
I
@VI
D(x;t)ru(x;t)  df + QI(t); (5.10)
The algebraic structure of the numerical discretisation depends on the specic geometry
under consideration.
For the simplest and most common case of rectangular grids in three dimensions with
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lattice constants x, y, z one can improve the accuracy by directly discretising (5.5)
@ui;j;k
@t
= +
(Di+1;j;k   Di 1;j;k)(ui+1;j;k   ui 1;j;k)
4x2 + Di;j;k
ui+1;j;k   2ui;j;k + ui 1;j;k
x2
+
(Di;j+1;k   Di;j 1;k)(ui;j+1;k   ui;j 1;k)
4y2 + Di;j;k
ui;j+1;k   2ui;j;k + ui;j 1;k
y2
+
(Di;j;k+1   Di;j;k 1)(ui;j;k+1   ui;j;k 1)
4z2 + Di;j;k
ui;j;k+1   2ui;j;k + ui;j;k 1
z2
+Qi;j;k ; (5.11)
which is second-order accurate1 in space (Bronstein et al. (1997)). Equation 5.11 is only
valid for the volume elements not residing on the boundary of the reaction volume. In
these volume elements the boundary conditions (i.e. Dirichlet or von-Neumann) have to
be discretised independently.
Within a Voronoi tessellation the simulation space is decomposed into disjunct volume
elements VI, for which every point within a volume element (Voronoi cell) is closer to
a point called its generator xI than to any other generator. The mechanisms of spatial
tessellations, which are mentioned brie
y in the following, will be introduced in detail in
section 7.1. If one uses the Voronoi tessellation for the denition of volume elements VI,
equation 5.10 reduces to
@uI
@t
=
1
VI
X
J2N(I)
AIJ
jxI   xJj
(uJ   uI)DIJ + QI ; (5.12)
where VI is the volume of the Voronoi cell I, and J 2 N(I) denotes the next neighbours
of cell I with generator xI. Consequently, the terms AIJ denote the contact area of the
adjacent Voronoi cells I and J. Linear interpolation on the connection lines between the
generators of I and J yields for the diusion coecient
DIJ = DJ;I =
1
2
DI

1 +
!J   !I
(xJ   xI)2

+
1
2
DJ

1  
!J   !I
(xJ   xI)2

(5.13)
at the position of the Voronoi boundary. This reduces to the simple arithmetic average in
case of equal weights !I = !J.
Within this thesis solution, modelling of the reaction diusion equation on a grid as
described by equation 5.11 was the method of choice. As the Voronoi boundaries of the
cell are available from the triangulation of the cell system, an approach using equation 5.12
might be of great interest for further investigations.
A pseudo-steady-state approximation has been applied for the RDEs of the nutrients (see
Schaller (2006)) as the diusion coecients of oxygen and glucose are orders of magnitude
larger than typical random cell motilities. The nutrient concentrations are recalculated
from the time-dependent cellular positions at xed timesteps of tdiffev = 300s, although
1The discretisation of the second derivatives can be derived by using a virtual grid with halved lattice
constants.
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this timestep is likely to be smaller as handled by the diusion solver. The pseudo-steady-
state approximation is justied because the diusion length LD =
p
6Dtdiffev associated
with the timestep and the smallest occurring diusion coecient (glucose in tissue) is larger
than the largest spheroid radius observed during the agent-based simulations.
Linear operator form and solving strategies
The general handling of equations (5.12) and (5.11) diers in the way of discretisation.
The equations can be written as
Denition 6 (Linear operator form)
@uI
@t
= LuI + QI(t); (5.14)
where L is a linear operator describing the geometry and diusional properties of the
system.
Equation 5.14 can be discretised in time accordingly to equation 5.8:
un+1
I   un
I
t
= Lun
I + QI(t); (5.15)
with un+1
I = uI(t + t).
This linear operator form can be solved with dierent strategies:
 Forward-Time-Centred-Space (FTCS), Courant stable (see equation 5.17)
 Backward-Time-Centred-Space (BTCS), unconditionally stable
 Crank-Nicholson scheme (CNS), average of FTCS and BTCS, unconditionally stable
The simplest explicit scheme (Forward-Time-Centred-Space, FTCS) is realised by eval-
uating equation 5.15 at time t, i. e.,
un+1
I = f1 + tLngun
I + tQn
I ; (5.16)
which has the advantage that the solution u(t + t) can be readily obtained from u(t)
without necessitating matrix inversion. However, already for constant diusion coecients
a von-Neumann stability analysis Press et al. (1994) on rectangular grids shows that this
solution scheme becomes numerically unstable if
Denition 7 (Courant-condition)
Dt
x2 +
Dt
y2 +
Dt
z2 
1
2
; (5.17)
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a constraint which is known as Courant-condition.
Numerical instability implies that the numerical errors will increase exponentially in
time, which is a serious limitation for practical applications. As the Courant condition
involves both spatial (x) and temporal (t) resolutions, one can either decrease the
timestep or decrease the spatial resolution to obtain correct numerical solutions with a
method that is dependent on the Courant condition. An illustration of the underlying
principle for equation 5.17 can be found in gure 5.10.
Numerical stability can be recovered if one applies a fully implicit scheme (Backward-
Time-Centred-Space, BTCS), i. e., by evaluating 5.14 at time t + t one yields

1   tLn+1	
un+1
I = un
J + tQn+1
J ; (5.18)
which is still rst order accurate in time. However, one can show by von-Neumann stability
analysis that this scheme is unconditionally stable, i. e., timesteps larger than allowed by
the Courant condition do not lead to an exponential increase of the numerical errors
(Schaller (2006)). Note that the existence of L on the left hand side necessitates the
inversion of a sparsely populated matrix.
ADI Algorithm
A method of choice is to combine the advantages of explicit and implicit algorithms by an
average, i. e.,
Denition 8 (Crank-Nicholson scheme)

1  
t
2
Ln+1

un+1
I =

1 +
t
2
Ln

un
I +
t
2
 
Qn
I + Qn+1
I

; (5.19)
which is a sparsely populated linear system that can be solved for un+1
I with knowledge of
un
I, Qn
I, and Qn+1
I . This method is referred to as the Crank-Nicholson scheme, and von-
Neumann stability analysis shows that it is unconditionally stable for the free diusion
case (Press et al. (1994)). Furthermore, it is second order accurate in time, since here both
the left and right-hand sides are centred at time tn + t=2. The resulting system is tri-
diagonal in one dimension, which enables a fast and simple algorithmic matrix inversion.
This, however, does not hold true in higher dimensions. In this case, approaches such as
operator splitting can help to reduce sparse matrices to several tri-diagonal ones (as shown
in Press et al. (1994)).
For the two dimensional case the application of the alternating-direction implicit method
(ADI) is demonstrated explicitly in Press et al. (1994). The basic idea is to divide each
timestep into several sub-steps. Within each sub-step, a single dimension is treated implic-
itly, whereas the other dimensions are treated explicitly. In two dimensions, this procedure
preserves unconditional stability, whereas in three dimensions the updating scheme from
Press et al. (1994) can be generalised, L = Lx + Ly + Lz, to (reaction terms omitted)
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Figure 5.10: The Courant condition: A dierencing scheme is stable if the solution to a problem
at a point depends only on a dierencing domain which is larger than the PDE domain. As the
Courant condition (equation 5.17) involves both spatial (x) and temporal (t) resolutions, one
can either decrease the timestep or decrease the spatial resolution to obtain correct numerical
solutions with a method that is dependent on the Courant condition. Figure from Press et al.
(1994).
Denition 9 (Alternating-direction implicit method)

1  
t
3
Ln+1=3
x

u
n+1=3
i;j;k =

1 +
t
3
Ln
y +
t
3
Ln
z

un
i;j;k ;

1  
t
3
Ln+2=3
y

u
n+2=3
i;j;k =

1 +
t
3
Ln+1=3
x +
t
3
Ln+1=3
z

u
n+1=3
i;j;k ;

1  
t
3
Ln+1
z

u
n+3=3
i;j;k =

1 +
t
3
Ln+2=3
x +
t
3
Ln+2=3
y

u
n+2=3
i;j;k ; (5.20)
which replaces a sparse system by three tri-diagonal ones. Unfortunately, the above split-
ting scheme sacrices numerical stability at Dt=x2  1=2 (see Schaller (2006)). How-
ever, this drawback can be compensated by a solver implementation which automatically
breaks the timestep down into sub-steps, in agreement with the Courant condition equa-
tion 5.17, as it is done within the solver employed within this thesis.
Realistic boundary conditions
Assuming that a tumour spheroid resides in a well stirred medium (in vitro) this can be
modelled by Dirichlet type boundary conditions. Concentration on the nodes lying on the
boundary of the diusion grid is kept constant at the given value (e.g. 16.5 mMol glucose
according to Freyer and Sutherland (1986)). Nutrients are assumed to diuse in from an
innite reservoir outside the reaction cuboid. The type of boundary conditions, boundary
concentrations and initial concentrations for an instance of the soluble-class are dened
within the application's parameter le and passed on to the solver by the parameter parser.
An example of a simulation run showing the nutrient concentration is shown in gure 5.11.
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(a) Glucose concentration after 30 min of simulation.
(b) Glucose concentration after 5000 min of
simulation.
(c) Glucose concentration after 10000 min of
simulation.
(d) Glucose concentration after 14000 min of simulation.
Figure 5.11: Solution of the reaction diusion system as given by equation 5.10. Figures show
a section through the middle of the reaction cuboid, x and y axis depict grid nodes while the z
axis show the glucose concentration in mmol. The alternating-direction implicit method (ADI)
as described in Press et al. (1994) was used to solve the system. Implementation is done in the
soluble-class of the application. Initially the reaction cuboid is lled with a nutrient concentration
of 16:5mmol glucose. This concentration decreases due to the fact that the growing tumour
spheroid is consuming nutrients faster than the diusive in
ux through the boundary can sustain.
566 Cytokinesis modelling
6.1 Cell division and the abrupt transition of cytokinesis
Having completed the growth and synthesis phases, the cell enters the mitotic phase as
described in section 5.1. Mitosis in eukaryotes can be broken down into two functional
phases:
karyokinesis where the cell core is divided and thus the separation of the duplicated DNA
into two equally sized groups of chromosomes takes place
cytokinesis which is the physical division of the entire cell whereby the cytoplasm of a
single cell is divided to spawn two daughter cells.
The process of karyokinesis is assumed to be an internal process of the proliferating cell
within the simulation. Although it is possible to model karyokinesis within the simulation,
its eects on the surrounding medium are marginal.
From a technical point of view the spherical cell begins to deform into a bell-shape and
nally splits up into two spherical objects. The demanding part in modelling this process
in a simulation is the fact that proliferation is an abrupt transition where a new agent
has to be inserted into the simulation. Furthermore the triangulation is built to handle
spherical objects only, so the cell elongation must be captured by a combination of spheres.
Referring to the mitotic cell as the \mother cell "and to the two osprings as \daughter
cells", the two daughter cells will have to be inserted close to each other. Using the JKR
interaction model this yields extreme velocities, which, although they may be treated with
the adaptive stepsize routine, break down the applicable timestep for the dynamics. This
leads to an increase in computational eort, which would render the simulation of larger
systems infeasible.
Possible algorithms for cytokinesis
At this point a detailed implementation of the mitotic process is needed that does not
require a timestep smaller than the one used during non proliferative growth of the system.
Multiple approaches are imaginable. The simplest method consists in shrinking the mother
cell to initial size, displacing it in a random direction and inserting a daughter cell inversely
to the mother's displacement. This method works as long as the resulting displacements
are relatively small. However, it lacks elegance and is not able to capture the dynamics
of cytokinesis itself. Moreover, in a dense tissue of proliferating cells this implementation
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will lead to severe articial speedups of cell velocities due to unfavourable congurations
rising. An eective algorithm has to take care of situations were two proliferating cells are
neighbours and the randomly determined proliferation direction is chosen in a way that
would move the daughters into each other. There are multiple favourable solutions to this
problem:
1. Proliferating cells are interacting normally but the reciprocity between sister cells is
disabled during proliferation and replaced with an velocity that is kept constant until
mitosis is completed (e.g. until both cells are close to the mutual JKR equilibrium
distance). This approach may lead to cells staying arbitrary long in the mitotic
phase.
2. Proliferating cells can exert forces onto neighbouring cells not currently undergoing
mitosis, but this interaction is not considered to be symmetric - the mitotic cell is
only aected by interactions with other proliferating cells; the resulting forces are
projected onto the plane dened by the proliferation direction as normal vector in
order not to aect the sister separation. This approach can ensure a dened mitotic
phaselength which is sucient to separate the sister cells.
3. Interaction between common daughter cells is disabled and replaced by a cytokinesis
velocity that ensures full separation within mitosis time. Proliferating cells fully
interact with neighbouring cells but forces imposed on them are projected onto
a plane perpendicular to the proliferation direction in order not to interfere with
cytokinesis (see gure 6.1 and 6.2 for a sketch of this method).
The latter algorithm was used as a standard method for the implementation of proliferation
throughout the simulation, and is referred to as advanced cytokinesis model. It oers the
possibility to model the process of cytokinesis in detail, which might be of interest in itself,
since a complex rearrangement of surface proteins is essential for cytokinesis (see Bauer
et al. (2008) for details). Furthermore, if combined with an local and global adaptive
stepsize algorithm, it oers a tremendous improvement in simulation runtime compared
to straightforward proliferation methods (as shown in gure 6.5).
6.2 Details on the cytokinesis algorithm for agent-based
simulations
Upon mitosis, a random direction is determined and the mother-cell is slightly displaced
in this direction while a daughter cell is inserted inversely. The displacement of both cells
is chosen to be much smaller than the nal equilibrium distance in order to minimise the
disturbance to the simulation. To model the bell-shape during mitosis both cells separate
with a constant velocity (vmit), while their radii are decreased at the same time according
to the shrinking factor (fshrink) (see gure 6.3).
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The magnitude of the mitotic velocity vmit is determined to ensure full separation into
the corresponding JKR equilibrium position:
vmit =
(djkrequi   dmit)
M
(6.1)
with djkrequi being the equilibrium distance of two cells of initial size (rinitial) under JKR
interaction, dmit the slight displacement of the cells at the beginning of cytokinesis and
M the length of the mitotic phase in minutes.
Similar to the cell growth factor in phases G1 and G2:
fgrow =
(rtar   rini)
(G1 + G2)
(6.2)
a shrinking factor for cytokinesis is calculated to ensure volume conservation and bring
the daughter cells down to the preferred initial cell size:
fshrink =
(rtar   rini)
M
: (6.3)
In order to ensure volume conservation, the radius of daughter cells after cytokinesis
(start of the G1-phase) must be determined so that two daughter cells take up the same
volume as one large mother cell before cytokinesis (at end of the G2-phase):
rini = rtar2 1=3 (6.4)
(6.5)
Where rini refers to the decreased cell radius after proliferation (at the start of G1) and
rtar to the nal cell radius (at the end of G2). Example values for the cell radii are given
in table 3.2, as cell sizes vary according to the cell type.
Cell interaction during mitosis
Cell-cell interaction during cytokinesis is limited in a way that the interaction between
common mitotic daughter cells is replaced by the articial mitotic force and other inter-
action forces are projected onto the plane perpendicular to the proliferation direction:
nmit  p = 0 (6.6)
nmit  F res = 0 (6.7)
where nmit is the vector in mitosis direction (normal vector of the plane), p an arbitrary
vector lying in the perpendicular plane and F res the projection of the force vector onto
the perpendicular plane.
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Fint
t
Fmit
Fres
Figure 6.1: Sketch of the cytokinesis handling implemented in this thesis. Cells draw a random
cytokinesis direction upon the start of mitosis and spawn a daughter cell nearby to model the bell
shaped deformation (see gure 6.3). In a dense layer of mitotic cells this may lead to cells being
moved into each other, in the case of unfortunate cytokinetic directions. This collision is detected
due to the fact that mitotic cells show full interaction with other mitotic cells. However, the force
Fint along with all other interaction forces between mitotic and non-mitotic cells will be projected
onto the plane dened by the cell's mitosis direction as plane normal. This ensures full separation
of mitotic daughters after a predetermined timespan as the mitotic force Fmit is left unchanged.
6.3 Eects of the algorithm on the overall simulation
performance
The newly developed advanced proliferation mechanism yields a signicant performance
improvement of the simulation, due to decreased maximum velocities as seen in gure 6.4.
Unnatural cell velocities as a result of unfortunate cell conformations are decreased, there-
fore making the global adaptive stepsize on average larger, what yields a signicant increase
in simulation performance (see gure 6.5).
This eects add up to a highly increased simulation performance (note the decrease of
the iteration number due to the adaptive timestep in gure gure 6.5).
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Figure 6.2: Sketch of the force projection during proliferation as implemented in the cytokinesis
algorithm. Interaction forces Fint are projected unto the plane of proliferation dened by the plane
normal nmit. The projected forces Fres are used for the propagation of mitotic cells together with
their mitotic force, to ensure full separation within the according phaselength M and still preserve
as much system dynamics as possible.
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(a)
(b)
Figure 6.3: (a) Mitosis in vivo: chromosomes (shown in purple) line up in the metaphase plate
and are pulled apart. Tubules of the ER (stained red) bind to chromatin. During the later stage of
karyokinesis DNA binding proteins that reside in the ER immobilise some of the tubules. They are

attened out to create the nuclear membrane for cytokinesis. (b) In silico simulation of the cell
cycle and mitosis according to the implemented cytokinesis algorithm. From top left to bottom
right: growth of cell in G1 and G2, begin of cytokinesis (top right), separation process accompanied
by shrinkage of the daughter cells (lower left), nal equilibrium position for both cells at initial
cell size (lower right). Black spots in (b) are not identical with the cells nucleus but are results
of the POV-Ray rendering. Source picture used to create collage (a) by Daniel J. Anderson, Salk
Institute for Biological Studies.
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(a) simple cytokinesis model (b) advanced cytokinesis model
Figure 6.4: Comparison between a sample simulation without and including the advanced pro-
liferation method. Note the dramatic change in maximum velocity peaks due to a smoother
proliferation.
(a) simple cytokinesis model (b) advanced cytokinesis model
Figure 6.5: Comparison between a sample simulation without and including the advanced pro-
liferation method. Note the dramatic change in the number of iterations per timestep due to a
smoother proliferation.
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7.1 Dening neighbourship relations through spacial
tessellations
Eukaryotes aggregate in large colonies and eventually form tissues, in which direct inter-
action is limited to cell neighbours which are in contact. However, determining which
cells should interact is not a trivial task, since the tissue-simulation is done in free space
and cross checking all cells would results in a quadratic runtime. Instead of checking all
cells for neighbourship with each other, it would be useful to obtain a list of interaction
partners for each cell agent.
This can be done in an ecient and elegant way using a Delaunay triangulation of
the simulation space. A straightforward way to introduce the Delaunay triangulation is
through its dual, the Voronoi tessellation (see Aurenhammer (1987); Okabe et al. (2000)).
In solid state physics the Voronoi tessellation is also known as partition into Wigner-Seitz
cells. Within the scope of tissue simulations the Voronoi tessellation oers direct access
to cell contact surfaces and cell volumes (see gure 7.2).
As the complexity of triangulations lies beyond the scope of this thesis, the following
section will be limited on introducing the necessary terms and concepts. For a detailed dis-
quisition on spatial tessellations and their ecient algorithmic implementation the reader
is referred to Beyer et al. (2005b) and Beyer (2007).
Voronoi tessellation
The Voronoi tessellation of a set of generators is dened as the partition of space into
Voronoi cells Vn for which every point of one cell is closer to its generator vn than to any
other generator vm.
Denition 10 (Vertex)
Let x 2 R3 dene a point. The pair X = (x;wx) 2 R3  R is called a vertex. wx is
called weight of the vertex X.
Together with its weight a vertex can be interpreted as a sphere with radius
p
wx at
position x, and therefore vertices can represent cells in a regular triangulation. However,
the concept of triangulations can be applied to objects of higher dimension in an equal
way.
For the later denitions two more objects are of great importance:
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(a) (b) (c)
Figure 7.1: Duality between the Delaunay triangulation and the Voronoi diagram. (a) A Delaunay
triangulation of a random set of generators vn. (b) Voronoi tessellation of the same point set. (c)
Overlay of Delaunay triangulation from (a) in black and Voronoi tessellation from (b) in orange
showing the fundamental relationship of duality between them.
Denition 11 (Simplex)
A simplex  is dened as the convex hull of d + 1 points vi 2 Rd in a d-dimensional
space.
In 2 dimensions the corresponding 2-simplex will be a triangle as depicted in g-
ure 7.1(a), in 3 dimensions the term simplex (or 3-simplex) is a synonym for a tetrahedron.
To simplify the notation the points of a simplex hP1;P2;P3;P4i will be noted by the vertices
with the corresponding coordinates pi; i = 1;2;3;4. Another simplication of notation is
Denition 12 (Edge and face)
An edge (1-simplex) hP1;P2i is the line connecting the points p1 and p2. A face
(2-simplex) hP1;P2;P3i is the triangle formed by pi; i = 1;2;3.
A classical approach from solid state physics for the generation of the Voronoi tessellation
is to draw the connection lines between all neighbouring generators vn and then add the
perpendicular bisectors of the sides. The area around the generator bound by the bisectors
is the Voronoi cell of the generator (see gure 7.1(b)).
An example of a voronoi tessellation is the investigation of the natural patches of post
oces in a city. The logical patch for each post oce will consist of all areas of the city
for which the distinct post oce is nearer than any other oce.
Following the introduction from Beyer (2007) from this point on we can dene a voronoi
tessellation as
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(a) (b)
Figure 7.2: Correspondence of the Voronoi tessellation to the cell form in a real tissue. (a) Voronoi
tessellation created according to the empty circumsphere criterion. Green points are vertices in the
Delaunay triangulation corresponding to cell centres. The blue polyhedra is the Voronoi cell which
can correspond to the biological cell. Vertices of the Voronoi cell are shown as red points. (b) Cells
in a tissue under the microscope. The actual cell shape is polyhedral and therefore modelled in an
optimal way within a Voronoi approach. Cell centres marked with green dots, cell edge vertices
with red dots. Source for gure (b) is Lecuit and Lenne (2007).
Denition 13 (Voronoi tessellation)
a subdivision fCng of space such that
[
n
Cn = R3 with Cn =

x 2 R3 : kx   vnk < kx   vmk 8 m 6= n
	
: (7.1)
The points v 2 S are called the generators and the Cn are called Voronoi cells.
For the case dened in equation 7.1 the resulting Voronoi cells are polyhedra in three
dimensions.
Considering the duality of the Delaunay triangulation and the Voronoi tessellation each
face of the Voronoi cell polyhedra corresponds to an edge in the Delaunay triangulation
between the vertices being the generators of those two cells (see gure 7.1). With the help
of gure 7.2 it becomes obvious that the centre of the circumsphere of the simplices of the
Delaunay triangulation are the endpoints of the polyhedra forming the Voronoi cells.
If dierent weights are assigned to the generators vn (corresponding to cells of dierent
sizes) then the result is a generalised Voronoi tessellation, also refered to as power dia-
gram, which always exists and guarantees the existence of its dual, the regular Delaunay
triangulation (which is dened in the next section). In the weighted case the normal Eu-
clidean distance is replaced by a weighted norm. This requires the denition of the power
distance and the orthosphere:
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Figure 7.3: The Voronoi tessellation is
the dual graph of the regular triangulation.
Here it is shown for the vertex indicated by
the red disk. The neighbour vertices are
marked as grey disks. The Voronoi cell is a
polygon shown in green.
Denition 14 (Power distance)
The power distance of two vertices U;V is given by
(U;V ) = ku   vk
2   wu   wv: (7.2)
With k:k denoting the Euclidian distance in R3.
With the help of the power distance the orthosphere of a simplex can be dened:
Denition 15 (Orthosphere)
The orthosphere M of a simplex hV1;V2;V3;V4i is dened as the solution M = (m;wm)
of the equations (Vi;M) = 0; 8i = 1;2;3;4.
In case the weight wm of the orthosphere is positive it can be interpreted as a sphere such
that the tangential planes of M at the intersecting points of the spheres representing the
vertex weights wi are orthogonal to the tangential planes of these spheres. Note that, even
when all vertices Vi have a positive weight, the orthosphere M can still have a negative
weight and the radius is given by
p
jwmj.
The formal denition of a weighted voronoi tessellation is given by:
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Figure 7.4: Orthocircles of a triangulation
in 2D. Each orthocircle M (green) corre-
sponds to a simplex and intersects all cir-
cles associated with the vertices of that
simplex perpendicularly. The weight of
each vertex is represented as the radius
p
w
of the circles. The vertex indicated by the
red disk is redundant because it lies outside
of all orthocircles of all simplices formed by
the surrounding vertices indicated as grey
disks. Thus, the redundant vertex is not
endpoint of any simplex and the structure
of the triangulation does not change if this
vertex is present or not.
Denition 16 (Weighted Voronoi tessellation)
A weighted Voronoi tessellation is a subdivision fCng of space such that
[
n
Cn = R3 (7.3)
with
Cn =

x 2 R3 : kx   vnk   wvn < kx   vmk   wvm 8 m 6= n
	
(7.4)
=

x 2 R3 : (X;Vn) < (X;Vm) withX = (x;0) 8 m 6= n
	
: (7.5)
The vertices V 2 S are called the generators. The Cn are called Voronoi cells or
Laguerre cells.
The Voronoi cells of this type are also called Laguerre cells and the tessellation is called
a weighted Voronoi tessellation. The duality between the weighted Voronoi tessellation
and the regular triangulation is similar to the simple Voronoi/Delaunay case. Instead of
circumspheres the centers of the orthospheres of the simplices are the endpoints of the
Laguerre cells (see gure 7.3).
Regular Delaunay triangulation
The Delaunay triangulation of a point set is a collection of edges satisfying an \empty
circle" property: for each edge we can nd a circle containing the edge's endpoints but not
containing any other points. Alternately, it can be dened as a triangulation of the sites
with the additional property that for each triangle of the triangulation, the circumcircle
of that triangle is empty of all other sites.
The triangulation T is said to be a regular triangulation (also known as weighted De-
launay triangulation) if the orthosphere of every simplex  < A;B;C;D >2 T contains
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no vertices (see gure 7.4).
Considering the duality of the Delaunay triangulation and the Voronoi tessellation each
face of the Voronoi cell polyhedra corresponds to an edge in the Delaunay triangulation
between the vertices being the generators of those two cells (see gure 7.1). With the help
of gure 7.2 it becomes obvious that the centre of the circumsphere of the simplices of the
Delaunay triangulation are the endpoints of the polyhedra forming the Voronoi cells.
Access and usage of the triangulations properties
For applications, mainly three properties of the weighted Voronoi tessellation are needed.
These are the volume of the Voronoi cell, the area of the face between two cells and the
distance between a face of the cell and its generating vertex. The regular triangulation of
the system Edelsbrunner and Shah (1996); Okabe et al. (2000); Ferrez (2001) is the basic
geometric structure used for cell modelling throughout this thesis. The used algorithm
to implement a dynamic and kinetic triangulation is described in detail in Schaller and
Meyer-Hermann (2004) and Beyer et al. (2005b).
7.2 The 
uid-tissue analogy and cell sorting
Large amounts of cells can eectively behave like a 
uid. This phenomenon is known as
the 
uid-tissue analogy. Cells show dierential adhesion depending on the type of and
amount of CAMs expressed on their surface (as implemented according to equation 3.7)
much like liquids do according to their surface energy (see equation 7.6). Cell sorting and
aggregation can be explained based on this mechanisms of dierential interaction Lecuit
and Lenne (2007). Also large parts of complex tissue formation reside on the use of this
mechanism. This dierential adhesion hypothesis can also be used to explain tissue sorting
by anity in the early embryonic development Townes and Holtfreter (1955).
Surface tension and tissue sorting
Cell surface tension is analogous to the tension occurring at the boundary layer of a 
uid.
In a 
uid, surface tension is caused by the attraction between the molecules of the liquid
by various intermolecular forces. In the bulk of the liquid each molecule is pulled equally
in all directions by neighbouring liquid molecules, resulting in a net force of zero. At the
surface of the liquid, the molecules are pulled inwards by other molecules deeper inside the
liquid and are not attracted as intensely by the molecules in the neighbouring medium.
Therefore, all of the molecules at the surface are subject to an inward force of molecular
attraction, which is balanced by the resistance of the liquid to compression (see gure 7.5).
This inward pull tends to diminish the surface area, and in this respect a liquid surface
resembles a stretched elastic membrane. Thus the liquid squeezes itself together until it
has the locally lowest surface area possible under the given boundary conditions.
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Figure 7.5: Surface tension can ex-
plain large parts of complex tissue
formation shown in (b). Mecha-
nisms for droplets in 
uids (a) and
cells in tissue (c) are functionally
similar. (d): Cells are sorting de-
pending on their expression level of
cadherins on their surface. Picture
from Lecuit and Lenne (2007).
Equation 7 (Surface energy)
A change in surface energy can be described by the expression
E = S (7.6)
where E is the surface energy dierence, S the change in surface area and  the
surface energy coecient.
As a results of equation 7.6 a liquid must minimise its number of boundary molecules (and
therefore its surface area) in order to minimise its energy state (see also gure 7.5).
Another way to approach this phenomenon is to assume that a molecule in contact with
a neighbour is in a lower state of energy than if it weren't in contact with a neighbour.
This view can be implemented straightforward into modelling of separation phenomena,
with the use of energy models such as the Potts model (see Graner and Glazier (1992)).
In tissue sorting cells obey a mechanism which eectively implements equation 7.6.
Binding energy is mediated through the level of CAM-adhesion. If two populations of
cells, which are dierent in respect to the preferential binding of their CAMs, are mixed,
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they will tend to separate as binding between cells of the similar population is preferable
(as illustrated in (d) of gure 7.5).
This tissue sorting is reproduced straightforward within this modelling approach (see
section 9.2).
Articial boundary pressure
Within the simulation, cells which lie on the boundary of the growing spheroid may be
subject to an articial force pointing to the spheroid centre. This is in correspondence to
the surface energy dened in equation 7.6. Furthermore, the mechanism has been included
to mimic the in
uence of surrounding tissue in a rst approach. The favourable approach
would be to surround the growing tumour by a layer of benign tissue. However, this
involves simulation of a high number of cells which are healthy and, therefore, of minimal
interest for the investigation. To minimise the thickness of this surrounding layer and to
simulate a realistic environment without having to apply excessive computational power,
a combination of both mechanisms can be used. In this combination the articial forces
are acting only on the surrounding healthy tissue, which can deliver a realistic interaction
to the growing spheroid.
7.3 Mechanical inhibition
Cells in a tissue are in competition for limited resources such as glucose or cellular growth
factors all the time. Therefore, when multiple cells come into contact, they may come
to an arrest of cell growth due to contact inhibition. Even cells which are genetically
modied to suppress apoptosis maintain this phenomenon, which complicates handling of
cell cultures in laboratories. Cancerous cells often lose this property, and thus grow in an
uncontrolled manner even when in contact with neighbouring cells.
The mechanisms through which contact inhibition is mediated are not fully understood
yet. Depletion of growth factors and other solubles from the extracellular space by the
surrounding tissue might play an important role, as it is seen in in vitro tissue cultures.
This eect can be easily integrated into the simulation with the help of a soluble diusion
system for growth factors.
Pressure-mediated inhibition
Another possible source of contact inhibition can be termed as mechanical inhibition. It
stems from the pressure imposed on a single cell by its neighbours. If this pressure exceeds
a certain limit, the cell can react by going into quiescence.
This cell pressure can be obtained locally for each cell in an agent-based simulation
through the properties of the voronoi tessellation. As pressure is dened as force divided
by area, the eective pressure on a cellular agent is given by the sum of the interaction
force divided by the voronoi face shared with the according neighbour:
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Denition 17 (Cell pressure)
Ptotal
i =
X
jN
Pij =
X
jN
Fij
Aij
(7.7)
where Pij denotes the pressure imposed on cell i by its neighbour j, Fij the force and
Aij the voronoi contact surface between those two cells.
Due to the nature of the voronoi tessellation the JKR force will always be parallel with
the plane normal of the voronoi face and therefore perpendicular with the plane itself.
Fij k nvf (7.8)
This pressure can be computed at any time and may be checked at the restriction point
to decide whether the cell should initiate mitosis or go into quiescence. It is also valuable
in order to obtain the pressure distribution inside the tumour spheroid. Possible further
implementation can include a pressure repulsion of highly compressed cells acting on their
neighbours of lower pressure.
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The developed application is written in C++ code. There are two largely independent
classes which are at the centre of the simulation: the cell-class and the triangulator-class.
An instance of the rst is spawned for each cell in the simulation and handles all of the
cells properties and abilities through its variables and member functions. The latter one
is used to store the arrangement and layout of the cells and to obtain the neighbourhood
topology with the help of a kinetic dynamic triangulation. An overview of the simulation
algorithm is given in pseudocode (see algorithm 8.4 on page 76).
8.1 Classes and libraries
This section will only give a brief overview about the basic mechanism used to implement
the application for this thesis. For a complete and documented functions overview see the
header les of the according class class.h or the doxygen documentation.
The cell-class
The cell-class provides variables and functions that may be used by every instance of that
class. It is developed in order to capture all possible cell mechanisms which are of interest
to the modelling. Each cell is spawned by the constructor function of this class and is
thereafter existent as an individual object, as described in section 2.2. Some important
functions of the cell class:
 Cell ( Spacepoint<double>& colourtemp, int phasetemp, ... ){}
Constructor - inserts a coloured cell given by colour-vector in an initially dened
cell-phase with initially dened phaselength
 void calculate_velocity ( Triangulator<double,Cell>& tri );
Calculates the velocity of an agent using an overdamped approach
The cell state is stored in the private variables of the cell class. Some examples can be
found here:
 int phase;
Stores the current phase of the cell
 double phaselength;
Remaining time until phase-transition-checkpoint is reached
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 bool proliferating;
Marks if the cell is in the mitotic state
 Spacepoint<double> v;
Vector representation of the current cell velocity
 double elastic_modulus;
elastic modulus  of the agent in Pascal
 double ligand_concentration;
ICAM ligand concentration average on cell surface
check_phase() and update_phase() are the two functions which are at the heart of
the cell cycle class, triggering events which happen according to the internal cell timing.
check_phase()
G_0 decrease phaselength
G_1 decrease phaselength, grow
S decrease phaselength
G_2 decrease phaselength, grow
M decrease phaselength, shrink
N if nutrients below necrosis threshold send into necrosis
if phaselength = 0 ( update_phase() )
update_phase()
G_0/G_1 check_nutrients && check_pressure
G_1/S check_nutrients && check_pressure
S/G_2 check_dna_integrity
G_2/M proliferate
The triangulator-class
The triangulation is stored as a connected simplex list. The data for a simplex is stored as
pointers to its four vertices and to its four adjacent simplices. The faces of outer simplices
that have no adjacent simplex are omitted. The vertices are also stored in a list. Each of
the vertices has a list of pointers to simplices which have this vertex as endpoint. A list
of neighbour vertices is also stored using pointers.
Other variables important for the dynamic and ecient update of the triangulation are
stored within the simplex data structure. For each pointer to a neighbour simplex the
result of the last orthosphere criterion calculation is stored, together with a 
ag indicating
its last update. Depending on the subroutine which are presented below, the result of a
former computation can be reused without actually performing the calculation.
The triangulation can be recalculated from the scratch at any time, but is usually
dynamically updated at all times, which yields a great performance improvement (see
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Beyer et al. (2005a)). Even for relatively small system sizes of about 1000 spheres the
complete re-triangulation is a faster method for determining the neighbourhood topology
than the naive method of cross-checking all spheres (as shown in Schaller (2006)). Update
of a existing delaunay triangulation is orders of magnitude faster than the cross-checking
method. The update of the triangulation is done with the help of sophisticated 
ip-
algorithms, which can locally restore the delaunay triangulation if its validity was lost
through movement of vertices (spheres).
For the purpose of using the dual graph { the Voronoi tessellation { the center of the
orthosphere is stored in the simplex structure, again invoking a 
ag that indicates if a
recomputation is needed. The changes to the triangulation are handled dierently for
simplices and vertices. Simplices are only created and destroyed. Vertices keep their
data structure and change properties in the case of triangulation kinetics. They are also
created/removed during triangulation dynamics.
Since the triangulator code is ready for parallel computing, it makes use of a unique
metapointer concept to identify vertices (cells) on all processes (see Beyer et al. (2005a)
and Beyer (2007)). The parallel implementation is based on the Message Passing Interface
(MPI). The concept is to run the same program on dierent processes { which are usual
dierent physical processors or even computers { and include code that denes which pro-
cess performs which instruction, including sending or receiving data from other processes
through some type of network provided by the hardware.
Further classes
Further important classes include the soluble-class, which is used to solve reaction-
diusion-equations with the ADI-algorithm, and the random-class, as an interface to pro-
vide sophisticated random functions.
Important libraries
Important libraries in use are SPRNG1 for parallel random number generation, boost 2,
iRRAM3 for exact arithmetic in C++, and ParMETIS4 for parallel graph partitioning and
ll-reducing matrix ordering.
8.2 Further features
The application can write out the actual state of the triangulation and cell agents either in
vrml or POV-Ray compatible format. This can be used to visualise the tumour dynamics
as it was done within this thesis (see section 9).
1http://sprng.cs.fsu.edu/
2http://www.boost.org/
3http://www.informatik.uni-trier.de/iRRAM/
4http://glaros.dtc.umn.edu/gkhome/metis/parmetis/download
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8.3 Parameters and system setup
A parameter parser was integrated into the application in order to allow the change of
simulation parameters at runtime and store them in ordered parameter-les. With the help
of this parameter le it is possible to setup scripted runs with dierent input parameters
automatically. A detailed explanation on the parameters is provided within the parameter
le itself.
System setup and agent insertion
In order to initialise the system randomly but close to an equilibrated solution a Monte
Carlo method was used, where particles are randomly inserted into a cubic volume, but
kept only if they lie within an spherical boundary volume, Vt:
Vp =
4
3
r3
p (8.1)
Vt =
4
3
r3
t 
X
p
Vp = #pVp (8.2)
rt =
3
q
#pr3
p (8.3)
For the simulation of avascular growth the typical initial conguration will be a core of
malignant cells (or just one cell) surrounded by a shell of benigm tissue.
8.4 Simulation algorithm in pseudocode
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parameter used in simulation literature value remark
G1-phase G1 8 h (6:0  1:0) h (1), type dependent
S-phase S 6 h (10  2:0) h (1), type dependent
G2-phase G2 4.5 h (2:0  0) h (1), type dependent
mitotic phase M 1 h (1:0  0) h (1), type dependent
G0-phase G0 1.5 h { eective value
apoptosis duration A 10 h (10  2) h (1), type dependent
necrosis duration N 24 h (50  2) h (1), type dependent
initial cell size (radius) rini 7.94 m { see table 3.2
target cell size (radius) rtar 10 m { see table 3.2
cell elastic modulus E 1000 Pa 1000 Pa (2)
cell Poisson number  0.5 0:5 (3)
cell surface energy  0.1 nNm 1 {
ECM viscosity  5  10 3 kg m 1s 1 5  10 3 kg m 1s 1 (5)
contact inhibition crit. Pcrit 500 Pa 600 Pa (5), (13)
G0 crit. nutrient conc. CG0 0-12 mmol m 3 { highly variable
N crit. nutrient conc. CN 0-2 mmol m 3 { highly variable
boundary pressure force Fbound 1 nN { eective value
oxygen diusivity DH20
ox 2440:0 m2s 1 2440:0 m2s 1 (6)
oxygen diusivity Dtiss
ox 1750:0 m2s 1 1750:0 m2s 1 (7), (8)
glucose diusivity D
H2O
gl 691:0 m2s 1 691:0 m2s 1
glucose diusivity Dtiss
gl 105:0 m2s 1 105:0 m2s 1 (9)
diusion grid size xdiff 800 m { cuboid volume
grid notes per dimension ndiff 40 { ndiff
3 nodes total
glucose boundary conc. Cbgl 16.5 mmol { Dirichlet boundary
oxygen boundary conc. Cbox 0.28 mmol { Dirichlet boundary
overall oxygen uptake ox 20.0 amol cell 1s 1 20.0 amol cell 1s 1 (12),(14)
overall glucose uptake gl 95.0 amol cell 1s 1 95.0 amol cell 1s 1 (15),(12),(14)
default timestep t 5 min { adaptive stepsize
typ. global adaptive stepsize tga 1.5 min { typical value
displacement threshold x 0.25 m { smaller than 0:1rtar
diusion rate update interval tdiffup 10 min { typical value
default diusion timestep tdiffev 5 min { handled by solver
Table 8.1: Parameter table used for agent-based simulations of cell objects within this thesis. Cell
phase durations in (1) are for EMT6/Ro spheroids and were altered in order to suit the cycle times
of a more general cell type. Many parameters vary greatly depending on the type of system that
is modelled - given values are exemplary in that cases. Stability of the application is independent
of the choice of parameters. Compiled from sources: (1) Zacharaki et al. (2004), (2) Guck et al.
(2001), (3) Maniotis et al. (1997), (4) Chu et al. (2004), (5) Galle et al. (2005c), (6) Baranov et al.
(2000), (7) Grote et al. (1977), (8) Rofstad et al. (1996), (9) Casciari et al. (1988), (10) Landry
et al. (1981), (11) Freyer and Sutherland (1986), (12) Casciari et al. (1992), (13) Helmlinger et al.
(1997), (14) Wehrle et al. (2000), (15) Kunz-Schughart et al. (2000), Schaller and Meyer-Hermann
(2005a), and Schaller and Meyer-Hermann (2005c).
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Algorithm 1 (Simulation overview in pseudocode)
1: parsing of parameters
2: initialisation of random number generators
3: diusion grids
4: triangulator
5: cell agent insertion into triangulation
6: for t  tend do
7: force based cell interaction
8: cell velocity calculation
9: global adaptive timestep (tga = x
vavefave)
10: if vcell  vavefave then
11: local adaptive timestep tla = x
vcell
12: end if
13: check phase
14: if phaselength  0 then
15: update phase
16: end if
17: synchronous displacement
18: if t mod tdif = 0 then
19: diusion grid update
20: end if
21: if t mod tvis = 0 then
22: output of visualisation and data
23: end if
24: end for
25: output of simulation statistics
8.5 Simulation performance and scaling
Multiple sources contribute to the overall simulation runtime. The scaling of the trian-
gulator in use is nlogn, close to linear behaviour (see Beyer et al. (2005a) for details).
Initial exponential growth of the tumour as simulation object leads to an exponential rise
in necessary computational eort. This contribution cannot be lowered but due to growth
saturation its scaling is getting smaller with time. Solving the reaction diusion grids
takes up a fair amount of time in the beginning of the runtime depending on the preci-
sion aspired. The contribution from the diusion solver loses importance with increasing
runtime due to the exponential simulation scaling of the interaction part later on.
Runtime improvement such as the global and local adaptive stepsize and sophisticated
cytokinesis algorithms greatly increase overall simulation performance (as shown in g-
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ures 4.4 and 6.5). The upper limit for simulations run on a single machine is about 106
cells. Growth of a tumour spheroid up to an amount of 200.000 cells over 20 days can be
simulated within about 4 days on a single cpu of 3GHz (at high precision of about 1%
cell's radius for xdisp). In order to be able to push the simulation size beyond this bound-
ary further improvements on the simulation performance are necessary. Simple methods
include asynchronous updates, in the sense that slow cells are not displaced until their
displacement reaches the chosen simulation resolution xdisp. Sophisticated methods will
treat simulation regions with slow dynamics as a single object in the process of coarse
graining. However, such methods are beyond the scope of this thesis (see Drasdo (2005)
for details on coarse graining in simulated cell systems). Due to the parallelisability of the
problem (local interactions only) a signicant performance increase can be expected from
parallel execution. This possibility is already implemented in the triangulator class from
Beyer et al. (2005a).
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9.1 Cell motility
Typical velocity prole
As there is no active cell movement by default, the typical cell velocity prole is solely
determined by cell-cell interactions and the pressure generated by mitotic cells. A ma-
jor component in the velocity spectrum is the typical velocity of the mitotic daughter
cells, which are pushed into equilibrium during mitosis. Cell velocity is increased in the
intermediate region of the spheroid, which corresponds to the regime of high pressure
(see gure 9.1 for details). If an active movement component is introduced, the velocity
spectrum changes accordingly.
It is possible to calculate the typical cell velocities resulting from the displacement
accuracy xmax = 0:25m which is used by the global adaptive timestep algorithm (see
section 4.3) to determine the integration timestep. Displacement from the equilibrium
position of two cells by xmax yields a JKR force of  2nN, respectively  4nN in the
worst case when both cells are displaced exactly against each other (assuming a cell size
of 20m). Using the equation for the cells' velocity (equation 4.8)
_ xi(t) =
1


F total
i (xi(t);xj(t)) (9.1)
with the expression

 = 6Ri (9.2)
yields, for Ri = 15:8m and  = 0:083nNmin
m2 , velocities of about 0:16
m
min.
Displacement-velocity ratio
JKR-interaction between cells yields a force which leads to a distinct velocity depending
on the cell radius. The displacement-velocity ratio for an exemplary cell size of 12:5m is
given in table 9.1, in order to illustrate typical cell velocities.
Initial cooldown of the spheroid
If the simulation is started with a high number of cells, the conguration can either be
read in from a le or obtained via the insertion of cells according to the Monte Carlo
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Figure 9.1: Typical velocity prole of a multicellular tumour spheroid in simulation. Cells in the
necrotic core (0-150 m) are almost motionless. The section between the inner quiescent cells and
the proliferating boundary experiences the greatest pressure (300-400 m). Accordingly, velocities
in this region are high. In the outer proliferating rim of the tumour (500-600 m) the velocity
spectrum is dominated by the mitotic separation velocity of about 0.1
m
min. See also the spectrum
of this velocity distribution in gure 4.3.
cell displacement [m] JKR-force [nN] resulting velocity [
m
min]
0.1 0.27 0.015
0.35 1 0.05
1 3.5 0.18
2 7.2 0.36
4 20 1
13.5 100 5
Table 9.1: Typical cell velocities for average cell radius of 12.5 m, resulting out of a given cell
displacement due to JKR-interaction. Frictional coecient 
  20,  = 0:0833nNmin
m2 .
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(a) speed distribution for initial random congu-
ration
(b) speed distribution after 15 mins
(c) speed distribution after 75 mins (d) speed distribution after 150 mins
Figure 9.2: Cooldown of a randomly initialised cell spheroid. Huge initial overlaps lead to arbitrary
high velocities in the initial conguration (a). These are handled by the global adaptive timestep
algorithm (b). Without proliferation, the corresponding velocities in the spheroid decrease (c+d).
algorithm described in section 8.3. Since optimal packing of spheres in 3 dimensions is
far from being a trivial task, the more suitable option of a Monte Carlo algorithm for
initial cell insertion is used. This algorithm produces congurations with large overlaps.
However, since the simulation comprises an adaptive timestep algorithm, the simulation
stepsize is decreased until reasonable velocities are found and the initial conguration is
equilibrated. An initial cooldown phase without cell cycle progression can be used at the
start of each simulation to obtain the equilibrated system conguration. For an example
of this cooldown see gure 9.2 for the velocity distribution or 9.3 for the visualisation.
9.2 Tissue sorting through cell interaction
Objects that show dierent interaction properties tend to separate when brought into a
mixed state. This behaviour is also found on a larger scale, when considering mixtures
of cells (see gure 7.5, which depicts the basic mechanisms at work). Cell separation has
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(a) t = 0min (b) t = 2min
(c) t = 4min (d) t = 6min
Figure 9.3: Cooldown of a randomly initialised cell spheroid seen in POV-Ray visualisation.
Randomly inserted cells may show huge overlaps at t = 0min in (a). Resulting dynamics are
handled by the adaptive stepsize algorithms (global and local) which leads to a quick equilibration
of the cell positions (b). After 4 minutes the spheroid is largely equilibrated, if cell growth and
proliferation is neglected (c). Only small changes can be observed for the spheroid shown here at
later time (d). Equilibration may take longer for larger systems, but the time is always negligible
when compared to the typical overall simulation timescale.
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(a) initial random conguration after 15 minutes
of interaction
(b) conguration after 735 mins - cluster forma-
tion starting
(c) conguration after 1485 mins - single cells
might be separated temporarily from the popu-
lation by their random walk
(d) conguration after 4485 minutes - dense cell
packing with clusters moving as solid objects
Figure 9.4: Separation of cells with dierent surface energies including active cell movement.
Interaction parameters between similar cells:  = 0:5; E = 1Pa ;  = 0:5nNm 1; between mixed
cells:  = 0:5; E = 1Pa ;  = 0:1nNm 1. Cells repolarise (choose a new random movement
direction) after 100 minutes - velocities for active movement are drawn from a random distribution
with a maximum of 0:3
m
min.
been modelled with great success using Potts model (Graner and Glazier (1992)). See
gure 9.6 for a comparison of the Potts model results with results obtained within the
agent-based approach of this thesis. Moreover, as described in section 7.2, the formation
of organised tissue complexes during ontogenesis depends strongly on dierential cell in-
teractions. Therefore, cell separation is a suitable test system for the cellular interactions
in the agent-based model.
Simulations show separation results in agreement with what is expected from real sys-
tems (see gures 9.4 and 9.5). Within the separation tests, cells are actively moving
with a random velocity drawn from a distribution with a dened maximum. Upon con-
tact between two cells of identical interaction properties, the cells form an aggregate due
to coalescence. This is only mediated by the nite surface energy term, as depicted in
equation 3.7. The aggregates grow with time and tend to become spherical to minimise
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surface energy. Separation of cells from an aggregate is in principle possible, and can be
observed in the simulation (see gure 9.5). The grade of de-mixing observed depends on
the cells' temperature corresponding to the cells' velocity. Higher velocities lead to faster
segregation into clusters of similar cells. However, overly high velocities lead to complete
segregation of all cells, as the velocities get high enough for them to escape binding in a
cluster.
The obtained results clearly show that the given simulation is able to capture the ex-
pected behaviour of a real interacting cell system. Dierential adhesion and changes in
connected cell parameters are of importance for the interaction of tumour tissue with its
surroundings (in particular for invasion and metastasis; see Conde-Ramis et al. (2008) and
Anderson (2005)), opening up the possibility to use the agent-based approach to examine
these phenomena
.
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Figure 9.5: Cell separation due to
dierent surface energies. JKR pa-
rameters for interaction between sim-
ilar cells:  = 0:5; E = 1Pa ;  =
0:5 nN
m; between mixed cells:  = 0:5;
E = 1Pa ;  = 0:1 nN
m. Visualisation
after 30, 750, 2250 and 8520 min of
dynamics (top to bottom). Two dif-
ferent cell \temperatures" were used,
implemented through a random cell
velocity drawn from a distribution
with jvmaxj = 0:3
m
min for the left and
jvmaxj = 1
m
min for the right series.
The grade of de-mixing depends on
the cell temperature. Higher veloc-
ities lead to faster segregation into
clusters of similar cells.
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Figure 9.6: Cell separation within the current model compared to separation results obtained
with the Potts model from Graner and Glazier (1992). Results from the agent-based simulation
are given as lateral cuts through the cell cluster rearranging in 3D (right side; intial conguration
on top, system after 330 min and 10000 min of dynamics below). Results from the Potts model
are 2D (left side; initial conguration on top, system after 100 and 3000 Monte Carlo steps below).
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(a) (b) (c)
Figure 9.7: (a) Cross section of 1m thickness through a tumour spheroid, showing the outer rim
of viable cells and the necrotic core. (b) Cross section of a tumour spheroid simulation obtained
with the application developed within this thesis. The Spheroid is comprised of about 100000
cells. The proliferating boundary, the necrotic core and the quiescent region in between are visible.
Through agent-based modelling it is possible to stain the cells according to their actual cell cycle
phase (lower half of the section). (c) Dierential interference contrast picture of a tumour spheroid
cross section. Images (a) and (c) taken from http://www.vet.purdue.edu/cristal/oci-info.
htm
9.3 Avascular Tumour growth
MCTS growth
Multicellular tumour spheroids (MCTS) are three dimensional cultures of cancerous pro-
liferating cells which can be studied as a model system of avascular tumour growth. The
basic mechanisms which govern their growth were introduced in section 1.2. As MCTS
show a distinct topology as a result of nutrient concentration and cell dynamics, this topol-
ogy, shown in gure 1.2, should be reproducible by an agent-based model as a starting
point for further investigation of tumour dynamics.
Simulations can start with a single cell entered into the system in a random cycle phase
(of interphase). This cell will start to proliferate and eventually form cell colonies which
comprise up to O(6) cells within a simulation run. Cells in the spheroid take up nutrients
for biomass conversion in their metabolism. This is handled in the model via a reaction
diusion system, as described in section 5.4. Exemplary results for these nutrient dynamics
are shown in gure 5.11. The core of the spheroids will usually consist of necrotic cells, due
to extreme nutrient depletion in the inner tumour volume. An interlayer of quiescent cells
is generated either through comparison of nutrient availability or pressure on a cell to the
respective threshold value CG0 or Pcrit at the restriction point (G1=S-transition). Unless
otherwise noted a nutrient-induced quiescence was used throughout the simulations.
Visualisations shown are generated with POV-ray and depict lateral cross sections of
the spheroids. Cell properties such as cycle phase, pressure and mitotic status are stained
in colour. The material presented here is exemplary, more data including videos of the
tumour dynamics is available upon request.
The visualised results e.g. in gure 9.8 show a formation of the typical layered MCTS
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morphology as seen in histological results (see gure 9.7).
The spheroid is growing uniformly up to a threshold of about 6000 cells. Cell cycle
phase synchronisation is declining only slowly over time due to the low randomisation of
the phaselengths (drawn form an uniform distribution with a width of 30% up and down).
Only few cells re-entering the cycle from quiescence are observed in this run. Therefore
their contribution to desynchronisation is small. If an uniform phaselength distribution
with higher width is used, desynchronisation can be reached within few cell cycles.
Limited nutrient availability leads to the rise of a quiescent core shown in gure 9.8(b).
From this point on the tumour is deviating from its projected exponential growth curve
depicted by the dashed line in gure 9.9. This curve models the tumour growth assuming
a simple exponential growth, also referred to as the Malthusian growth in population
dynamics. It can be dened by
Equation 8 (Malthusian growth model)
X(t) = X(0)ert (9.3)
where X(t) is the population size at time t, X(0) the initial population size and r the
growth rate (corresponding to the inverse of the cell cycle time).
Of course this simple model cannot take into account eects of limited nutrient avail-
ability, but in the initial growth phase of the tumour such eects are not present. More
sophisticated models, like the Gompertz model are well suited to model the advanced
growth stages of a tumour (see Lo (2007), Castorina et al. (2007) and section 11.4 in the
appendix).
Within the simulation, continued growth of the boundary layer of active cells eventually
leads to the onset of necrosis. This happens when the nutrient concentration in the core
drops below the dened threshold CN for the induction of necrosis. From this point on
the growth of the tumour spheroid might get close to a saturation, due to mitotic inactive
cells in G0 and dead cells in N balancing the mitotic activity of the outer tumour layer
of dividing cells. The thickness of the dierent cell layers depends on the threshold values
CG0, CN and Pcrit.
The simulation run depicted in gure 9.8 used a critical nutrient threshold to send cells
into quiescence at the restriction point. An alternative approach can be implemented
via the cell pressure, as described in section 7.3. This was done for the simulation run
shown in gure 9.11. Including this mechanism the growth is deviating from the simple
projection done with the help of equation 9.3 right from the start. Onset of necrosis
in this run was due to a combined critical nutrient threshold for glucose and oxygen
(Ccomb = CglCox) determined in Schaller (2006). However the critical nutrient threshold
of Ccomb = 0:035mmol2 was not undercut within the simulation run, therefore no necrosis
was observed.
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(a) t = 3000 min (b) t = 4680 min
(c) t = 6030 min (d) t = 8460 min
Figure 9.8: Growth of a multicellular tumour spheroid visualised with POV-ray. The growth
curve associated with this run is depicted in gure 9.9. Spheroid is growing uniformly up to a
threshold of about 6000 cells in (a). Limited nutrient availability leads to the rise of a quiescent
core shown in gure (b). Continued growth of the boundary layer of active cells eventually leads
to the onset of necrosis, due to nutrient depletion in the inner core, at a tumour size of about
14000 cells (c). This leads to a nal state of growth saturation where necrotic death in the tumour
centre is balanced by mitotic activity of the boundary layer (d). Colour code: quiescent cells (G0)
in blue, viable cells (G1, S, G2) in turquoise, necrotic cells (N) in grey.
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Figure 9.9: Growth curve for the multicellular tumour spheroid visualised in gure 9.8. Depending
on the thresholds for the induction of quiescence (CG0) and necrosis (CN) the tumour is dominated
by a large population of quiescent cells. Due to the composition of the tumour in spherical shells
the amount of quiescent cells in the intermediary layer (with a larger radius) will always be bigger
than the amount of necrotic cells.
According to the observed deviation from exponential growth pressure inhibition alone
could suce to reach a growth saturation within the tumour spheroid. However, this
question is the target of further investigations.
Growth curves compared to experimental results
Data obtained within the simulation is compared to experimental growth curves in g-
ure 9.12. Experimental data was taken from Freyer and Sutherland (1986): within
these experiments the oxygen and glucose concentration on the system boudary was
xed during the cultivation of EMT6/Ro multicellular tumour spheroids. Dependence
of growth saturation and onset of necrosis upon the nutrient concentrations were stud-
ied. Data in Freyer and Sutherland (1986) comprises tumour radius and cell number
estimates for two dierent populations, therefore the error of the growth curves is sup-
posed to be high. Extraction of the datapoints was done with the help of scah2.6 http:
//th.physik.uni-frankfurt.de/~drescher/soft/scah2.6.
The nutrient conditions were modelled to suit the ones used in the experiment of Freyer
and Sutherland (1986), using Dirichlet type boundary conditions as described in section 5.4
(glucose concentration of 16.5 mMol, oxygen concentration 0.28 mMol). A quiescence
threshold depending on a single nutrient concentration (glucose) was used in addition to
the growth-induced quiescence depending on cell pressure. Necrose was induced upon
undercut of a critical glucose threshold dened by CN.
The simulation results correspond to the results obtained experimentally. However,
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Figure 9.10: Runtime statistics for the simulation run of the multicellular tumour spheroid visu-
alised in gure 9.8. Timestep for propagation of the system is controled by the global and local
adaptive timestep algorithms described in section 4.3. Average cell velocity is dominated by ve-
locities resulting from mitotic separation forces and cell growth. Maximum cell velocity vmax is
rising with the pressure inside the tumour. Upon onset of quiescence vmax is falling again due to
reduced growth inside the tumour volume.
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Figure 9.11: Growth curve for a multicellular tumour spheroid growing under the restriction of
pressure-induced quiescence as described in section 7.3. Overall growth of the tumour is deviating
from the simple exponential growth projection right from the start due to cells being sent to
quiescence. Initial conguration consisted of one malignant and four quiescent cells, explaining the
initial deviation from exponential growth (before 3000 min).
there are signicant deviations which are to be discussed.
All simulation results shown are derived from agent-based models starting with a single
malignant cell. Therefore the initial growth is exponential and following the projected
growth (given by equation 9.3). Simulation I and II are growth curves obtained with the
application developed within this thesis. Simulation III is a growth curve from the agent-
based model of Schaller (2006), presented here for comparison of the used mechanisms.
When compared to growth curves obtained within this thesis (I+II), the growth curve of
simulation III shows a qualitative dierent behaviour in respect to the curvature between
8 and 12 days. The correspondence of simulation III with the experimental data is higher,
suggesting that the mechanism in use are better suited to model the tumour growth. The
main dierence between simulations I+II and simulation III is the cause of quiescence and
necrose. Within the simulation III, quiescence is induced by overly cell pressure (Pcrit =
600Pa; cell radius rtar = 5m). Although simulations I and II include an additional
mechanism for the induction of quiescence in the form of a critical nutrient threshold CG0,
their growth exceeds the growth observed in simulation III. This might be a result of the
dierent cell pressure threshold used (Pcrit = 300Pa; cell radius rtar = 14m) or of the
dependece of necrosis on a single nutrient (glucose) instead of a critical product of two
nutrients.
However, the growth curves obtained within agent-based modelling approaches are in
good correspondence to the experimental ones. This shows that the main mechanisms of
tumour growth were successfully modelled. An enhanced derivation and implementation
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Figure 9.12: Comparison of growth curves from agent-based simulations within this
thesis (Simulation I + II) and Schaller (2006) (Simulation III) to experimental results
from Freyer and Sutherland (1986). Discussion of results within the text. Values ex-
tracted from Freyer and Sutherland (1986) with the help of scah2.6 http://th.physik.
uni-frankfurt.de/~drescher/soft/scah2.6.
of growth parameters from experimental results would further improve this correspondence
(see section 11.2).
9.4 Fingering of tumours
Tumour spheroids may show a certain degree of irregular growth. This phenomenon,
called ngering, is discussed in the literature (see Anderson et al. (2006) and Macklin and
Lowengrub (2007)). If the growth of the spheroid is aected by a deviation from spherical
symmetry, this protuberance nds perfect nutrient conditions outside of the spheroid. This
adds a bias to the global growth of the spheroid and leads to the formation of a \nger"
on the tumour surface.
This phenomenon is also visible in agent-based simulations of tumour growth, as de-
picted in gure 9.13. The driving mechanisms behind the formation of the nger are the
same as in vivo. Cells leaving the boundary surface of the tumour are always subject to
optimal nutrient conditions and experience only small pressure forces from few neighbour-
ing cells (according to equation 7.7) at the same time. The ngering occurs even though
the mechanism for boundary pressure, described in section 7.2, is in use. Within this
approach every cell on the boundary layer of the spheroid (a situation which can be easily
detected with the help of the triangulation) is aected by a small force of 1nN towards the
origin (corresponding to the spheroid centre). This imposes a penalty on the formation
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of protrusions, but they nevertheless can be observed in the simulation. Fingering results
are reproducible, as shown in gure 9.14.
Proliferating cell fronts of the ngers consume a high amount of nutrients, reducing the
concentration below the threshold necessary in order to re-enter the cycle from quiescence.
Therefore, cells within the indentations stay in quiescence.
Parameters leading to an increased development of protrusions throughout the tumour
growth are of great interest, since they are of importance for invasion and separation of
parts from the tumour in metastasis (see also gure 9.15).
The main dierence between the runs showing distinctive ngering and the ones with
low levels of ngering was the usage of a prolonged phase-synchronisation of cells within
the former ones. Increased synchronisation lead to a growth of the tumour in spurts. Cycle
phaselengths were not drawn from a random distribution, but rather used as given in the
parameter le. Therefore, the only mechanism leading to desynchronisation of cell growth
is found in quiescent cells which re-enter the active cycle phases. While these cells are
present within the simulation runs under consideration, their number remains extremely
small compared to the overall cell count.
The eects of cell cycle synchronisation on the dynamics of the tumour development
are therefore of interest for further investigations.
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(a) Spherical tumour symmetry after t = 6000
min.
(b) Random development of a irregularity after t
= 9250 min.
(c) Continued growth of the protuberance after t
= 12300 min.
(d) Fingering of the tumour after t = 15700 min.
Figure 9.13: Tumour spheroids may show a certain degree of irregular growth (described as
\ngering" in the literature). If the growth of the spheroid is aected by a deviation from spherical
symmetry this protuberance nds perfect nutrient conditions outside of the spheroid. This adds a
bias to the global growth of the spheroid and leads to the formation of a \nger" on the tumour
surface. Final spheroid shown comprises about 150000 cells. Cell colour: green (G1,S,G2), red
(re-entered from G0), blue (G0), grey (N). Cells send into G0 due to a critical nutrient threshold.
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(a) Spherical tumour symmetry after t = 5800
min.
(b) Random development of a irregularity after t
= 8500 min.
(c) Continued growth of the protuberance after t
= 12000 min.
(d) Fingering of the tumour after t = 14250 min.
Figure 9.14: Reproducability of irregular growth (ngering) in tumour spheroids within a agent-
based model. Derivation from spherical symmetry may lead to a protuberance that tend to grow
due to better nutrient conditions outside of the tumour volume (shown in gure 9.13). This
penomenon is reproducible for dierent parameter sets. Final spheroid shown comprises about
51000 cells. Cell colour: green (G1,S,G2), red (re-entered from G0), blue (G0), grey (N). Cells
send into G0 due to a critical nutrient threshold.
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Figure 9.15: Simulation of the initial stage of an avascular tumour spheroid surrounded by healthy
tissue (about 41.000 cells in total). Malignant core started with a single cell and shows an invasive
mixing with the surrounding benign tissue upon proliferation.
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Particle therapy is a form of external beam radiotherapy that uses beams of protons,
neutrons, or atomic nuclei. In order to distinguish the therapeutical use of these particles
from the use of photons and electrons, particle therapy is also referred to as hadron
therapy (if it makes use of protons and neutrons) or heavy ion therapy (if it makes use
of more massive particles, such as carbon nuclei). There are few cases where conservative
methods of radiation treatment with photons and electrons are preferable, for example
tumours of the eye or tumours with low penetration depths in general. Conservative
methods are also available at lower costs, and require less technical equipment, as usually
no linear accelerator or synchrotron is needed. However, in the majority of cases, heavy
ion radiation is superior to conservative treatments, due to the many advantages that
will be discussed throughout this chapter. As treatment costs are decreasing its general
availability is rising, with heavy ion therapy centres under construction throughout the
world (e.g. the HIT, Heidelberg 1 going online in fall 2008).
Investigation and realistic modelling of the processes involved is therefore of high in-
terest. The important mechanisms for therapeutical success are discussed within this
chapter.
A very wide variety of tumours can be eectively treated with hadron therapy, including
all solid tumours (e.g. in the brain, lung, skin or stomach). Due to the fact that, in hadron
therapy, the radiation dose can be deposited very precisely with only limited eects on the
surrounding tissue, it is also suited to be used in treatment of tumours which are located
next to vulnerable regions, such as the CNS.
Treatment of tumours with heavy ions (such as carbon) has shown to be a promising
therapy for inoperable tumours. First trials started in 1997 at the GSI, Darmstadt2 and
the success rate was outstanding, with tumour growth stopped in 75-90% of all cases.
Heavy ions exhibit a multitude of advantages and characteristics favourable to radiation
therapy, such as:
 Preferable dose distribution
 High Relative Biological Eectiveness (RBE) because of high linear energy transfer
(LET)
 Smaller dependence on oxygen concentration
1http://www.klinikum.uni-heidelberg.de/Heidelberger-Ionenstrahlen-Therapie-HIT.1165.0.
html
2http://www.gsi.de/portrait/Broschueren/ionenstrahlen_e.html
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Radiation type Interaction mechanism Comment

 Photoelectric eect Low energy (E  0:1MeV )
Compton eect Mid-energy (0:05MeV  E  1MeV )
Pair production High energy (1MeV  E  6MeV )
 Ionisation
Bremsstrahlung
-electron production
Charged particles Ionisation
Nuclear interaction
Table 10.1: Important interaction mechanisms of radiation (not exhaustive).
 Reduction of cell repair due to cluster damage
 Less variation in radiosensitivity throughout the cell cycle
These advantages will be explained in the following chapter.
10.1 Properties of particle radiation
Heavy-ion beams oer favourable properties for treatment, especially for deep-seated local
tumours. In contrast to photon beams, they have an inverted depth-dose prole (Bragg
curve) and the narrow Bragg peak can be adjusted precisely to the desired depth by
variation of the beam energy. In addition, ions heavier than protons oer an enhanced
biological eectiveness in the Bragg peak region, which can be explained by the very
dense ionisation towards the end of the particle track. In order to understand the special
properties of particle radiation, the interaction mechanisms of radiation with matter have
to be introduced brie
y.
Interaction of radiation with matter
Radiation can interact with matter in a multitude of ways, with some of the important
ones for hadron therapy depicted in table 10.1.
Ionisation is one of the most important mechanisms for the interaction of radiation
with a cancerous cell. In the most common case, a positively charged ion is produced
when an electron bonded to an atom absorbs enough energy to escape from the electric
potential barrier that originally conned it. The energy required for this process is called
the ionisation potential. In order for a particle to be ionising, it must both have a high
enough energy and interact with an atom of the target. Photons and charged particles such
as electrons, positrons, and alpha particles interact strongly with atoms and molecules, so
they can be ionising. An ionisation event normally produces a positive atomic ion and an
electron.
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Figure 10.1: Interaction mecha-
nisms for  (nuclei),  (electron), 

(photon) and neutron particles with
matter as explained in section 10.1.
Image is in open domain under terms
2.
Neutrons do not interact strongly and therefore do not cause ionisation directly. How-
ever, neutrons may collide with protons of the target material, which then turn into fast
and ionising recoil protons. Eventually neutrons may be captured by a nucleus in a (n,
)-
reaction, leading to a neutron capture photon being released.
High-energy beta particles may produce bremsstrahlung, or secondary electrons (delta-
electrons) when passing through matter; both can ionise and thus broaden the ion track
in tissue.
Gamma rays do not ionise all along their path, but rather interact with matter in
one of three ways: the photoelectric eect, the Compton eect, and pair production (see
table 10.1). Through the photoelectric eect electrons are emitted from matter after the
absorption of energy from electromagnetic radiation such as gamma rays. In a Compton
scattering event, the gamma ray transfers energy to an electron, and it continues on its
path in a dierent direction with reduced energy. Pair production is the creation of an
elementary particle and its antiparticle. This is allowed provided that there is enough
energy available to create the pair and that both energy and momentum can be conserved
(e.g. when a nucleus is present).
If radiation consisting of nuclei is interacting with matter, nuclear reactions along the
penetration path lead to a fragmentation of the initial nucleus and a build-up of lower-Z
fragments with increasing penetration depth. These fragments are responsible for the tail
distribution seen in gure 10.2. This tail develops due to the fact that the range of the
particles scales with Z2 according to the Bethe-Bloch formula (equation 10.1). However,
this tail distribution is relatively small for the common case of carbon ions. Furthermore,
the fragmentation can be used in Positron emission tomography-techniques (PET) for
in-vivo location of the Bragg peak as described later on.
Obviously there is a multitude of possible mechanisms which mediate the interaction
between heavy ions and tissue. However, since it will only be possible to model a simplied
system of interactions, within this thesis most mechanisms were not implemented directly.
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Energy deposition prole and LET
In contrast to photons, charged particles deposit most of their energy at a specic depth
inside the tissue depending on their energy. This region at the end of their track is the so
called Bragg peak. The phenomenon can be understood with the help of the Bethe-Bloch
formula, which describes the energy-loss by ionisation of swift charged particles (protons,
alpha particles, atomic ions, but not electrons) traversing matter.
Charged particles moving through matter interact with atomic electrons in the material.
These interactions may lead to excitation or ionisation of the atoms. The Bethe formula,
found by Hans Bethe in 1930 (see Bethe (1930)), describes the energy loss per distance
traveled:
Equation 9 (Bethe-Bloch formula)
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with  = v=c, v velocity of the particle, E energy of the particle, x penetration
depths, c speed of light, Z e particle charge, e electron charge, me rest mass of the
electron, n electron density of the target, I mean excitation potential of the target,
and "0 permittivity of free space.
The electron density of the material can be calculated by n =
NAZ
A , where  is the
density of the material, Z;A the atomic number and mass number, and NA the Avogadro
number.
A depth-dose prole (Bragg curve) resulting from equation 10.1 exhibits a 
at plateau
region in the entrance channel and a distinct peak near the end of the particles' range
(depicted in gure 10.2 and 10.3). This dose deposition behaviour of heavy ions is one of
their major advantages in radiotherapy.
In photon radiotherapy, on the other hand, the dose is deposited in stochastical inter-
actions along the whole path of the radiation, which confers a high dose to healthy tissue
in the entrance channel (compare gure 10.4).
Low lateral scattering of heavy ions allows for an improved dose conformity inside
the tumour. This again results in a lower integral dose deposited in the healthy tissue
surrounding the tumour, tremendously reducing the probability of developing secondary
cancer. Heavy ion therapy is thus favourable for tumours in the vicinity of sensitive or
vital organs.
Linear energy transfer (LET)
The linear energy transfer (LET) is a measure of the energy transferred to material as an
ionising particle travels through it. According to the behaviour of heavy ions, the LET is
greatly increased at the end of the ion's track. The LET is usually expressed in units of
keV=m.
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Figure 10.2: Deposition prole for a carbon beam in water measured at GSI, Darmstadt.
Deposition follows a Bragg curve as dened by the Bethe-Bloch formula (equation 10.1).
Fragmentation of the ion projectile is visible through the generation of secondary and
tertiary fragments. The data points are compared to a model calculation (solid lines).
From Schardt and The Heavy-Ion Therapy Collaboration (2007).
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Figure 10.3: (a) Calculated depth-dose prole for a 195MeV=u 12C beam. (b) Survival
of Chinese Hamster Ovary cells (CHO) as function of depth in water. From Schardt and
The Heavy-Ion Therapy Collaboration (2007).
Figure 10.4: Dose deposition
curves for dierent types of radi-
ation. Note that photons deposit
their energy in a multitude of
stochastic interaction processes
yielding a exponentially decaying
prole. Within hadron therapy
particles such as protons show an
inverse deposition prole with a
distinct Bragg peak according to
equation 10.1. This behaviour
results in a great advantage for
therapeutical use of hadrons.
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Figure 10.5: Ion track structure
showing the generation of -electrons
and ionisation events. Figure from
http://www.gsi.de/forschung/bio/
delta_electron_e.html.
Ion track and secondary particle production
An accelerated heavy ion penetrating tissue usually triggers a cascade of events (shown in
gure 10.5). About two thirds of the dissipated energy is transformed into kinetic energy
of -electrons (see Surdutovich et al. (2008)). These then produce secondary and tertiary
ionisation processes around the ion's trajectory, which form the ion track. The energy
spectrum of the emitted delta-electrons determines the diameter and the local dose inside
the track. This cascade is the main reason for the great dierence in biological eect
when comparing e.g. photons and ions in radiation treatment (see Kraft et al. (1999)).
According to the energy deposition prole of heavy ions, the majority of energy loss occurs
at the end of the ion's track. This means that most of the events are also triggered at
large penetration depths.
A multitude of Monte Carlo methods (SHIELD-HIT, FLUKA, GEANT, PHITS) are
in use for transport calculations in human tissues. Therefore, the energy deposition in
heavy ion irradiation can be studied with the help of sophisticated model kits for particle
interaction such as GEANT4 (as it is done e.g. in Pshenichnov et al. (2005)).
From LET to Relative biological eectiveness of radiation
The relative biological eectiveness (RBE), that describes the impact of radiation on
tissue, is drastically increased for ions with Z  2 as compared to protons. That is why
ions heavier than protons are called \heavy ions" in radiobiology, although they are light
compared to those referred to by the same terminology in nuclear physics.
The main reason for an elevated RBE is the increase in ionisation density in the individ-
ual tracks of the heavy particles, where DNA damage becomes clustered (see Kraft et al.
(1999)). For carbon ions the strongly elevated RBE region is restricted to the end of the
particle range, while in the entrance channel DNA damage that can be repaired predomi-
nates. The basis for the increased RBE of heavy ions is the localised dose deposition, that
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leads to the production of clustered DNA lesions which are dicult to repair (visualised in
gure 10.6). They can be indirectly visualised in nuclei of mammalian cells by microscopy
of immuno-stained repair proteins recruited to the damaged sites (see gure 10.7).
Because RBE depends on the possibility to repair the damage produced in the DNA,
the repair capacity of the irradiated tissue becomes relevant. In general, slowly grow-
ing tumours have a great repair capacity and are normally very radioresistant. For ion
treatment they show the greatest increase in RBE. This is why these tumours are most
appropriate for a therapy with carbon ions.
During treatments the actual physical dose has to be adjusted to the RBE by an iterative
procedure, in order to achieve a homogeneous biological eect.
10.2 Eects of heavy ion radiation on the cell
As introduced in the previous section, there exists a multitude of interaction mechanisms
on the sub-nuclear and nuclear level for heavy ions and matter, either for the primary
nucleus, its fragmentation parts or secondary particles. This spectrum results in multiple
ways how irradiation with heavy ions can aect a cell.
The main mechanism of action is the irreparable damage of DNA in cells that lie within
the treated area. As in chemotherapy, the ability of healthy cells to repair DNA damage
is superior to cancerous cells, further limiting the eects of radiation treatment on sur-
rounding tissue. For this reason radiation therapy is usually given in fractions, allowing
healthy tissue to recover between the treatments.
If the dose of irradiation is very high, the eect of irradiation on tissue may be seen
immediately, in the form of radiation poisoning. Lower doses, as applied in therapeutical
irradiation, have more subtle eects.
DNA damage
The radiobiological eciency of charged particles is mainly characterised by their local
ionisation density, which can directly be correlated to the local density of DNA damage.
Heavy ions (especially carbon) at high energies have a suciently low ionisation density
in the entrance region, and act mainly like photons, i.e. producing mostly repairable DNA
damage. Due to the particles slowing down towards the Bragg peak the ionisation density
increases signicantly, resulting in severe cluster damage to the DNA (see gure 10.3 for
actual survival rates and Scholz and Kraft (1996) for detailed description of the underlying
mechanisms).
DNA damage may come in various degrees, ranging from single strand breaks (SSB)
over double strand breaks (DSB) to severe cluster damage (CD). In general, SSBs can be
repaired by the cell without problems due to the redundancy of the genetic code. DSBs
are usually more severe events for the cell. They may result in wrong recombinations of
the DNA or even complete inability of the cell to repair the damage. In that case, the cell
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Figure 10.6: Damage to a DNA
helix due to dierent types of
radiation. While X-rays in
ict only
limited damage on the strands a hit
with heavy ion radiation generates
severe cluster damage. This is
partially a result of the generation
of secondary particles. Due to the
fact that heavy ion radiation can be
delivered very accurately this eect
can be applied to fray the DNA of
cancerous cell beyond repair. Source
image from http://www.nasa.gov/
centers/marshall/images/
content/98984main_1025SR.jpg
might use the apoptotic pathway to eliminate the potential genetic damage from the larger
tissue, or it will most likely die because of damage to its protein synthesis system. If DNA
damage is non-lethal for the cell, it may be passed on to the next cell generation which
might eventually lead to the onset of cancer (as it is often seen in the form of secondary
cancer in irradiation entry channels). Cluster damage to the DNA is most often so severe
that it leads to the \immediate" death of the cell (or at least clonogenic death, through
the end of mitotic activity).
.
Other impact mechanisms on the cell
Besides the mechanisms for interaction of radiation with the tissue described in the previ-
ous sections there are even more ways for the radiation to aect the tissue dynamics. The
energy deposited in a tissue by irradiation leads to an increase in the tissues temperature.
This eect can be used within a water calorimeter to determine the absorbed dose within
experiments. However, this eect does also aect the cells, since on a local scale the in-
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crease in temperature can be quite high. Within normal tissue, heating will lead to an
increase in blood 
ow through the tissue in order to cause cooling. The increased blood

ow will also deliver oxygen into the aected area. Since the blood supply in avascular
tumours is poor, the usage of blood 
ow to cool down the tissue is limited. This fact can
be used within hyperthermia-treatment to slow down the tumour growth. In combination
with sophisticated heat-delivery methods, as i.e. tumour-targeting gold-nanoparticles and
microwave-heating, this approach can even destroy parts of tumours.
Another secondary eect of radiation is the production of free radicals through water
radioloysis. The ionisation of water molecules leads to the creation of for example hydrogen
H and hydroxy OH free radicals (and many others such as reactive oxygen species
(ROS)). These radicals are highly reactive as they attempt to form a covalent bond. That
is, they can break an existing bond within another molecule and thus destroy organic
components of the cell.
Equation 10 (Reaction of a free radical)
RH + OH ! R  +H2O (10.2)
where R can be an arbitrary organic molecule.
Free radicals are cancerogenetic, but, within the context of radiation treatment, play an
important part in the damaging of cancerous cells (see Dewhirst et al. (2008) and Anderson
et al. (2006)).
Lack of tumour oxygenation has long been recognized as a signicant factor causing
resistance to radiotherapy. This decreased radiosensibility complicates the treatment with
conventional radiation. Heavy ion radiation has an greatly increased eect on hypoxic
tissues when compared to conventional radiation treatment, as it does not depend on
radiolysis to an large extent (Kr amer et al. (2003)). Its high LET is a possible strategy
to overcome hypoxia-induced radioresistance as it is known to be less dependent on tissue
pO2.
Eect on mitochondrial DNA
As it was brie
y mentioned in chapter 2, the mitochondria within the cell carry a set
of genetic code called mitochondrial DNA (mtDNA) on their own (see Nass and Nass
(1963)). Irradiation of cells will also aect the mtDNA with the same mechanisms that
were described in the previous section.
Even though the vast majority of proteins present in the mitochondria are coded for by
the nuclear DNA, this might have eects on the protein production in the mitochondria.
Eects on the mitochondria will eventually lead to defects in the cell metabolism. The
eect of mtDNA-damage might be even quite pronounced, as it is known that mtDNA is
particularly susceptible to oxidative damage, as mediated by free radicals. However, since
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Figure 10.7: Microscopic visualisation of the ex-
tremely localised DNA damage induced in nuclei
of mammalian cells following irradiation with ac-
celerated ions. Immuno-
uorescence stained repair
proteins accumulate at the lesions along the indi-
vidual ion tracks traversing the nucleus of a hu-
man cell, appearing as parallel streaks. DNA coun-
terstain (Propidium Iodide) in blue, repair protein
(Mre11) in purple. Source image from www.gsi.
de/forschung/bio/dna_damage_repair.html
each mitochondrion is estimated to contain up to 10 mtDNA copies (see Wiesner et al.
(1992)), this eect might depend on multiple hits.
10.3 Beam generation and delivery methods
Production of heavy ion beams
Modern radiation therapy makes use of linear accelerators (linacs) to generate high quality
radiation for treatment. A typical linear particle accelerator comprises multiple important
parts (see gure 10.8). The source provides the particles for acceleration, which might be
electrons (for e.g. from a cathode), protons or ions (from specialised ion sources). The
design of the source depends on the particle that is being accelerated. The initial injection
is usually done with a high voltage source that shoots the particles into an evacuated
cylindrical cavity. Lengths of this tube vary greatly, from about half a meter for x-ray
acceleration to several kilometres as primary accelerator for a synchrotron. The cavity
contains cylindrical electrodes which get longer from the injection point towards the end
of the cavity. The length of each electrode is determined by the frequency and power of
the driving power source and the nature of the particle to be accelerated, with shorter
segments near the source and longer segments near the target. A source of radio frequency
energy is used to energise the cylindrical electrodes. Accelerators of high power use one
source for each electrode. Acceleration is achieved through precise switching of the eld so
that particles are always attracted by the next electrode and repulsed by the last electrode.
This requires power, frequency and phase to be exactly regulated. Accelerated particles
are either extracted to a target, stored in a ring with the help of magnetic elds, or injected
into another accelerator (e.g. a synchrotron).
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(a) Linac construction principle (b) Section through a linac
Figure 10.8: (a): A linear accelerator in principle (b): Picture of a cut through a
linac. Note the growing size of the drift tubes. Image (a) is in open domain un-
der terms 2, (b) from http://pfzema.cs.infn.it/pfzema/photos/CERN-03summer/Microcosm/
html/Microcosm_-_Linac.html
Beam application methods
Conventional external beam radiotherapy (2DXRT)
The most basic delivery method is the 2DXRT method, in which the radiation beam from
a linac is delivered to the patient from several directions. Radiation planning is done on a
x-ray based simulator. 2DXRT is cheap and reliable, but not applicable in most sensitive
treatment areas. As an outdated treatment method, 2DXRT is being increasingly replaced
by 3DCRT.
3-dimensional conformal radiotherapy (3DCRT)
Through the availability of new imaging methods, such as CT and MRI, treatment planing
was greatly improved, as the tumour can now be delimited precisely from the surrounding
healthy tissue.
An enhancement of virtual simulation is called 3-Dimensional Conformal Radiotherapy
(3DCRT), in which the prole of each radiation beam is shaped to t the prole of the
target from a beam's eye view (BEV), using a multi-leaf collimator (MLC) and a variable
number of beams. As a result of the treatment volume conforming to the shape of the
tumour, the relative toxicity of radiation to the surrounding normal tissues is reduced,
allowing a higher dose of radiation to be delivered to the tumour in comparison with
conventional techniques.
A typical MLC consists of 2 sets of 20-40 leaves, each around 5 mm thick and several
cm in the other two dimensions. Newer MLCs now have up to 120 leaves. Each leaf in the
MLC is aligned parallel to the radiation eld and can be moved independently to block
part of the eld. This allows the dosimetrist to match the radiation eld to the shape of
the tumour, thus minimising the amount of healthy tissue being exposed to radiation. On
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a machine without an MLC this must be accomplished using several hand-crafted blocks.
Using a MLC to shape the beam, however, imposes serious disadvantages on the beam
quality due to fragmentation and diraction of the beam. Furthermore, beam losses and
contamination by nuclear fragmentation in passive beam shaping elements in front of the
patient are likely.
Intensity-modulated radiotherapy (IMRT)
The next step in beam delivery is the IMRT, an advancement of 3DCRT. IMRT also
improves the ability to conform the treatment volume to concave tumour shapes, for
example when the tumour is wrapped around a vulnerable structure, such as the spinal
cord or a major organ or blood vessel.
Computer-controlled x-ray accelerators distribute precise radiation doses to malignant
tumours or specic areas within the tumour. The pattern of radiation delivery is deter-
mined using highly-tailored computer applications to perform optimisation and treatment
simulation (Treatment Planning). The radiation dose is made consistent with the 3-D
shape of the tumour by modulating the radiation beam's intensity. In some systems this
intensity modulation is achieved by moving the leaves in the MLC during the course of
treatment, thereby delivering a radiation eld with a non-uniform, modulated intensity.
IMRT is especially useful when treating tumours near complicated body sites such as
CNS, head and neck, prostate, breast and lung. Unfortunately, IMRT is limited by its
need of additional time from experienced medical personnel in order to design an individual
treatment plan.
Image-guided radiation therapy (IGRT) / 4DXRT
IGRT augments radiotherapy with imaging in order to increase the accuracy and precision
of target localisation, thereby reducing the amount of healthy tissue in the treatment
eld. Real-time imaging is combined with real-time adjustment of the therapeutic beams.
This new technology is called image-guided radiation therapy (IGRT) or four-dimensional
radiotherapy.
IGRT makes use of a fully-active intensity-controlled beam delivery system, in which
the particle beam is scanned across the target volume by horizontal and vertical scanning
magnets. This is done in multiple slices, in order to irradiate a target volume exactly
equal to the tumour. The underlying principle is analogue to the generation of an image
on a TV screen by the scanning of an electron beam. Penetration depths for the slices can
be regulated through the synchrotron control system, which provides a pre-dened set of
beam energies corresponding to dierent positions of the Bragg peak. Beam intensity and
focussing may be changed from pulse to pulse by the therapy control system.
The treatment is done in a 3D irradiation matrix, which typically consists of about
20.000 raster points. In order to ensure that each voxel receives exactly the planned
dose, the scanning system has to be intensity-controlled and needs a feedback from a
fast beam monitor. This has the clear advantage that any prescribed 3-dimensional dose
distribution can in principle be generated. Therefore, also tumours near critical structures
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Figure 10.9: Principle of the magnetic scanning system at GSI. The target volume is irradiated by
moving the ion beam (80-430 MeV/u 12C) with fast magnets over each slice. The required beam
energies - corresponding to the depth of the Bragg peak for each slice - are supplied on a pulse-
to-pulse operation by the synchrotron (SIS) control system. From Schardt and The Heavy-Ion
Therapy Collaboration (2007).
like the brain stem and optical nerves can be treated with maximum eciency. With the
present system the dose can be deposited with millimetre precision, but this implies that
it must be possible to immobilise the patient with about the same precision.
The irradiation of moving targets (such as the lung) demands new strategies, like for
example the development of a real-time motion-compensating system.
PET-techniques for in-situ range verication
Another plus of the carbon ions is the small amount of nuclear fragmentation of the
projectile ion. This is frequently seen as a drawback compared to proton irradiation,
because it produces a small tail of dose beyond the Bragg maximum consisting of protons
and other light ions, as shown in the previous section.
However, through the production of positron-emitting carbon isotopes 10C and 11C,
it becomes possible to measure the actual beam position by the coincident registration
of the annihilation quanta. As the isotope undergoes positron-emission decay it emits a
positron, which, after travelling up to a few millimetres, encounters and annihilates with
an electron. This produces a pair of annihilation photons of discrete energy moving in
opposite directions. Coincident recording of the annihilation radiation in two opposite de-
tector heads and applying tomographic reconstruction algorithms opens up the possibility
to calculate their origin (see gure 10.10 for a sketch of the method).
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Figure 10.10: Left: Principle of the in-situ range verication by PET techniques. Right:
Superposition of a measured +-activity distribution (contour lines) and the corresponding frontal
slice of patient CT data. The carbon beam entered from top right, the PET-detector heads were
located vertically above and below the patient table. From Schardt and The Heavy-Ion Therapy
Collaboration (2007).
According to this PET-data it is possible to adjust the beam position in real-time, in
order to correct deviations from the planed target position. This confers an advantage to
carbon ion irradiation comparable to actually seeing a target while shooting at it instead of
ring blindly. A comprehensive overview of the positron-emission in heavy ion-treatment
can be found in Pshenichnov et al. (2006) and Pshenichnov et al. (2007).
Clinical results
Since December 1997 more than 300 patients were treated at the GSI, Darmstadt, most
of them within clinical phase I/II trials. Standard treatment procedure encompased a
fractionated carbon ion irradiation in 20 consecutive days with a median total dose of 60
Gy, which was well tolerated without severe side eects. Three-year local control rates
of 81% for chordomas, 100% for chondrosarcomas and 62% for adenoid cystic carcinomas
were reported (for detailed statistics see Schulz-Ertner (2004)).
Especially treatment of inoperable tumours in the skull-base region was of high success
(see Schulz-Ertner (2007) and gure 10.11 for an example for tumour regression after
carbon ion treatment).
Due to the overall positive clinical results obtained in the GSI pilot project, a dedicated
hospital-based ion treatment facility is under construction in Heidelberg, Germany. The
facility will have a planned capacity of 1000 patients per year. The accelerator will consist
of a rf-linac and a synchrotron, providing beams of protons, helium-, carbon- and oxygen-
ions.
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Figure 10.11: Regression of a chordoma. Left: before treatment. Right: 6 weeks after carbon ion
radiotherapy. Source picture from Schardt and The Heavy-Ion Therapy Collaboration (2007).
10.4 Mechanism of irradiation simulation
A variety of models for the complex eects of radiation therapy on tissue exists (see e.g
Dionysiou et al. (2004), Ribba et al. (2006) and Zhang et al. (2007)). However, these
models are often limited, in a sense that they are specialised to suit a specic treatment
situation. Most of them rely on an abstract implementation of processes which can be
modeled for themselves (such as mitosis or necrosis). Although these models can be used
to investigate certain parts of the irradiation process, most of them are lacking spatial
resolution and cannot integrate experimental parameters, as it is possible in a force-based
model.
The basis for an realistic model of irradiation simulation will be a detailed dose depo-
sition prole from an advanced simulation environment for particle interaction such as
GEANT4. It is possible to calculate the deposited dose for a distinct position e.g. every
cell's nucleus within this approach. Furthermore, even the type of radiation acting on a
cell can be determined in the simulation, and therefore the activation of very distinct and
realistic mechanisms becomes posible.
However, to develop this model of extremely complex processes, which are at the base
of a tumour's reaction to irradiation, is beyond the scope of this thesis. It is the target of
continued work within the CARADI project mentioned in section . However, to demon-
strate the principal feasibility to model these eects within an agent-based approach, a
simplied system of irradiation was implemented and tested within this thesis.
Neglecting the details of the multitude of available mechanisms for the impact of radia-
tion on a cell leads to an eective summation of these mechanism's eects (as depicted in
gure 10.12). These eects include:
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DNA damage
Irradiation
Cell death
Clonogenic Death
Cluster damage SSB/DSB
Futile repair Successful repair
Reenter cycle
Figure 10.12: Sketch of the implemented mechanism for tumour irradiation. A dened tumour
volume can be treated with the irradiate-function. Each cell within the volume is aected in a
way that either results in interphasic death (i.e. through cluster damage), or simple DNA damage
(single strand breaks or double strand breaks) with a dened probability. DNA damage may be
repaired re-entering the cell into the cycle or, after a distinct threshold of futile repair tries, the
cell undergoes clonogenic death through senescence in G0.
 interphasic death: cells are sent into necrosis straight away due to severe damage
 DNA damage: cells not dying of interphasic death are marked as DNA-damaged
and cannot pass the G2 checkpoint until repair
{ at G2-checkpoint cells are marked as repaired with a distinct probability
{ otherwise the repair-trial count is increased
{ upon a too high trial-count cells are sent into senescence (clonogenic death;
permanent G0)
 mitotic death: cells can only undergo a distinct number of further mitotic events
before being sent into senescence
 accelerated dierentiation: cells go into terminal dierentiation (clonogenic death)
Irradiation in this simplied application is handled in the following way by the irradiate
function. A treatment centre and radius is passed to the irradiate-function which then
brings cells which lie within this volume into necrosis with a predened probability (inter-
phasic death). Possible modications and extensions include necrosis-probability depen-
dency upon the distance to the irradiation centre or on the RBE of the used radiation.
Alternatively, the whole tumour may be treated. Cells which are not sent into direct
necrosis are marked as DNA-damaged. This prohibits cells from passing the G2=M check-
point until the damage is repaired. Again this is handled via a stochastic process, giving
the cell a repair chance within distinct timesteps. If this chance is missed multiple times,
the cell is nally sent into senescence (clonogenic death). Mitotic death and accelerated
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dierentiation are not accounted for in the model directly. Cells may have a probability
of being unaected by the irradiation.
An improved approach would be to model the deposited radiation type and energy with
the GEANT4 toolkit, according to the current tumour morphology (see Pshenichnov et al.
(2005)). As a result of the calculated dose deposition, necrosis probabilities or other eects
(such as arrest of the cell in G2 due to severe DNA damage) could be calculated.
10.5 Results of modelling
Cell cycle arrest in G2 after irradiation
Upon irradiation cells are likely to acquire severe DNA damage as described in section 10.2.
Since cells possess multiple mechanisms which are used to assure the delity of the DNA
passed on to osprings, this DNA damage can have severe eects on a cell's cycle pro-
gression. A prominent eect of this is mediated by the G2=M-checkpoint as introduced
in section 5.1. Thus, upon the detection of damage, the cell cycle is arrested via inacti-
vation of the Cdc25 phosphatase, in order to prevent transmission of damage to daughter
cells. Repair mechanisms are activated, but as they are working the progress of the cell
from G2-phase to M-phase is prohibited. This leads to an accumulation of cells in G2
phase. This eect can be quantied with the help of cell cycle analysis tools (as done
in Bohl (2006)). As described in section 5, cells double their DNA content during S-
phase while keeping the DNA's ploidy constant. This leads to the fact that cells in G2-
and M-phase have about the double amount of DNA content compared to cells in G0 or
G1. DNA content of cells in the process of DNA duplication during S-phase lies between
these values. Experimental results of this pheonomenon are shown in gures 10.13(a) and
10.13(b). Within the experiments, glioblastoma cells cultured in vitro were exposed to 8
Gy irradiation and a DNA content analysis was performed 12 hours later for an irradiation
sample and a control sample. The cell phase distribution changed drastically in response
to the radiation treatment. Progression of damaged cells from the G2 to the M phase
was limited, therefore a shift in the cell phase distribution was observed. In normal cell
colonies the relative amount of cells within a phase resembles its relative length according
to the overall cell cycle. As observed in gure 10.13(a) the majority of cells are in G0 or
G1 phase and accordingly have single DNA content. Only about 20% of cells reside in the
G2 or M phase. After irradiation this distribution was shifted to about 62% of the cells
residing in G2 or M phase.
This process of G2-arrest is also found within the simulation of tumour irradiation.
Cells damaged by irradiation cannot pass the G2=M-checkpoint until repairs of their DNA
were successful according to the minimal irradiation model (see gure 10.12). Although
the DNA content of the cell is not quantitised within the cell implementation, statistics
comparable to the experimentally obtained results are available through the discrete cell
cycle phases of the cell agents. Upon irradiation of the full tumour volume, cells were
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(a) DNA ploidy before irradiation in vitro (b) DNA ploidy after irradiation in vitro
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Figure 10.13: (a+b): Cell cycle arrest at the G2=M-checkpoint due to DNA damage after heavy
ion irradiation, from Bohl (2006). Cells were irradiated with a dose of 8 Gy and cell cycle analysis
performed for an irradiated and a control sample after 12 hours. Amount of cells in G2=M rises
from 20% to 62% after irradiation. (c+d): Simulation results of cell cycle distribution without
and with irradiation of cells. The minimum irradiation model as described in section 10.4 was
used. Cells show a shift of the cell cycle distribution after 12 hours as in the experimental results
(a+b).
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either sent into necrosis (interphasic death) with a probability of 33%, damaged with a
probability of 62% or remained unaected with a probability of 5%. Damaged cells were
allowed 5 repair tries at the G2=M checkpoint, each possibly successful with a probability
of prep = 20%. Upon an unsuccessful repair try cells were prohibited for the length of
the G2 phase G2 to try again. Cells not repaired after 5 tries were sent into senescence
(clonogenic death) with an corresponding probability of (1   prep)5  33%.
The according results from the simulation are shown in gure 10.13(c) and 10.13(d). A
shift in the relative amount of cells residing in G2 or M from 24% to 50% is visible 12
hours after irradiation. This result corresponds to the experimental data. This agreement
suggests that it is, in general, feasible to implement radiation damage mechanisms within
an approach similar to the minimal model. Derivation of realistic probabilities for this
model from experiments which are dealing with cell cycle responses to irradiation (such
as Hanin et al. (2006)) will be the next step towards an realistic irradiation model.
Total tumour irradiation
Irradiation of the total volume is comparable to a treatment with image-guided radiation
therapy scanning-techniques. Every cell inside the tumour spheroid will be aected with
a given probability according to the mechanisms discussed in section 10.4. According
to the chosen probabilities cells will be sent into necrosis or marked as DNA-damaged,
prohibiting the passage of the G2=M-checkpoint.
Eects of treatment are best visualised within a tumour mass curve over time as depicted
in gure 10.14. Determining parameters for the irradiation are the probabilities pnec and
pdna. For the run in gure 10.14 these were set to pnec = 33% , pdna = 62% leaving
a 5% chance for cells to remain completely unaected by the treatment. As seen in the
simulation, this choice of probabilities is not suited to result in a reduction of tumour mass.
Even if the tumour growth is stalled immediately after irradiation, it resumes as soon as
the eects of the G2-arrest are overcome. Cells have a repair probability of prep = 20%
at the G2=M-checkpoint if marked as damaged according to the mechanisms described in
section 10.5.
An actual regression of tumour mass can be achieved if the parameters for the minimal
irradiation model are changed. A higher probability for interphasic death pnec = 65% is to
be used. Accordingly, the probability for DNA damage must be decreased to pdna = 35%
leaving no cell unaected by the treatment. Additionally, the repair probability can be
decreased to prep = 10%, resulting in an overall probability of cell death by DNA damage
of (1   prep)5  0:60%, or even to prep = 5% (yielding an overall probability of cell death
by DNA damage of (1   prep)5  0:77%).
Further mechanisms governing the dynamics of tumour spheroids under irradiation will
be studied within a partial irradiation model.
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Figure 10.14: Cell phase distribution in response to irradiation of the total tumour volume. De-
pending on the probabilities used in the minimal irradiation model (see section 10.4) growth stag-
nation of the tumour after irradiation can be observed. Cell cycle arrest at the G2=M-checkpoint
is visible with a peak approx. 9 hours after irradiation.
Partial tumour irradiation
The general idea of modelling the partial irradiation of tumours is to study the dynamic
eects which rise in the tumour system upon elimination of a population part.
The results of partial tumour irradiation are obtained using the minimum irradiation
model, as described in section 10.4. However, emphasis was put on interphasic death
through severe cluster damage, not on the mechanisms resulting from SSBs or DSBs.
Starting point of the irradiation simulation is a dynamic tumour spheroid which devel-
oped from a single malignant cell. Simulation can also be performed on predened tumour
spheroids, skipping the initial growth phase, as the tumour conguration can be saved in
any intermediate step. Realisation of clinical tumour cases is in principle posible on a
basis of imaging techniques providing details of the tumour composition. This, however,
assumes that suitable coarse graining mechanism are available to handle the extreme high
number of cells.
A sample run illustrating the dynamics of the tumour system is shown in gures 10.17
and 10.18. Results shown within this section are exemplary, more data is available upon
request. The absolute and relative cell phase distributions for this run are given in g-
ures 10.16 and 10.15.
Irradiation of tumour spheroids leads to a temporary increase in the amount of actively
dividing cells, visible in gure 10.15. Since the majority of the spheroid is comprised
of cells in quiescence, irradiation of a larger volume has a severe impact particularly on
the cells in G0 (compare gures 10.17(a) and 10.17(b)). However, as the quiescent cells
were not contributing to the tumour growth, eradication of a large number of them does
not have a distinctive impact on the tumour size (see gure 10.16). Instead, the sudden
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Figure 10.15: Cell cycle distribution of a tumour spheroid under partial irradiation. Notice the
sudden rise of actively proliferating cells (in interphase) upon irradiation at 4000 and 8000 minutes.
This is due to the fact that irradiation kills mostly quiescent cells and leads to a sudden rise in
nutrient availability for the remaining cells. Simulation started with 500 malignant cells - spheroid
comprises 14.000 cells at the end of simulation.
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Figure 10.16: Cell cycle distribution of a tumour spheroid under partial irradiation. Notice the
sudden rise of actively proliferating cells (synchronised in interphase) upon irradiation at 4000
and 8000 minutes. This is due to the fact that irradiation kills mostly quiescent cells and leads
to a sudden rise in nutrient availability for the remaining cells. Note also the excessive regrowth
of the tumour in response to irradiation that leads to necrosis of quiescent cells (visible within
the bumps in the according curves of necrotic and quiescent cells at the end of the \irradiation
plateau"). Simulation started with 500 malignant cells - spheroid comprises 14.000 cells at the end
of simulation.
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necrosis of cells leads to an increase in the availability of nutrients and to a decrease in
the overall pressure inside the tumour. This yields a rise in the number of cells in the
interphase, since a large number of cells are now able to pass the restriction point.
Figuratively speaking this is due to the fact that, through partial irradiation, the tumour
surface is eectively increased so that it can support a larger number of actively dividing
cells in the surface layer. In addition, the nutrient consumption is decreased due to
necrosis of irradiated cells, which leads to an overall rise in nutrient availability. A possible
channeling of nutrient diusion through the spongy tissue cannot be observed within the
simulation due to limited resolution of the diusion grid. Therefore, modelling a small test
system with superior resolution of the diusion grid is of interest for further investigations.
The re-entry of large amounts of previously quiescent cells into the cell cycle leads
to regrowth of the tumour volume (see gure 10.17(c)). As a result, reformation of a
quiescent core due to rising cell pressure is seen. Furthermore, nutrients are even depleted
inside the tumour core, what leads to the rise of necrosis in the tumour centre (visible
in gure 10.17(d)). As necrotic cells are shrinked and removed from the simulation, the
tumour reaches a state where only few cells are undergoing necrosis in the centre as
it grows on the surface (see gure 10.18(a)). Upon repeated irradiation the eect of
pressure-reduction is responsible for the re-entry of a major part of quiescent cells into the
cell cycle. The reduced pressure is visible within gure 10.18(b), with cells bleached out
according to their to their pressure (low pressure cells bleached). The second irradiation
is applied to the same position and, therefore, aects less cells due to the new tumour
shape in response to the prior irradiation. Rising pressure through the rise in mitotic
activity eventually leads to necrose in the tumour core, as observed in gures 10.18(c) and
10.18(d), as it was seen in the rst irradiation.
Throughout the corresponding growth curves (gures 10.15 and 10.16) a fast relapse
after irradiation is visible. Even though a signicant amount of cells suers interphasic
death, necrosis removal and re-growth of the tumour are balanced to keep the overall size
constant (counting necrotic, but not removed cells, as part of the total cell number).
Partial irradiation is not sucient to reduce the tumour spheroid in size. It even leads
to an excessive growth of the tumour above the threshold that is supported within the
shell of viable nutrient and pressure conditions. This relapse leads to the induction of
necrosis within the population of still quiescent cells. This eect is visible in gures 10.15
and 10.16 as a small bump in the amount of necrotic cells at the end of the \irradiation-
plateau" and the corresponding defect in the curve depicting the amount of quiescent cells
(or in the corresponding visualisation in gures 10.18(b) and 10.18(c) through the rise of a
distinct necrotic core). Another example of this re-entry eect is depicted in gure 10.19.
The relapse eects should be more pronounced with rising tumour size as the number of
quiescent cells rises drastically.
Another eect of partial irradiation is the resynchronisation of cell cycle progression.
This happens due to the passage of foremost quiesent cells at the restricition point upon
irradiation. Entry from G0 into S happens within a short timespan of G0 which corre-
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(a) t = 3100 min (b) t = 4200 min
(c) t = 4800 min (d) t = 5400 min
Figure 10.17: Visualisation of partial tumour irradiation. Relative and absolute cell phase distri-
butions for this run are given in gures 10.15 and 10.16. Figure (a) shows the tumour spheroid
with a developed quiescent core due to pressure inhibition. Upon irradiation this pressure decreases
immediately (see gure (b)), what reduces the level of quiescent cells signicantly. Formation of a
small necrotic core due to a shortage of nutrients is visible in (c). Pressure inside the spheroid is
rising again fast due to the growth of cells re-entered into the cycle. This leads to a reformation of
the quiescent layer in (d). Colour code: quiescent cells in blue, viable cells in turquoise, necrotic
cells in grey. Cells under low pressure bleached out.
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(a) t = 8000 min (b) t = 8300 min
(c) t = 8670 min (d) t = 9500 min
Figure 10.18: Visualisation of partial tumour irradiation continued from gure 10.17. Relative
and absolute cell phase distributions for this run are given in gures 10.15 and 10.16. Tumour
spheroid prior to second irradiation shown in (a). Small necrotic core and quiescent layer visible,
boundary layer of viable cells is partially bleached out in the visualisation according to their
reduced pressure (see gures 10.16 for the total number of viable cells). Irradiation in (b) leads
to a decrease in pressure and an increase in nutrient concentration, followed by an re-entry of
quiescent cells into the cycle. Shrinkage and removal of necrotic cells lead to a further decrease
in pressure on the irradiation site in (c) (visible through the bleaching of cells). Necrotic core is
forming again due to shortage of nutrients. A rise in pressure due to cell growth and mitosis leads
to the nal, largely quiescent, conguration shown in (d). Colour code: quiescent cells in blue,
viable cells in turquoise, necrotic cells in grey. Cells under low pressure bleached out.
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(a) t = 5980 min (b) t = 6040 min
(c) t = 6260 min (d) t = 7660 min
Figure 10.19: Visualisation of cell re-entry after partial tumour irradiation. A section of a fully
developed tumour spheroid shown in (a) is irradiated at 6000 minutes runtime in gure (b).
Interphasic death of cells in the irradiation volume leads to fast re-entry of cell on the outer
layer of quiescence, especially in the region of irradiation (as shown in (c)). Fast regrowth of the
tumour leads to re-entry of the cells into quiescence and to the development of a necrotic core due
to nutrient depletion in the centre (visible in (d)). Colour code: quiescent cells in blue, viable cells
in turquoise, necrotic cells in grey, cells re-entered from quiescence in red.
sponds to the responsiveness of quiescent cells to the newly rising suitable environmental
conditions. The degree of resynchronisation observed therefore depends directly on G0
and is of interest for further investigation.
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11.1 Goals achieved and signicance of the results
Within this thesis multiple goals were achieved during the process of obtaining the nal
simulation application. These comprise:
Abstraction of relevant cell characteristics The relevant properties for the modelling of
cells within the scope of this thesis were successfully abstracted, both into basic
mathematical models and into an agent-based class. The chosen implementation
is highly 
exible and can be extended to include every cell attribute of interest in
further investigations.
Realistic cell interactions Contact models such as the JKR-model were used to capture
the cell interactions, including dierential cell-cell adhesion. The interaction model
was able to reproduce cell sorting as it is observed in experiments.
Cell cycle regulation and metabolism An extendable model of the cell cycle and its reg-
ulation was implemented, together with the handling of cell nutrients in a reaction-
diusion system.
Implementation of realistic cell dynamics The forces resulting from the contact interac-
tion were integrated using adaptive stepsize algorithms allowing the simulation of
bigger cell systems in a reasonable amount of time.
Adaptive stepsize algorithms Global and local criteria were developed to ensure system
integration within given accuracy which at the same time yield a signicant improve-
ment in simulation runtime.
Development of advanced cytokinesis algorithm A sophisticated method for the han-
dling of cytokinesis was developed, which is able to model the process of cytokinesis
close to its dynamics in vivo. Articial velocities rising in regions of high mitotic
activity were thus diminished, further improving the simulation performance.
Simulation of tumour growth Spatio-temporal dynamics of tumour spheroids were mod-
elled, yielding the commonly accepted layered morphology of MCTS. Tumour Growth
curves in correspondence to experimental results could be obtained with the nal
application. Through comparison of dierent simulation models to the experimen-
tal data it was possible to draw conclusions about their level of correspondence to
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the modelled cell properties. A comparison between nutrient- and pressure-based
mechanism for contact inhibition could be performed.
Simulation of tumour irradiation First results were obtained and compared to experi-
mental visible eects (cell cycle arrest). Multiple eects in the tumour dynamics
were observed which were caused by irradiation and are of interest for further mod-
elling (resynchronisation, excessive growth).
Qualitative correspondence to experimental results was obtained, however further im-
provements to the model are eligible in order to capture the growth behaviour of larger
cell systems.
Overall the model could benet from a better combination of its implemented mecha-
nisms for cell cycle regulation in response to environmental parameters (such as nutrient
concentration or cell pressure). The question, wheter quiescence is primarily induced by
contact inhibition or nutrient scarceness, should be investigated in experiments. The ex-
perementally observed reactions of cells could be used in order to gauge the cell agents'
response within the model. In general, improvements could be achieved through extrac-
tion and itegration of more parameters from experiments. This cooperation could lead to
a synergy eect from which theory and experiment could benet likewise.
Another mechanism that needs further investigation is the modelling of cell starvation.
This, however, suers from the lack of cell nutrient uptake rates discussed in the literature.
Consumption rates are usually averaged over large cell populations, which dier in their
phase distribution, resulting in a limited usability within an agent-based implementation.
A simple experimental approach would be, to halt a cell population in distinct phases
of the cycle, e.g. through the inhibition of the corresponding cyclin dynamics, and then
measure the nutrient consumption rates associated with the according cycle phase.
Some model mechanisms which are already implemented within this thesis need an
extension, including more details of the process. This is especially the case for the minimal
irradiation model, that can just be considered a demonstration of feasibility and has to
be extended to capture the full scale of cell reactions to radiation with respect to extern
parameters (such as nutrient concentration, hypoxia). Implementation of genetic networks
for the cell agents could also benet the simulation through availability of new interaction
mechanisms, particularly for the eects of radiation on the cell.
A question which needs further attention is the handling of necrotic and apoptotic cells.
It is not clear if their removal from the simulation represents a good approximation of
the in vivo process. Removal eventually leads to the re-lling of parts of the tumour
core through an inwards drift of the surrounding cells. Even though this intermixing is
observed in other models, the process is in contradiction to the experimental nding that
tumours have a hollow core under high pressure. Further investigation of the process is
necessary to develop a more realistic model.
Although adaptive stepsize algorithms yield an immense performance increase, the sim-
ulation is still limited to low cell numbers compared to sizes of many tumours found in
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vivo. This deciency has to be overruled by the development of ecient coarse graining
mechanisms, enabling systems greater than O(6) cells to be modelled.
The model is of great applicability when cellular processes like mitosis and phase syn-
chronisation are of importance, since eects of mitosis, necrosis and apoptosis can be
modelled in detail within the agent-based approach. This distinguishes the model from a
great many of alternative models for tissue dynamics. Spatial resolution benets the mod-
elling process and extension to a combined modelling of the sub-cellular level could even
extend this advantage. Therefore, a further suitable eld for application of the system is
the modelling of processes which happen on a small scale, such as the eects of mitosis
on cell systems or even the process of mitosis itself. Within the eld of small systems the
agent-based approach is unparalleled in respect to its applicability. Inclusion of intracel-
lular dynamics or even usage of an deformable model for the cell would be possible within
these smaller systems.
Application of the model to a xed cell type (e.g. glioblastoma cells) could include
unique mechanisms and parameters in the process of tailoring the code to the cells under
consideration. However, generalisability of the code is an advantage that should not be
easily abandoned, as it opens up the possiblity to model quite dierent systems with the
application.
11.2 Further mechanisms
The developed application can be extended with various mechanisms that would lead to
a more realistic model of tumour dynamics. A rst approach would be the inclusion
of pressure repulsion, depending on the cell pressure dened in equation 7.7. Pressure
between interacting cells can be compared, yielding a repulsion force in the direction of
the pressure gradient:
Equation 11 (Pressure force)
F
pres
ij = fpres(pi   pj)eij (11.1)
fpres being a scaling factor, pi and pj the pressure on cell i and j. eij is dened by
xi xj
jxi xjj with p(i) > p(j).
Another mechanism which could be added to the cell dynamics is dierential adhesion
to the ECM. This can be implemented straightforward via a dependency of the cell-ECM
friction on e.g. the cell cycle phase. A common assumption would be to \anchor" cells in
certain phases in the ECM, restricting their motility. Intercellular shear forces could be
implemented following the approach used in Schaller (2006).
Possible mechanisms which could increase the magnitude of the cell systems which can
be modelled are of special interest. Coarse graining approaches may be implemented
based on a \core freeze-out", reducing dynamics in the necrotic and quiescent regions
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of the tumour. This is possible by making cells in long-time quiescence immovable, or
through the introduction of a force threshold for movement of those cells. The Voronoi
tessellation might oer further starting points for coarse graining. Freezing out whole
regions of low dynamic, by keeping the corresponding voronoi boundary to tissue on a
higher dynamic scale constant, could be a suitable approach.
The dynamics resulting from the modelling of cytotoxic substances from necrosis will
also be of interest as a further mechanism, adding a new layer of self-interacting dynamics
to the system. Cells surrouding necrotic regions are subject to die in an in
ammation or
due to cell lysis driven by the necrosis of their neighbours.
Furthermore, the diusion coecient should be made dependent on the spatial position
to yield a more realistic diusion of the solubles under consideration . Improvements in
the simulation of surrounding tissue will also be of great interest, particularly in respect
to the modelling of tumour invasion and metastasis.
11.3 Further investigations
The results within this thesis open up the possibility for a multitude of further investiga-
tions, including:
Invasion and metastasis Changed adhesion properties and other parameters such as syn-
chronisation of the cell cycle progression have eects on the proliferation of the
tumour. Furthermore the importance of the mechanism of tumour-ngering for in-
vasion and metastasis should be investigated (see Conde-Ramis et al. (2008)).
Interaction with surrounding tissue The eects of pressure, and the surrounding tissue in
general, on the tumour development should be studied in more detail (see Anderson
et al. (2006), Macklin and Lowengrub (2007)).
Response to unfavourable conditions The combination of mechanisms which are respon-
sible for induction of quiescence at the restriction point should be investigated. Are
nutrient conditions or pressure-mediated contact inhibition the main reason for the
rise of quiescence?
Importance of intracellular genetic networks Tumour suppressor genes (TSGs) and onco-
genes have tremendous eects on the mechanisms available within cancerous cells
(e.g. the blockage of the apoptotic pathway). With genetic networks the genetic
characteristics of each tumour cell (e.g. its p53-gene-status) could be taken into
consideration (see Zhang et al. (2007)).
Cell cycle re-synchronisation The in
uence of cell cycle re-synchronisation observed in
response to irradiation has to be determined, which is related to the responsiveness
of quiescent cells to changes in their environment. What is the general response of
the cell cycle to irradiation (see Hanin et al. (2006))?
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Relapse and excessive growth Tumour relapse upon irradiation could have eects on the
optimal treatment procedures (see Luk et al. (1986)). A possible increase of nutrient
diusion through spongy tumour tissue should also be a target of further investiga-
tion.
Parameters for radiosusceptibility Cell response to irradiation depends on parameters
such as the oxygen concentration within the tissue. The mechanisms involved should
be implemented and analysed within the model system (see Dewhirst et al. (2008)).
This list of possible further investigations is not exhaustive. Taking into account that
the layout of the developed code is, due to its generality, usable for the simulation of a
wide variety of problems, further elds of investigation could be:
Human space exploration Astronauts are subject to high doses of cosmic background ra-
diation (CBR) which involves high energy heavy ions, eventually leading to can-
cerogenesis. Shielding is partialy inecient since it generates showers of slower
carcenogenic particles. This process could be simulated with the help of GEANT4
(showering of CRB after passage through a compact shielding layer) with the aim
of minimising the risk of cancer.
Acidity in tumour surroundings The cell metabolism is partialy variable due to the posi-
bility of anaerobic combustion. This however may lead to the rise of a self-generated
acidic surrounding of the tumour. Such a change in the environment will have eects
on benigm tissue next to the tumour.
Eects of irradiation on the mitochondrial DNA (mtDNA) Damage to the mitochon-
drial DNA might have grave eects on the cell metabolism. This eects could open
up new approaches to improve the eciency of therapeutic irradiation.
Interaction with the immune system The complex interplay between the tumour and
the immune system was neglected so far. However, the immune system might provide
possible mechanisms for the tumour's destruction. Immuno-agents and the according
interaction with cancerous cells could be integrated into the simulation.
Possible role for cancer stem cells The question whether or not cancer is a regulatory
stem cell disease remains a hot topic in the scientic community. Malignant stem
cells might play an important role in the development and treatment of cancer.
Agent-based models can investigate the eect of a limited stem cell pool on the
growth and treatment of the tumour.
Tumour vascularisation Attachment of the tumour to the blood and lymph system is a
key in advanced tumour growth and metastasis. The induction of vascularisation
through e.g. the VGEF-generation of tumour cells could be investigatied within the
model.
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Furthermore, the modelling of other tumour treatment approaches such as virotherapy
or immunotherapy is feasible within the developed application. An interesting eld might
also be the modelling of combined therapies for cancer, provided the mechanism for both
therapies are well understood within the model.
11.4 Onwards to irradiation modelling
Statistically, one person in two will get cancer throughout its life and one person in ve
will eventually die of cancer (see Jemal et al. (2007)). About half of all cancer patients
receive radiation therapy at some point as a part of their treatment, with the cancer being
curable in about half of these patients.
Therefore, radiation therapy (especially with heavy ions) should be the main target of
further investigations, as any improvement to radiotherapy, even a small contribution, will
benet a great many people.
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Abbreviations and technical terms used within this thesis (not exhaustive)
MCTS multicellular tumour spheroid
senecent cell terminally in quiescence
quiescent cell removed from the active cell cycle in a phase of \stasis"
oncogene gene which can cause cancer upon deragulation
TSG tumour suppressor gene
linac linear accelerator
CT computed tomography
MRI magnetic resonance imaging
PET positron emission tomography
XRT external radiation therapy
BEV beam's eye view
MLC multileaf collimator
3DCRT 3-Dimensional Conformal Radiotherapy
IMRT Intensity-Modulated Radiation Therapy
IGRT image-guided radiation therapy
ROS reactive oxygen species
DNA deoxyribonucleic acid
CDK cyclin-dependent kinase
CDKC cyclin-dependent kinase complex
MPF mitosis promoting factor
TNF tumour necrosis factor
TNFR TNF receptor
CAC Citric acid cycle
ATP Adenosine triphosphate
ER Endoplasmatic reticulum
ODE ordinary dierential equation
PDE partial dierential equation
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Mathematical model of tumour growth with the Gompertz
function
The Gompertz function is a sigmoid function, where growth is slowest at the start and
end of a time period. It can be used to model the growth of populations under bounded
resources and has the typical form:
y(t) = aebect
(11.2)
where a is the upper asymptote, c is the growth rate, b, c are negative numbers, e is the
Euler's Number. As its description suggests the Gompertz curve can be used to model
the growth of tumours which was done rst by A.K. Laird (see Laird (1964)).
Interestingly, the Gompertz model ts the growth processes of many populations, indi-
viduals, and even the growth of many avascular tumours remarkably well (see Araujo and
McElwain (2004)).
Denoting the tumor size as X(t) the Gompertz function can be written as:
Equation 12 (Gompertz equation)
X(t) = K exp

log

X(0)
K

exp( t)

(11.3)
with X(0) beeing the tumor size at the starting observation time, K is the carrying
capacity,  is a constant related to the proliferative ability of the cells.
K denotes the maximum size that can be reached with the available nutrients. In fact it
is:
lim
t!+1
X(t) = K (11.4)
independently on X(0)  0. Note that, in absence of therapies, it is usually X(0)  K,
whereas, in presence of therapies, it may be X(0)  K.
Even if mathematical modelling of growth curves is possible with certain success this
does not enable the researcher to gain information about the spatial position of certain
cells in the tumour. It remains a phenomenological approach to the problem under con-
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sideration. There is a variety of processes inside of growing tumour which may only be
captured correctly within an agent-based modelling approach.
Compton scattering
Compton scattering or the Compton eect is the decrease in energy (increase in wave-
length) of an X-ray or gamma ray photon, when it interacts with matter. Inverse Comp-
ton scattering also exists, where the photon gains energy (decreasing in wavelength) upon
interaction with matter. The amount the wavelength increases by is called the Compton
shift.
The interaction between electrons and high energy photons results in the electron being
given part of the energy (making it recoil), and a photon containing the remaining energy
being emitted in a dierent direction from the original, so that the overall momentum of
the system is conserved.
Equation 13 (Compton scattering equation)
0    =
h
mec
(1   cos) (11.5)
where  is the wavelength of the photon before scattering, 0 is the wavelength of the
photon after scattering, me is the mass of the electron,  is the angle by which the
photon's heading changes, h is Planck's constant, and c is the speed of light.
h
mec = 2:43  10 12 m is known as the Compton wavelength.
Amdahl's law
Amdahl's law, also known as Amdahl's argument, is named after computer architect Gene
Amdahl, and is used to nd the maximum expected improvement to an overall system
when only part of the system is improved. It is often used in parallel computing to predict
the theoretical maximum speedup using multiple processors.
In the case of parallelisation, Amdahl's law states that if P is the proportion of a
program that can be made parallel (i.e. benet from parallelization), and (1   P) is the
proportion that cannot be parallelized (remains serial), then the maximum speedup that
can be achieved by using N processors is
Denition 18 (Amdahl's law)
1
(1   P) + P
N
(11.6)
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In the limit, as N tends to innity, the maximum speedup tends to 1
(1 P). In practice,
performance per price falls rapidly as N is increased once there is even a small component
of (1   P).
As an example, if P is 90%, then (1   P) is 10%, and the problem can be sped up by
a maximum of a factor of 10, no matter how large the value of N used. For this reason,
parallel computing is only useful for either small numbers of processors, or problems with
very high values of P: so-called embarrassingly parallel problems. A great part of the craft
of parallel programming consists of attempting to reduce (1   P) to the smallest possible
value.
Triangulation of a vertex system and local interaction of according cell-agents is a good
example of an embarrassingly parallel problem and can therefore benet greatly from
parallelisation
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